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ABSTRACT
Fetal gonadal development is a complex process dependent on maturation and
differentiation of several cell types with different functions. Adequate development
is important for normal sexual development and fertility potential. However, to date
the factors that are involved in the regulation of gonadal growth and differentiation
are not well understood. The aim of this thesis was to investigate the role of survival
and proliferative factors, namely the c-kit proto-oncogene receptor and ligand and
the family of neurotrophins in human gonadal development during mid-trimester.
The involvement of metalloproteinases (MMPs) and their inhibitors (TIMPs) in
tissue remodelling in both human fetal testes and ovaries was also considered.
C-kit and its ligand have been demonstrated to be essential to the processes of germ
cell migration, proliferation and survival in the rodent and their expression was
investigated in human fetal gonads. Expression of c-kit mRNA and the protein was
demonstrated in both ovary and testis throughout mid-trimester. Testicular germ cell-
specific expression of c-kit mRNA was confirmed using laser capture microscopy
and c-kit protein was localised to the germ cells in both ovaries and testes. These
data demonstrate that the expression of c-kit mRNA and protein is germ cell specific
in human fetal gonads and are consistent with an important role for the c-kit/kit
ligand signalling system in germ cell proliferation and survival in the developing
human gonad.
Neurotrophins are survival and differentiation factors in the nervous system. The
presence of neurotrophins and their receptors and their role in germ cell survival was
investigated in the human fetal gonads. Expression and localisation of neurotrophins
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and their receptors was detected throughout mid-trimester in both ovaries and testes.
The effects of the tyrosine kinase receptor inhibitor K252a were studied in organ
cultures. In the ovary, treatment with K252a resulted in a significant fall in germ cell
number and proliferation. In the testis, cell-specific marked decrease in both
gonocyte and peritubular cell number and proliferation was seen after treatment with
K252a, with little effect on Sertoli cells. These findings therefore demonstrate the
expression of neurotrophins and their receptors in human fetal gonads during the
second trimester and indicate possible roles in the regulation of proliferation/survival
of germ cells and peritubular cells.
MMPs and TIMPs are major regulators of tissue remodelling of the extracellular
matrix (ECM) and may also be involved in the control of growth factor availability.
Their production and localisation was investigated in the human fetal gonad. Tissue
was collected and analysed for the presence of MMP-2 and -9 and for TIMP
activities using zymographic techniques. These MMPs and in addition, MMP-I and
TIMPs were localised using immunohistochemistry. The secretion of MMP-2, -9 and
all four TIMPs was demonstrated from both testis and ovary, the predominant
gelatinase produced being MMP-2. In both gonads, MMP-I, -2, -9 and all TIMP
family members were localised to specific cell types. This therefore indicates that
MMPs and TIMPs are likely to play a role in ECM remodelling during fetal gonadal
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1.1 HUMAN GONADAL PROLIFERATION AND DEVELOPMENT
Although germ cells are not essential for the survival of the body they hold the key to
the life cycle and the survival of mankind. The foundation for normal puberty and
adult reproductive function is established during fetal life. The increasing
identification of factors that regulate gonadal paracrine and autocrine function, as
well as the emerging application of molecular biological techniques, have provided
new insight into rodent and larger mammalian fetal growth and development.
However, relatively little is known about the processes regulating fetal gonadal
development in the human.
It is vitally important that the mechanisms involved in the development of the gonad
during fetal life are better understood. Until this is achieved, therapeutic options
available to treat pathological conditions such as premature ovarian failure and
methods designed to promote germ cell development in vitro will remain sub-
optimal.
The ensuing literature review will initially cover the development of the indifferent
gonad and then specifically the ovary and the testis. The factors which are likely
involved in the regulation of this development will then be considered.
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1.2 MAMMALIAN GONADAL DEVELOPMENT - INDIFFERENT
STAGE
Gonadal life begins in the human embryo with the differentiation of primordial germ
cells (PGC) in 4.5-day old blastocysts. At this time the embryo lacks any specific
gonadal structures, but the ultimate development of a female or male gonad is
predetermined by its chromosomal sex. The PGC start their amoeboid migration
(Fujimoto et al 1977; Witschi E 1948) from the endoderm of the yolk sac through the
gut endoderm and into the mesoderm of the mesentery to the coelomic epithelium of
the urogenital ridge. By 5 to 6 weeks of gestation, the indifferent gonad is composed
of PGC, supporting cells of the coelomic epithelium and the mesenchyme of the
gonadal ridge. The future sexual development of the gonads is indistinguishable at
this stage.
1.21 MATERNAL GONADOTROPH INS AND THE EFFECT ON FETAL
GONADAL DEVELOPMENT
Human chorionic gonadotrophic hormone (hCG) is secreted by the fertilized ovum
from the blastocyst stage and is later secreted by the syncytiotrophoblast of the
placenta. It stimulates oestrogen and progesterone production and peaks and 8-10
weeks of gestation, falling after this and plateauing at 18-20 weeks of gestation. hCG
is responsible for sex differentiation in the male fetus by stimulating the Leydig cells
to produce testosterone and initiating development of male secondary sexual
characteristics. The fetal pituitary does not start to secrete LH until after the 12th
week and it is responsible for the later development of male secondary sexual
characteristics. In early pregnancy, oestrogen is mainly produced in the corpus
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luteum and these levels reach a maximum by 10 weeks. From 6 weeks maternal and
fetal androgens are converted into oestradiol and oestrone by the placenta. The fetal
adrenals develop very early in pregnancy and undergo remakable growth, becoming
the main source of oestrogens in later pregnancy as maternal serum oestrogens rise
progressively throughout the pregnancy. By 20 weeks, the fetal hypophyseal-portal
system is fully developed and the fetal adrenals become progressively under control
of the prolactin and adrenocorticotrophic hormone (ACTH) secreted by the fetal
pituitary. Because of high maternal oestrogen and progesterone levels, follicle
stimulating hormone (FSH) and luteinising hormone (LFI) are suppressed.
Progesterone levels progressively increase as pregnancy advances, first being
fU
produced by the corpus luteum until the 10 week and then by the placenta. It is
regarded as the dominant pregnancy hormone as its levels are 10 times that of
oestrogen (Edmonds DK 1995).
In sheep, a transient period of steroid synthesis occurs in the fetal ovary between
days 35-55 of gestation and this broadly coincides with the onset of meiosis in the
germ cells (Mauleon P 1977). The ontogeny of fetal hypothalamic function has been
studied in sheep, demonstrating that LH secretion is essential for normal
development of the testis and there is a critical window for this in late pregnancy
(Brooks AN et al 1996; Brooks et al 1995). There is little data on the effect of serum
gonadotrophins on ovarian development but these investigators have shown that
GnRH positively regulates the synthesis and secretion of gonadotrophins in the fetus
and that reduced fetal gonadotrophic support during the last half of gestation results
in a reduction in testicular growth but has no effect on ovarian development (Thomas
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et al 1994). Enviromental oestrogens have also been suggested to be detrimental to
fetal testis development, resulting in a reduction in testicular size and in the number
of Sertoli cells (Sharpe et al 1998).
1.22 HUMAN FETAL TESTICULAR DEVELOPMENT
Gonadal differentiation into a testis is controlled by a multitude of genes beginning
with Sry, located on the Y chromosome, which is believed to represent the testis
determining factor (Berta et al 1990). Sry is active for a brief period in the genital
ridge in order to initiate Sertoli cell differentiation and triggers a cascade of gene
activity, acting on Sox9, steroidogenic factor-1 (SF-1) and the dosage-sensitive sex
reversal-adrenal hypoplasia congenita critical region on the X chromosome (DAX-1)
(Ramkissoon et al 1996; Wagner et al 1994). Sox9 is up-regulated by Sry and is a
testis specific Sertoli cell transcription factor (Kent et al 1996; Morais et al 1996).
SF-1, a member of the nuclear hormone receptor superfamily plays a critical role in
gonad morphogenesis and transcriptional activation of several relevant genes,
including Sox9, anti-Mullerian hormone (AMH) and DAX-1 (Lovell-Badge et al
2002). DAX-1 has an antagonistic effect on Sertoli cell differentiation and is down-
regulated as testes develop whereas it continues throughout ovarian development
(Swain et al 1996; Swain et al 1998).
Following migration of PGCs from the yolk sac to the nephrogonadoblastic ridge, the
first sign of testicular differentiation is the appearance of testicular cords consisting
of PGCs enclosed by Sertoli cells (Byskov 1986). In the human, this is initiated at 6-
7 weeks gestation and continues for several weeks. The Sertoli cells have an
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important paracrine (secretion of AMH) and endocrine (secretion of inhibin) function
as well as inhibiting the onset of meiosis of the spermatogonia. The Leydig cells
secrete testosterone, causing differentiation and growth of the Wolffian duct
structures (Boehmer et al 1999). AMH is a glycoprotein produced by the fetal Sertoli
cells. Its primary role in sex development is to cause a gradient of cranial to caudal
regression of Miillerian ducts at 8-10 weeks of gestation in the human (Durlinger et
al 2002).
Dihydrotestosterone, created by the metabolism of testosterone, causes growth of the
prostate and phallus and fusion of the labiosacral folds (Thigpen et al 1993) (Wilson
et al 1993).
Unlike their counterparts in the developing ovary, male germ cells do not start
meiotic division until puberty, and the germ cells (termed gonocytes or
prespermatogonia) continue mitotic division until approximately 22 weeks gestation
(Hilscher 1991).
Steroid secreting Leydig cells appear in the interstitium at a gestational age of 8
weeks (Black V.H. 1969). They are intermingled with mesenchymal cells and small
capillaries. Shortly after their appearance, androgen concentrations rise and reach a
maximum at 15 - 18 weeks (George et al 1978; Skinner 1991). This corresponds
with a peak in Leydig cell number which then declines and by term very few Leydig
cells are seen (Niemi M 1967). The pattern of Leydig cell development parallels
closely with fetal hCG levels during pregnancy and suggests a regulatory role for this
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hormone (Pelliniem LJ 1969). Mesonephros-derived cells also contribute to the
peritubular myoid cell population which form a layer of cells around the basement
membrane of the cords (Buehr et al 1993). Around the time of Leydig cell
proliferation, there is increased expression of steroidogenic enzymes (particularly
3(3-hydroxysteroid dehydrogenase and P450 17a-hydroxylase/C17-20-lyase) and
expression of the androgen receptor (AR) in the peritubular myoid cells (Murray et al
2000). The migration of the testis from the lower pole of the kidney on the
abdominal wall is a two-stage process of transabdominal migration and inguino-
scrotal descent (Hutson J.M. 1992). The gubernaculum in the male contracts,
thickens and develops a bulbar outgrowth which, with regression of the cranial
suspensory ligaments, results in the testis located in the lower abdomen by the
internal inguinal ring. Inguino-scrotal descent is androgen dependent and insulin-like
factor 3 has also been implicated (Bernstein et al 1988; Lim et al 2001; Tomboc et al
2000).
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1.23 HUMAN FETAL OVARIAN DEVELOPMENT
In the human the indifferent gonadal stage persists longer in the female than in the
male. In the absence of the male sex determining gene Sry, Sertoli cell
differentiation does not occur. Rather germ cells migrating into the primordial gonad
differentiate as oogonia and cells derived from the mesonephros differentiate into
stromal cells, some of these eventually becoming granulosa cells. In the absence of
secretion of AMH by Sertoli cells and testosterone by Leydig cells, the Mullerian
ducts differentiate and grow as female internal genitalia and the external genitalia are
feminized. Between 7 and 9 weeks, primitive germ cells, most of which are oogonia,
are scattered throughout the ovarian tissue and divide mitotically. Cytoplasmic
cleavage may be incomplete and results in daughter cells sometimes remaining
linked by cytoplasmic bridges allowing the transfer of macromolecules and
cytoplasmic organelles (Pepling et al 1999). 'Nests' of syncytial germ cells tend to
develop until associations break down at meiosis. These germ cell nests are
interspersed with cell streams of somatic cells originating from the mesonephros
(McNatty et al 2000). Meiosis begins in the human fetal ovary around 11-12 weeks
gestation (Gondos et al 1971; Gondos et al 1986). The leptolene stage begins around
8 to 11 weeks (Baker 1963; Baker et al 1974; Gapienko 1975) and the maximum
number of oocytes in this stage can be seen at 14-26 weeks (Kurilo 1981)
amounting to approximately 2% of all germ cells (Baker 1963; Kurilo 1981).
Oocytes enter the zygotene stage of meiosis between 10.5 and 12 weeks of gestation
(Baker 1963) (Kurilo 1981)and cells at this stage subsequently become abundant.
The maximum number of oocytes at zygotene occurs after 16 weeks of development
and near term their amount does not exceed 5% (Kurilo 1981). Pachytene, the stage
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during which pairing of chromosomal homologues takes place (Baker 1963; Kurilo
1981; Speed 1985), initially occurs between the 10.5-14 weeks of fetal life. There is
some discrepancy over the timing of cells passing into the diplotene stage. Baker
(Baker 1963) first found cells at this stage at 16 weeks, with cell numbers reaching a
peak at 19 weeks of gestation. However a more recent study detected cells in
diplotene 3^1 weeks earlier (Kurilo 1981). The oocyte is suspended in the diplotene
stage of prophase until resumption of meiosis later in reproductive life.
It is at the diplotene stage that genetic recombination occurs and in 1968, Henderson
and Edwards (Henderson et al 1968) proposed a link between recombination and
non-disjunction, suggesting that declining levels of recombination were the cause of
the maternal age effect on trisomy. Their model, the so-called 'production line'
hypothesis of maternal age non-dysjunction, suggested that meiotic chromosomes of
older women were held together by fewer chiasmata, and that consequently the
chromosomes were more likely to nondisjoin at meiosis I. It was not until the 1980s
when DNA polymorphism analysis arrived that it became possible to test this
hypothesis and it is now clear that this model cannot explain the maternal age effect
on human trisomy. However, it seems that their major premise was correct, i.e. that
alterations in recombination are an important determinant of human trisomy.
Three distinct waves of atresia occur in the human fetal ovary, affecting (1) oogonia
undergoing mitosis (atretic divisions), (2) oocytes largely at the pachytene stage ('Z'
cells), and (3) oocytes at the diplotene stage. The number of germ cells rises steadily
from 600 000 at 8 weeks of gestation and peaks at approximately 7 million at 16-20
25
weeks (Baker 1963) with a subsequent reduction to about 2 million cells at term
(Figure 1.1).
The primary oocytes at diplotene stage and some argue also the pachytene stage
(Ohno 1962; Ohno 1961) become associated with stromal cells, the precursors of
granulosa cells and form primordial follicles. The first of these are seen at around 16-
21 weeks gestation (Baker et al 1974; Konishi et al 1986), although some report
follicles as early as 11.5-12 weeks (Kurilo 1981). Preantral follicles develop around
24 weeks gestation and antral follicles can be found in ovaries near term or in the
neonate (Peters et al 1978). However, such follicles are rarely observed and
constitute an insignificant portion (0.1-0.5%) of the total number of oocytes in the
follicles. Some of the disparity in the gestations at which these stages of oocyte
development are observed may be due to researchers variously using the date of the
last menstrual period or the date post coitum.
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Total germ cells in human fetal ovaries
1 2 3 4 5 6 7
gestational age (months)
Figure 1.1 Graph showing numbers of germ cells in human ovaries throughout fetal
life (based on figure from (Baker 1963).
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The interstitial cells of the ovary appear to reach their maximal numbers at around 18
weeks and thereafter decline in number. Since ovarian interstitial cells are not
associated with the developing follicles, they appear to be distinct from thecal cells.
It is only in the latter stages of pregnancy that theca cells with steroidogenic potential
are found surrounding the developing follicles (Gondos et al 1971; Guraya 1977). In
the human ovary, folliculogenesis appears to be independent of gonadotrophins, as
little or no steroid synthesis can be detected prior to this process (Payne et al 1971).
The aromatizing system appears to function as early as the 8th week but the ovary is
incapable of synthesizing steroids de novo (Bloch 1974; Noumora 1966).
It is clear that many factors are involved in the normal progression of the germ cell
lineage during gonadogenesis. From the initial step of migration of the PGCs to the
urogenital ridge there is activation of various pathways, such as bone morphogenetic
proteins (BMPs), the c-kit receptor and its ligand and Bcl-x (a cell survival factor)
and Bax (a cell death factor) (Kierszenbaum et al 2001). Once the PGCs have
colonized the developing gonad, an immense amount of tissue remodelling occurs,
along with PGC proliferation, differentiation and apoptosis. An array of proliferative
and apoptotic factors are implicated in these processes in the mammalian gonad. The
ensuing paragraphs will discuss in detail: (1) the structure and function of the c-kit
receptor and ligand and its role in cell migration, proliferation and survival; (2)
extracellular matrix (ECM) cleavage and remodelling under the influence of matrix
metalloproteinases (MMPs) and their inhibitors (TIMPs); (3) the structure of
neurotrophins and their receptors and their participation in cell differentiation,
migration, proliferation, and survival in neuronal and non neuronal tissue; (4) K252a,
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a compound known to inhibit the actions of neurotrophic growth factor (NGF) and
other neurotrophins; (5) fibroblastic growth factors (FGFs), a family of mitogenic
factors which act via tyrosine kinase receptors and appear not to be inhibited by
K252a.
1.3 C-KIT
The tyrosine kinase receptor C-kit and its ligand have previously been demonstrated
in rodents to affect the proliferation, migration and survival of germ cells,
melanocytes and haematopoietic progenitor cells during embryogenesis and adult
life. Both receptor and ligand are encoded at the White spotting (IV) and Steel (SI)
loci respectively (Chabot et al 1988; Copeland et al 1990; Geissler et al 1988; Nocka
et al 1990; Zsebo et al 1990). In homozygous mice most mutations are lethal, and
those surviving are generally sterile (Russell 1979). In SI/SI homozygotes, it is
evident PGCs have not migrated from the hindgut to the gonadal ridge. In W/W
homozygous mice, some migration does occur (Loveland et al 1997).
C-kit is predominantly expressed by germ cells in the rodent testis although it has
also been suggested to be expressed by Leydig cells (Manova et al 1990), whereas kit
ligand (KL; also known as stem cell factor (SCF), mast cell growth factor (MGF) and
steel factor (SLF)) is expressed by a wider range of cell types. The presence of a
functional c-kit receptor has been implicated in spermatogonial proliferation,
survival and adhesion to Sertoli cells (Loveland et al 1997). Monoclonal antibodies
have been used to block the effect of c-kit and K1 in the postnatal testis ofgenetically
normal mice. This resulted in disruption of the proliferation of Type A
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spermatogonia, hence indicating that c-kit is involved in mitotic activity of germ
cells (Tajima et al 1994; Yoshinaga et al 1991). The expression of C-kit by
pachytene spermatocytes has been demonstrated and it has been proposed that the C-
kit/Kl interaction is also essential for meiosis (Vincent et al 1998). Consistent with
the suggestion that signalling via C-KIT is important in normal male germ cell
development and function, alterations in C-K1T/KL expression have also been
demonstrated in some patients with defective spermatogenesis (Mauduit et al 1999),
with reduced expression associated with increased germ cell apoptosis.
Messenger RNA encoding C-kit and Kl has been detected in fetal mouse ovaries
between embryonic days 8 and 14.5 consistent with a role in germ cell migration and
proliferation (reviewed by (Driancourt et al 2000). Functional effects of Kl/C-kit in
the ovary may persist into adult life, for example in the regulation of persistence of
meiotic arrest (Horie et al 1991) (Ismail et al 1997)and activation of primordial
follicle growth (Parrott et al 1999; Yoshida et al 1997). In mouse mutants, some SI
mutant phenotypes display reduced follicle numbers and fail to initiate follicular
growth from the primordial follicle stage (Driancourt et al 2000). Several steps of
folliculogenesis also appear to have graded requirements for C-kit and Kl. A limited
reduction in amounts of Kl seen in heterozygous mice results in alterations in oocyte
growth, granulosa cell proliferation in preantral follicles and in antrum formation
(Reynaud et al 2001).
C-kit is a receptor glycoprotein in the platelet - derived growth factor receptor family
with tyrosine kinase activity encoded in a split kinase domain. In humans, the C-KIT
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gene on the proximal arm of chromosome 4 covers 20 kb and is comprised of 21
exons (Giebel et al 1992; Vandenbark et al 1992). Mutations at the IT locus have
been described and include large deletions, point mutations and rearrangements.
These can alter the amount of C-kit protein expressed and the level of kinase activity
(Dubreuil et al 1990; Nocka et al 1989). The ligand appears to interact with the C-kit
receptor as a dimer and the subsequent dimerisation of C-kit results in
autophosphorylation of the C-kit subunits to affect signal transduction (Blume-
Jensen et al 1991; Lev et al 1992; Reith et al 1991). Autophosphorylation of C-kit
activates intracellular signaling pathways that can affect cell proliferation, survival
and adhesion.
The ligand for C-kit is an integral membrane glycoprotein encoded at the SI locus
(Anderson et al 1990; Copeland et al 1990; Flanagan et al 1990; Martin et al 1990;
Nocka et al 1990; Zsebo et al 1990). KL is encoded by nine exons in the human
(Martin et al 1990). Two different forms of Kl mRNA exist, one including and one
excluding exon 6, and these show tissue specific patterns of expression (Huang et al
1992). The cleavage of the extracellular portion of the growth factor can produce a
soluble form of the ligand, incorporating exon 6, while the form lacking this exon
can be cleaved at other sites at a slower rate (Huang et al 1992). The soluble (sKl)
and membrane-bound (mKl) forms have different effects on c-kit in target cells.
After ligand binding, signal transduction cascades are initiated by the stimulation of
receptor autophosphorylation (Ullrich et al 1990). In the case of sKl, tyrosine
phosphorylation of C-kit is rapid, followed by a decline in phosphorylation. This
decline in phosphorylation coincides with receptor internalization and endocytosis,
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(Gommerman et al 1997) leading ultimately to receptor degradation. In contrast,
phosphorylation of c-kit by mKl persists over much longer periods (Miyazawa et al
1995). This persistence in tyrosine phosphorylation is attributed to the enhanced
stability of the C-kit receptor on the cell surface after mKl stimulation, likely to be
due to prevention of receptor internalization by this form of ligand. In the mouse
testis at birth, mKl is predominant in early development, but sKl is prevalent in the
adult (Manova et al 1990). Both forms produced by Sertoli cells could interact with
the C-kit receptor on spermatogonia, while the soluble form could potentially reach
distal targets such as c-kit on Leydig cells.
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1.4 MATRIX METALLOPROTE1NASES AND TISSUE INHIBITORS OF
METALLOPROTEINASES
Within gonadal tissue, the extra cellular matrix (ECM) provides the scaffolding
which cells attach to and also by binding to specific cell surface receptors modulate
their activity. Remodelling of the ECM may play an integral role in fetal gonadal
development, including cell migration and organisation. Matrix metalloproteinases
(MMPs), so called because of their dependence on metal ions for catalytic activity,
are a family of enzymes that are primarily responsible for the cleavage of
components of ECM, both interstitial matrix and basement membrane. They can be
categorized, in relation to their specificity for the ECM and location, into subgroups
such as collagenases, gelatinases, stromelysins, membrane-type MMPs and a
miscellaneous group. In total, seventeen MMPs have been characterized (see Table
1.1).
MMPs have been identified in the rat ovary and are known to be produced by various
cell types (Bagavandoss 1998). Specific inhibitors of MMPs (TIMPs) have also been
found in gonadal tissue (Curry, Jr. et al 1990) and these not only inhibit MMPs but
also promote proliferation of various cell types (Edwards et al 1996a).
MMPs are zinc dependent metallopeptidases, secreted as latent soluble or membrane
bound forms. These inactive proMMPs or zymogens, are activated by proteolytic
cleavage to give the active enzyme (Hulboy et al 1997). At the amino terminus is the
'pre' domain, which signals for cellular export. Cleavage and removal of the 'pro'
domain which is adjacent to the 'pre' domain converts the proMMPs to the active
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enzyme. A variety of activators have been described, such as other MMPs including
membrane bound MMPs (Foresta et al 1997), serine proteases (plasminogen
activator and kallikreins) (Espey L 1992) and mast cell proteases (Suzuki et al 1995)
and these convert proMMPs to the active enzyme. The disengagement of a cysteine
residue (cysteine switch mechanism) in the pro domain sequence PRCGVPDV is the
key mechanism in pro domain cleavage. This reveals a zinc ion which is held in
position by binding to 3 histidines in the active site (amino acid sequence
HEXGHXXGXXHS) in the adjacent catalytic domain. It is the binding of water to
the zinc ion in the active site that completes the MMP activation. MMP-2 is
refractory to activation by serine proteinases and is instead activated at the cell
surface through a unique multistep pathway involving MT-MMPs and TIMP-2
(Strongin et al 1995).
All MMPs except MMP-7 possess other regions that bestow diversity when they
associate with the ECM or substrate. Fibronectin domains (MMP-2 and MMP-9)
facilitate gelatin binding, haemopexin-like domains (all MMPs) allow association to
the ECM and MMP inhibitors (Baragi et al 1994), Mt-MMPs contain a
transmembrane domain that localizes the enzyme to the plasma membrane and Mt-
MMPs and MMP-11 possess a region which binds furins, which are protein-
processing enzymes.
Expression of pro-MMP genes is subject to control during transcription, translation,
by changes in mRNA stability, at the activation of the pro-enzymes by proteolytic
cleavage and by the association and dissociation of MMPs with their specific
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inhibitors. MMP release can be stimulated by cytokines (interleukin-1 (IL-1), tumour
necrosis factor a (TNF-a) and interleukin-6 (IL-6), ECM components, MMPs,
lipopolysaccharides (LPS), nitric oxide and PGE2 and inhibited by secretory
leucocyte protease inhibitor (SLPI), cytokines (interleukin-4 (IL-4), interleukin-10
(IL-10), tumour necrosis factor P (TNF-P) and interferon y (IFN-y), oestrogen and
progesterone (Hulboy et al 1997).
The principal inhibitors of MMP function are the liver derived, serum borne a2-
macroglobulin and the natural inhibitors, the tissue inhibitors of metalloproteinases
(TIMPs) (Hulboy et al 1997). TIMPS consist of two domains linked by disulphide
bonds. The TIMPs bind to each MMP using non-covalent 1:1 stoichiometric binding
to their active site. To date, four TIMPs have been identified (Table 1.2) and they do
not appear to be selective among the MMPs they act upon.
Although MMPs can cleave virtually all structural ECM molecules, they can also
potentially influence cell behaviour by cleaving cell-cell adhesion proteins, by
cleaving cell surface molecules that transduce signals, or by releasing bioactive cell
surface molecules (Sternlicht et al 2001). For example MMP-3 and MMP-7 cleave
the adherens junction protein E-cadherin and the soluble fragment which is released
disrupts cell aggregation and promotes cell invasion via a paracrine mechanism
separate from cleavage itself (Lochter et al 1997; Noe et al 2001). The disruption of
the matrix can induce apoptosis in cells anchored in the ECM. Therefore, in the case
of normal physiological cell death such as involution of the mammary gland, MMPs
can play a role (Alexander et al 1996). Another potential function of MMPs is in the
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regulation of paracrine signaling and in breaking down non-matrix proteins
(Sternlicht et al 2001). MMP-2, -7, -9, and -12 are capable of cleaving plasminogen
to generate angiogenesis inhibitor angiostatin, thereby generating a breakdown
product with an entirely new biological function (O'Reilly et al 1999; Patterson et al
1997). The expression of MMPs can be induced by many factors including growth
factors, cytokines, chemical agents, physical stress and oncogenic cellular
transformation. This enhanced MMP expression may in turn be down-regulated by
suppressive factors such as transforming growth factor (3 (TGF P), retinoic acids and
glucocorticoids (Nagase et al 1999). Certain signaling pathways can lead to
expression of a particular MMP gene. Ultraviolet B irradiation can up-regulate
MMP-1, MMP-3 and MMP-9 expression in human dermal fibroblasts by stimulating
ERK, JNK and p38 MAP kinase pathways (Brenneisen et al 1998; Fisher et al 1996).
TIMPs are also multifunctional proteins, inhibiting cell invasion in vitro, tumour cell
growth, metastasis in vivo and angiogenesis (Gomez et al 1997). However, they
exhibit additional biological functions. TIMP-1 and TIMP-2 have mitogenic
activities on several cell types, but an over expression of these inhibitors reduces
tumour cell growth (Gomez et al 1997). TIMP-3 has been shown to induce apoptosis
of human colon carcinoma cells (Smith et al 1997) and TIMP-2 inhibits basic
fibroblast growth factor-induced human endothelial cell growth (Murphy et al 1993).
These varied biological activities of TIMPs are independent of MMP-inhibitory
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TIMP-1 28 000 Glycosylated Soluble in ECM and
body fluids
TIMP-2 21 000 Not glycosylated Soluble in ECM and
body fluids
TIMP-3 24 000 Not glycosylated Bound to ECM
TIMP-4 22 000 ? ?
Table 1.2 Tissue inhibitors of matrix metalloproteinases - nomenclature and
substrate specificity
1.5 NEUROTROPHIC
The neurotrophins are a family of related neurotrophic factors which are critical in
mediating the differentiation, migration, proliferation, and survival of neurons in the
developing brain and peripheral nervous system (Davies 1994; Henderson et al 1993;
Snider 1994). In addition, there is accumulating evidence for non-neuronal roles of
the neurotrophins, particularly in mesenchymal-epithelial interactions (Brill et al
1995; Dissen et al 1995; Mitsiadis et al 1995; Ojeda et al 1992; Sariola et al 1991;
Wheeler et al 1992; Yaar et al 1991).
The neurotrophin hypothesis states that the survival of developing neurons depends
on the supply of a neurotrophic factor that is synthesised in limiting amounts in their
target fields (Levi-Montalcini et al 1968; Thoenen et al 1980). Neurotrophin
synthesis commences in the peripheral target fields of sensory and sympathetic
neurons with the arrival of the earliest axons (Davies 1987; Korsching et al 1988).
When neuronal death occurs in the sensory ganglia, the level of neurotrophin present
is proportional to the final innervation density; high levels in future densely
innervated areas and low levels in future sparsely innervated areas (Harper et al
1990). After uptake by sensory and sympathetic fibres in their target fields,
neurotrophins are conveyed by fast axonal transport to the cell bodies of the
innervating neurons where they exert their survival promoting effects (Hendry et al
1974; Korsching et al 1983). The best known and most extensively studied among
these factors are the nerve growth factor (NGF) family of neurotrophins. NGF is the
founder member (Levi-Montalcini 1966) and several other neurotrophins have been
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identified, including brain-derived neurotrophic factor (BDNF) and neurotrophin 3
(NT3), neurotrophin 4 (NT4, also known as NT5) and more recently neurotrophin 6
(NT6) (Barde et al 1982; Ernfors et al 1990a; Gotz et al 1994; Hallbook et al 1991).
All the neurotrophins are initially produced as 30-35 kDa precursor proteins and
these unprocessed proneurotrophins often represent abundant forms of secreted
neurotrophin (Lee et al 2001). The proneurotrophins contain a signal peptide, sites
for glycosylation, and pairs of basic amino acids that are recognized by processing
enzymes. These enzymes, including the calcium-dependent serine protease furin
cleave each of the neurotrophins, releasing the biologically active 12-14 kDa C-
terminal product (Seidah et al 1996). The neurotrophin monomer has an elongated
shape with the central part of the molecule formed by two pairs of twisted,
antiparallel P-strands. There are three hairpin loops on one end, and the other end
carries a cysteine-knot motif, a step-like arrangement of three disulfide bridges. In
the biologically active form, two monomers are arranged in a parallel manner to form
a close-packed homodimer (Figure 1.2). All neurotrophins share a pair-wise
sequence identity of approximately 50%.
The main function of NGF in neuronal tissue is to support the survival of
sympathetic ganglion neurons and subpopulations of sensory neurons in dorsal root
ganglia (DRG) and trigeminal ganglia. BDNF and NT3 also support DRG and
trigeminal ganglia but in addition support nodose and vestibular ganglion cells
(Korsching 1993). However, neurotrophin expression is not restricted to neuronal
cells, and as previously mentioned, they have been found in many non-neuronal
tissues. Neurotrophins were first identified in the ovary in Xenopus laevis (Hallbook
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et al 1991) and have since been described in the mouse and rat ovary and in the adult
human ovary (Berkemeier et al 1991; Dissen et al 1995; Dissen et al 2001; Ernfors et
al 1990a; Klein et al 1989; Lamballe et al 1991; Lara et al 1990; Seifer et al 2002).
The homozygote iVgf-nuIl mice have markedly reduced numbers of primary and
secondary ovarian follicles and reduced somatic cell proliferation (Dissen et al
2001).
Several members of the neurotrophin family and their receptors have also been
identified in the developing rodent testis (Cupp et al 2000; Djakiew et al 1994;
Levine et al 2000b; Russo et al 1999). NT3, NGF and the neurotrophin receptor
tyrosine kinase C (TrkC) appear to be critical for cord formation in the rodent testis
and they may be important in the differentiation and maturation of Leydig cells and
germ cells as suggested by neurotrophin tyrosine kinase receptor knockout mice
(Cupp et al 2000; Cupp et al 2002; Levine et al 2000b).
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Figure 1.2 Ribbon diagram demonstrating the structure of neurotrophin dimers. N




The biological actions of the neurotrophins are mediated by tyrosine kinase receptors
which were first described in 1986, as the product of the trk oncogene, a chimeric
oncoprotein found in a human colon carcinoma (Martin-Zanca et al 1986; Martin-
Zanca et al 1989). In 1991 it was discovered that the physiological role of the trk
tyrosine protein kinase (TrkA) was to serve as a signalling receptor for NGF
(Hempstead et al 1991; Kaplan et al 1991). Subsequent studies have revealed that
TrkA belongs to a small family of closely related receptors that include TrkB and
TrkC (Barbacid 1994). These receptors have strong affinities for particular
neurotrophins, TrkA binding preferentially to NGF (Klein et al 1991), TrkB to
BDNF and NT4 (Berkemeier et al 1991; Ip et al 1992; Klein et al 1992), and TrkC is
the primary receptor for NTS (Lamballe et al 1991). NTS is also capable of binding
to and signalling through TrkA and TrkB at high concentrations. Both TrkB and
TrkC have a truncated form of receptor lacking the tyrosine kinase domain, but the
function of the truncated form is still unclear (Barbacid et al 1991). In addition, all
neurotrophins are recognised by a more widely-expressed low affinity receptor
known as p75, which is a member of the tumour necrosis receptor super family
(Chao 1994) (discussed in Section 1.65).
The generation of strains of transgenic mice deficient for each of the Trk receptors
has helped define the role neurotrophin signalling plays in mammalian development.
TrkA mice are small and display a wide array of sensory defects and have
extensive neuronal cell loss in trigeminal, dorsal root and sympathetic ganglia
(Smeyne et al 1994). TrkB targeted mice develop to birth but most die within the
43
first postnatal week. They do not respond to stimuli, are unable to feed and their
main neurological deficiencies are in the trigeminal and nodose/petrosal ganglia
(Klein et al 1993). Unlike the targeted TrkA~'~ and TrkB" mice, TrkC " develop to
birth and appear normal, respond to painful stimuli and take nourishment. However,
after birth they display abnormal movements, suggesting a defect in proprioception.
They have a limited lifespan (most die by P21) and most of their neuronal defects are
in the dorsal root ganglia and in muscle afferents (Klein et al 1994). With regard to
gonadal development, testes of TrkA'1' and TrkC''' mice contain reduced numbers of
germ cells and impaired seminiferous tubule development compared to wild type
(Cupp et al 2002) and TrkB " lack primordial follicle formation (Molinek M 2000).
Mice carrying a null mutation of the p75 gene appear to have normal numbers of
ovarian follicles (unpublished data cited in (Dissen et al 1995).
1.61 TrkA Receptor
The Trk proto-oncogene encodes two tyrosine protein kinase isoforms of 790 and
trk796 amino acid residues, designated as TrkA (also known as Trk, or gpl40 )
(Barker et al 1993; Horigome et al 1993; Martin-Zanca et al 1989; Meakin et al
1992). Both isoforms have a structure which includes a 32-amino-acid-long putative
signal peptide, followed by an ectodomain which includes cysteine clusters, leucine
rich motifs (LRM) and immunoglobulin-like motifs responsible for the interaction
with NGF. They also have a transmembrane region and a cytoplasmic region that
encompasses the tyrosine kinase catalytic domain. (Figl .3 A). It is the 790 amino acid
long isoform that has been found mainly in cells of non-neuronal origin (Barker et al
1993; Horigome et al 1993), although it appears that both isoforms have similar
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biological properties (Meakin et al 1992). During murine development TrkA is
expressed mainly in the PNS and has also been detected in both mammalian ovaries
and testes (Barbacid 1994; Dissen et al 1995; Levine et al 2000b)
1.62 TrkB Receptor
The TrkB receptor exists in two forms; the full length TrkB receptor (TrkB TK+) and
the truncated TrkB receptor (TrkBIK~). The full length form is a heavily glycosylated
molecule of 821 amino acid residues and it contains all the canonical motifs of the
tyrosine kinase receptors. Most of the homology between the receptors is in the
catalytic domain and like TrkA; this receptor has a 15 amino acid cytoplasmic tail.
The truncated form of the TrkB receptor has the same extracellular and
transmembrane domain as the full length TrkB. However it has a very short
cytoplasmic tail and lacks the entire kinase catalytic region. The size of the full
length and truncated receptors are 145,000-daltons and 95,000-daltons respectively.
TK~b * * TK.In general, in mice TrkB is located preferentially in neuronal tissue and TrkB
in non-neuronal cells. TrkB is expressed widely in the mouse CNS and PNS and has




TrkC locus encodes two classes of cell surface receptors. To date, four TrkC tyrosine
kinase isoforms have been described (Lamballe et al 1991; Lamballe et al 1993;
Tsoulfas et al 1993; Valenzuela et al 1993). TrkC K1 was first identified and is a 145
kd glycoprotein. The other TrkC tyrosine kinases differ from TrkC K1 in the
presence of 14 (TrkC 14), 25 (TrkC 25), or 39 (TrkC39) additional amino residues
and these sequences are encoded by alternatively spliced exons. All TrkC isoforms
engage in downstream signalling and induce resting cells to initiate DNA synthesis
upon addition ofNT3 (Lamballe et al 1993).
TICThe second class of TrkC receptors are similar in structure to the TrkB " receptors
and are termed TrkCTK~. They have the same extracellular and transmembrane
domains as the TrkC tyrosine kinases but lack the kinase domain. To date, four
different TrkC TK~ receptor isoforms have been described, termed as TrkC TK" 158,
TrkC TK" 143, TrkC TK113 and TrkC rK~ 108, based on the number of cytoplasmic
residues (Tsoulfas et al 1993; Valenzuela et al 1993). These isoforms are the result of
• TIC TIC
alternatively spliced exons. The precise physiological role of TrkB " and TrkC
non-catalytic isoforms is not clear but they may act as dominant inhibitory
modulators of Trk signalling, concentrate or prevent diffusion of neurotrophins or
mediate signalling events (Baxter et al 1997; Eide et al 1996; Kryl et al 2000).
TrkC is expressed throughout the CNS, in certain PNS structures in the mouse and
uniquely in the ganglia of the enteric nervous system (Lamballe et al 1994;
Tessarollo et al 1993). Outside of neural tissue it has been detected in both the ovary
and testis (Lamballe et al 1991; Tessarollo et al 1993). Interestingly, TrkC null
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mutations have reduced germ cell numbers and seminiferous cord area compared
with the wild type mice (Cupp et al 2002).
1.64 Trk Receptor signal transduction
The binding of neurotrophins to Trk receptors produces biological responses through
a two step process of activation. This involves the ligand mediated oligomerization
of receptor molecules at the cell surface followed by autophosphorylation of their
tyrosine residues. The phosphorylated tyrosine residues in the Trk cytoplasmic
domain serve as anchors for binding downstream signalling elements (Schlessinger
et al 1992). The membrane proximal domain of the Trk receptors has been identified
as the ligand binding site (Ultsch et al 1999) and upon binding, enzymes become
phosphorylated on tyrosine residues, which is required for their activation. The
adaptor molecules facilitate the interaction between other signalling molecules by
bringing them together at the cell membrane. Several proteins have been
characterized as substrates for the Trk family of receptors. They include
phospholipase C-y (PLCy) (Ohmichi et al 1991), the regulatory subunit (p85) of
phosphotidylinositol 3'-kinase (PI-3K) (Soltoff et al 1992), MAP kinase (Schanen-
King et al 1991), She (a SH2-containing adaptor protein) (Obermeier et al 1993) and
possibly the Ras GTPase activating protein (GAP) (Obermeier et al 1993).
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1.65 p75 Receptor
After cleavage of its 28-amino acid signal peptide, human P75 is a 399-amino acid
Type 1 transmembrane protein. It has an extracellular domain that contains four
cysteine-rich domains and multiple O- and N-linked glycosylation sites. The
intracellular domain contains a palmitoylation site at cysteine 279, two potential
tumour necrosis factor receptor associated factor (TRAF) binding sites, a Type II
death domain, a potential G protein activating domain and a PDZ (an amino acid
binding motif) domain binding motif (Fig 1.3B). The p75 receptor is highly
conserved among species and there are no similarities between p75 and the Trk
receptors in terms of sequences in the ligand-binding or cytoplasmic domains. This
receptor will bind to each mature neurotrophin with similar affinity and can be co-
expressed with any of the Trk proteins. Truncated p75 isoforms do exist and are
produced by alternative splicing and proteolysis.
In the rodent p75 is expressed widely in neural tissue, mainly in Schwann cells,
motor neurons and meningeal cells. Outside of the CNS, it has been localised to the
peritubular cells of the testis and to the stromal cellular compartment of the ovary
(Campagnolo et al 2001; Dissen et al 1995; Levine et al 2000b; Russo et al 1999).
Although p75 and Trk receptors are co-expressed in many cells, independent
expression of p75 and individual members of the trk family is also observed. The co-
expression of p75 and trk receptors contributes to the formation of high affinity
binding. p75 enhances the affinity of TrkA for NGF, while decreasing affinity for
NT-3. Similarly, p75 differentially modulates the interactions of TrkB for BDNF,
NT-3, and NT-4/5 (Bibel et al 1999). It can increase the binding affinity of NGF,
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either by passing the ligand to the Trk receptor, or altering the conformation of TrkA
receptors through allosteric interactions (Esposito et al 2001).
A role mediating apoptosis has been widely postulated for p75 (Barrett et al 1994;
Rabizadeh et al 1993). The receptor has a recognised death domain which shares
significant homology with the Fas and the TNF receptor family. The pathway
responsible for p75 signalling transduction has not been completely identified but
there is evidence for a number of second messenger systems, including ceramide, c-
jun kinase (INK), protein kinase B (PKB or Akt) and nuclear factor-KB (NF-kB)
(Barrett 2000). It also interacts with several adaptor proteins and of these
neurotrophin receptor interacting MAGE homolog (NRAGE) (86 kDa member of the
melanoma associated antigen (MAGE) family of proteins), p75 NTR associated cell
death executor (NADE) and neurotrophin receptor interacting factors (NRIF1 and
NRIF2) (closely related 94 kDa zinc finger proteins) have been associated with the
induction of apoptosis and fas associated phosphatase-1 (FAP-1), receptor interacting
protein-2 (RIP-2) and TRAF6 appear to promote survival (Roux et al 2002).
Differential effects of p75 during development have also been described, being
required for NGF-mediated survival in neurons at the stage of target innervation but
mediating an apoptotic signal at a later stage of cell development (Barrett et al 1994).
Different responses can be elicited depending on whether or not p75 and Trk
receptors are co-expressed: p75 alone can induce cell death, whereas in the presence
of Trk receptors p75 can promote cell survival (Casaccia-Bonnefil et al 1999).
However, the dual receptor system is complex and the form of neurotrophin which
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binds is crucial. The immature form of NGF, termed proNGF has a greater affinity
for p75 than the mature form of NGF (Lee et al 2001). However, proNGF bound
TrkA receptors much less strongly than mature NGF. The discovery that NGF may
be secreted as proNGF, which preferentially activates p75, or as mature NGF, which
preferentially activates TrkA, suggests that the balance between cell death and cell
survival may be in part determined by the ratio of proNGF and mature NGF secreted
by cells.
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Figures 1.3A and B. A shows Trk receptor structure (Barbacid 1994); B shows p75






















K252a, a microbial alkaloid isolated from the culture broth ofNorcardiopsis species,
possesses a polyaromatic aglycon structure was originally characterised as a potent
inhibitor of C kinase and cyclic nucleotide-dependent protein kinases, acting by
interfering at or near the ATP binding site. However, chemical modifications in their
sugar moiety can result in high specificity of the inhibitory action and, furthermore,
can induce other stimulatory and inhibitory effects on nerve cells. K252a is of
particular interest because it has been shown to inhibit the actions of NGF and other
neurotrophins without diminishing comparable actions of other growth factors which
act via tyrosine kinase receptors. This has been noted using PC 12 and NIH3T3 cells,
where the actions of neurotrophins were blocked by nanomolar concentrations of
K252a but epidermal growth factor (EGF) and FGF pathways remained intact (Berg
et al 1992; Hashimoto 1988; Nye et al 1992). Although it is known as a protein
kinase C blocker, the action of K252a does not affect the protein kinase C pathway at
these concentrations and rather the compound is thought to act directly on the
tyrosine kinase catalytic domain (Berg et al 1992; Hashimoto 1988). The mechanism
is thought to involve preventing ligand induced tyrosine kinase autophosphorylation
by competitively blocking the kinase nucleotide binding site. K252a appears to act
early in the NGF signalling pathway as almost all events induced by NGF in PC 12
cells are affected by the compound (Berg et al 1992). These include increases in
ornithine decarboxylase activity, stimulation of phosphotidylinositol breakdown,
activation of MAP2 kinase (Miyasaka et al 1990; Tsao et al 1990), increases in
intracellular calcium and the increase in c-fos transcription (Lazarovici et al 1989).
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K252a is therefore a specific Trk receptor antagonist but does not distinguish
between TrkA, TrkB and TrkC. Several more specific reagents have been previously
used in order to distinguish between the actions of each receptor. Chimeric fusion
proteins containing a Trk extracellular domain fused to human immunoglobulin
(IgG) have been developed that inhibit receptor dimerisation and bind to their
corresponding ligand to block biological activity (Shelton et al 1995).
1.8 FIBROBLAST GROWTH FACTOR
Fibroblast growth factors (FGFs) are members of a family of polypeptides
synthesized by a variety of cell types during the processes of embryonic development
and in adult tissues. There are at least 23 members of the FGF family and, of these,
10 are expressed in the developing CNS along with four FGF receptors (FGFR).
FGFs have mitogenic and angiogenic activity with a crucial role in cell
differentiation and development. They use a dual receptor system based on tyrosine
kinases and heparin sulphate proteoglycans and they are modulated by transforming
growth factor p (TGFp). Basic FGF (bFGF) is recognized as a multifunctional
growth factor which promotes the survival and neurite growth of brain neurons in
vitro and in vivo (Botta et al 2000; Lynch et al 2000). Outside the nervous system, it
has been located in the testis and ovary and acts as a survival and mitogenic factor
for germ cells (Dissel-Emiliani et al 1996; Han et al 1993; Lynch et al 2000) As
mentioned previously, although FGF acts via tyrosine kinase receptors, their actions
do not appear to be inhibited by K252a.
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1.9 SUMMARY
To summarise, the literature review has considered some of the factors including c-
kit receptor and ligand, neurotrophins and their receptors and MMPs and TIMPs
likely involved in the control and regulation of the development of the human fetal
gonad. Current knowledge as to their roles in cell migration, survival and
differentiation and in mammalian gonadal development was then considered.
1.91 HYPOTHESIS
It was then hypothesised that these factors play a vital role in the development of the
human fetal testis and ovary, in particular in germ cell differentiation and survival.
1.92 AIMS
The specific aims of this study were therefore to:
1. To investigate the expression and possible role of c-kit and its ligand in germ cell
development in the human fetal gonads during mid-trimester
2. To establish the secretion and localisation of MMPs and TIMPs to determine their
possible role in the development of the fetal testis and ovary.
3. To investigate the expression and localisation of neurotrophins and their receptors






The sources of all the reagents used for the experiments described in all the
following chapters are detailed in Appendix I.
2.2-2.7 METHODS
TISSUE COLLECTION AND CULTURE METHODS
2.21 TISSUE COLLECTION
Human fetal ovaries and testes were obtained following medical termination of
pregnancy. Women gave consent according to national guidelines (Polkinghorne,
1989) and the study was approved by the Lothian Paediatrics / Reproductive
Medicine Research Ethics Sub-Committee. Termination of pregnancy was induced
by treatment with mifepristone (200mg orally) followed by prostaglandin El
analogue (Gemeprost, Beacon Pharmaceuticals, Tunbridge Wells, UK) Img 3-hourly
per vaginum. None of the terminations were for reasons of fetal abnormality, and all
fetuses appeared morphologically normal. Gestational age was determined by
ultrasound examination prior to termination and confirmed by subsequent direct
measurement of foot length.
Gonadal tissue was dissected free, and either fixed or snap frozen and stored at -
70°C. Fixation was carried out in Bouins for 5 hours, followed by transfer to 70%
ethanol prior to processing in paraffin using standard methods.
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2.22 DEVELOPMENT OF TISSUE CULTURE METHOD
Fetal ovaries and testes were placed in a sterile petri dish in a small volume of
culture media. They were dissected free of adherent tissues using sterile technique,
bisected longitudinally and then cut into slices ~0.5mm thick using a dissecting
microscope with a measuring tape placed under the petri dish to ensure the slices
were approximately equal sizes. Samples of fresh tissue were fixed for histological
analysis (time 0 samples).
Initially, a culture method similar to that described by Dr. J. Tilly (Morita et al 1999)
was used. Several pieces of tissue were placed on sterile preformed 2% agarose gel
discs which were placed in each well of a 6-well organ culture dish. Enough culture
medium was then added to the well to form a meniscus with the gel but not submerge
the tissue. In order to create the optimum culture conditions a-minimum essential
medium (a-MEM) was used, adding either 10% fetal bovine serum (FBS) or bovine
serum albumin (BSA) and insulin/transferrin/selenium (ITS). a-MEM has been
shown (Wright et al 1999) to be the most effective medium at supporting human
ovarian tissue in culture, possibly because it contains amino acids, vitamins,
ribonucleosides and deoxyribonucleosides that simple salt solutions do not have.
Serum albumin and ITS have also been shown to be effective replacements for serum
in culture (Wright et al 1999), and having cultured tissue in both serum and serum-
free media an appreciable difference in the tissues at the end of culture was not
observed. Hence, the serum-free conditions were used thereafter as it would allow
testing of growth factor effects without the influence of serum in the media. The
initial culture method using agarose gel was time consuming to set up and when
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compared with the method described below using Millicell CM filters the latter
method was more effective at supporting tissue viability. After preliminary
experiments varying the culture time periods over 48 hours, 5 days and 7 days,
significant differences between treated and control groups after 48 hours was
observed and hence this time period used for all subsequent culture experiments.
2.23 TISSUE CULTURE
Tissue fragments were cultured on 0.4pm pore Millicell CM filters in a 24 well plate.
To each well 0.4ml of medium was added, enough to just cover the tissue fragments.
Any remaining wells were partially filled with medium to maintain humidity in the
culture vessel.
The medium comprised MEMa containing 3mg/ml BSA, antibiotics (lOOIU/ml
penicillin, 100 pg/ml streptomycin sulphate and 0.125 pg/ml amphotericin), ITS (5
pg/ml bovine insulin, 5 pg/ml transferrin and 5 pg/ml sodium selenite), 2 mmol/1
glutamine and 2 mmol/1 pyruvate. Factors added were the Trk inhibitor K252a at a
concentration of 100 nM and 0.05ng/pl basic fibroblast growth factor (bFGF). As
K252a was dissolved in dimethylsulfoxide (DMSO), an equivalent amount of DMSO
was added to control wells. The cultures were maintained at 37°C in a humidified
incubator under 5% CO2 in air for 48 hrs. Every 24hrs the media was removed and
replaced with fresh media. Twenty-four hours prior to the end of culture, 9 pg/ml of
bromodeoxyuridine (BrdU) was added to the medium in order to label proliferating
cells. At the end of the culture period, tissue was fixed for 1 hr in Bouins fluid and
then transferred to 70% ethanol before embedding in paraffin wax for histological
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analysis. The tissue was sectioned at 5 jam thickness and using
immunohistochemistry, stained for BrdU protein using the described protocol
(Section 2.4 and Section 5.2).
2.24 QUANTIFICATION ANALYSIS OF CULTURED TISSUE
Sections of uncultured control and cultured tissue were analysed to investigate the
effects of culture and of K252a on the number and proliferation of the various cell
types present. Analysis was carried out blind using the Area Fraction Probe in the
Stereologer software programme (Systems Planning and Analysis Inc, Alexandria,
VA, USA). This was a randomised stage microscope which chose grids to count
within the tissue, therefore minimising observer bias. Confirmation of accurate
identification of cell types was confirmed by a second observer. Numbers of germ
cells were counted for both ovary and testis, and numbers of Sertoli cells and
peritubular cells for the testis were recorded. The numbers of each of these cell types
that were proliferating (i.e. immunostained for BrdU) were recorded. Tissue was
serially sectioned at 5pm thickness and 4 sections of tissue were mounted onto each
slide to minimise the number of slides required to be stained. Several sections greater
than 20 pm apart were counted, ensuring the same cells were not counted more than
once. The counting was done using a 121 point grid in the eyepiece of the
microscope and only the cells whose nuclei lay beneath the intersections on the grid
were counted. The numbers of points lying out-with any tissue were also recorded
and the total cell numbers counted were corrected for this (using the formula: cells
counted x 121/ points on tissue). The primary outcome was total numbers of germ
cells. In order to decide the sample size required to be analysed to give standard error
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of 5%, the percentage of tissue that the germ cells occupied in both ovaries and testes
was estimated and the numbers of frames that would be required to be counted were
calculated in preliminary experiments. This was carried out using the following
formulae (Bancroft 1996). To calculate standard error:
Standard error = square root [Ppi (100-Ppi)/PT]
Where,
Ppi = Percentage of volume occupied by the object (i) counted ie: the number of
points intercepting with, i, expressed as a percentage of the total number of points
counted
Pt = Total number of points counted
To calculate percentage standard error:
Percentage standard error = (standard error/Ppi) x 100
Using these formulae I estimated that I needed to count approximately 600 points for
each sample of ovarian tissue and 3025 points for testicular tissue. The average
number of each cell type present per grid was calculated for each experimental
condition, and data were analysed using SPSS statistics package. The parametric
statistical test used to analyse data was the Students paired t test.
MOLECULAR BIOLOGICAL TECHNIQUES
2.3 ISOLATION OF RNA AND SYNTHESIS OF cDNA
To identify and study gene expression within tissues the very small amounts of RNA
present need first of all to be amplified. Firstly, RNA is converted to complementary
DNA using the enzyme reverse transcriptase. The polymerase chain reaction (PCR)
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is then performed on the cDNA using specific primers to manufacture enough DNA
copies to detect the required sequence.
Total RNA was extracted from snap frozen samples of fetal gonads (12-21 weeks)
using the RNeasy mini kit. Tissue was homogenised and lysed in a volume of buffer,
proportional to the amount of tissue, containing (3-mercaptoethanol (J3ME) and
guanidine isothiocyanate (GITC). This was centrifuged and 70% ethanol added to
provide appropriate binding conditions. This was mixed, added to a silica gel based
spin column (binding capacity approximately 100 pg RNA) and centrifuged at
12,000G at room temperature (RT). This allows adsorption of the RNA onto the
silica gel based membrane. A washing buffer was then added to the column and this
was spun prior to adding a second washing buffer. Again this was centrifuged and
finally RNase free H20 was added to the columns before spinning and the elute was
retained and the RNA content measured in a spectrophotometer. RNA was treated
with DNase and reverse transcription performed using a first strand cDNA synthesis
kit. Briefly, 1 pg total RNA was incubated with oligo (dT)i8 primer for 10 min at
65°C and then placed on ice. A reaction mix comprising buffer, 1 mM each
deoxynucleotide triphosphate (dNTP), ribonuclease inhibitor and 50 U reverse
transcriptase, was added to each tube in a total volume of 50pl and the tubes then
incubated at 40°C for 2 h. cDNA was then stored at -70°C.
2.31 POLYMERASE CHAIN REACTION (PCR)
PCR is an in vitro method of nucleic acid synthesis by which a particular segment of
DNA can be specifically replicated. It involves two oligonucleotide primers that
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flank the DNA fragment to be amplified and repeated cycles of heat denaturation of
the DNA, annealing of the primers to their complementary sequences, and extension
of the annealed primers with DNA polymerase. These primers hybridise to opposite
strands of the target sequence and are oriented so that DNA synthesis by the
polymerase proceeds across the region between the primers. Since the extension
products themselves are also complementary to and capable of binding primers,
successive cycles of amplification essentially double the amount of the target DNA
synthesised in the previous cycle. The result is an exponential accumulation of the
specific target fragment.
The polymerase chain reaction was performed by incubating 1-2 pi cDNA samples
with 0.25 pi Taq DNA polymerase (2u/pl) in buffer with 0.2 mM of each dNTP and
forward and reverse oligonucleotide primers, making up to 50 pi with RNase-free
water. All reagents were kept on ice and the taq polymerase was added last. PCR
cycling was carried out on a MJ Research PTC-100 thermal cycler for 35 cycles. The
annealing temperature varied depending on the product and primers used. Two
control tubes were run in parallel, one in which water replaced the RNA and a
second omitting reverse transcriptase to ensure there was no genomic DNA
contamination. Specific primers were used and these and the resulting product size
are shown in the relevant chapters. Primers were designed to span an intron to ensure
genomic DNA was not amplified. Primers for the constitutively expressed gene
glyceraldehyde-3-phosphatase dehydrogenase (GAPDH) were used to confirm the
integrity of the RNA and efficacy of the PCR reaction. After the PCR, the size of
product was ascertained using electrophoresis. Products were loaded on a 1%
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agarose gel (8 pi product : 2 pi dye used to visualise loading and dye front on
running gel) with ethidium bromide (see Appendix II for recipe) and placed in a tank
containing 1 x TBE solution (Tris, boric acid, EDTA, see Appendix II for recipe) and
run at 120 V over 45 minutes. Products were visualised using ultraviolet light.
Products were purified using the method described in section 2.33 and the identity of
all PCR products was confirmed by direct sequencing as described below.
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2.32 SEQUENCING OF DNA
The first step in sequencing is to denature the double stranded DNA into single
strands. The overall approach of sequencing DNA involves creating sub-fragments of
all possible lengths from the DNA we want to sequence, grouping them according to
which base they end with. To create these fragments a chain termination method is
employed called the dideoxy method. Dideoxy analogues of normal DNA precursors
cause premature termination of a growing chain of nucleotides being made by DNA
polymerase. This allows generation of fragments of the stretch of DNA we want to
sequence and by using four different dideoxy analogs, one for each of the four bases,
we can generate four sets of fragments. To identify these, the same DNA primer is
used for each reaction but four different fluorescent dyes are used, one for each of
the bases. When a sequencing gel is run, a separate colour is obtained for each base.
The bands are scanned by a laser beam and the four different dyes fluoresce in
different colours. The colour of each band is recorded by a computer which then
prints the sequence.
2.33 PURIFICATION OF PRODUCTS FOR SEQUENCING
This was performed for all products prior to sequencing using a Hi-Pure purification
kit in order to remove any primer dimers which may affect the sequencing signal.
First the amount of product present was measured and made up to 50pl with H20.
Binding buffer (250pl) was then added to each sample and the sample then added to
a column sitting in a collection tube. Next the samples were centrifuged at 13000g
for 1 minute. The elute was discarded and 500pl of washing buffer was added to the
column and this was centrifuged for 1 minute at 13000g. These two steps were
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repeated using 200pl of washing buffer and then 40pl of elution buffer was added to
a column sitting in a clean tube and centrifuged for 1 minute. The elute was then put
through the column again and products run on an agarose gel and tested in a
spectrophotometer to ascertain purity and quantification.
2.34 METHOD FOR SEQUENCING DNA
For the sequencing reaction, 30-90ng of purified PCR product was added to 4j.il of
sequencing mix, 4pl of Vi term ( 200mM Tris Hcl, pH 9.0; 5mM MgCh) and lpl of
primer at a concentration of 5pmol/pl. This was then made up to 20pl with H20 and
the mixture placed in the PCR machine at 96°C for 15 seconds, 50 °C for 25 seconds
and 60 °C for 4 minutes for 25 cycles. Once finished the tubes were spun briefly and
then 50pl of 96% ethanol and 2pl of 3M sodium acetate were added to each tube.
The samples were vortexed thoroughly and left at room temperature for 30 minutes
before spinning at 12,000 G at RT for 30 minutes. The supernatant was removed and
pellet washed with 100gl of 70% ethanol. This was spun again for 10 minutes and
supernatant removed and pellet allowed to dry. This was then resuspended in 4pi
formamide: Ethylenediaminetetraacetic acid (EDTA) buffer (5:1 ratio of deionised
formamide: 50mM EDTA) and was ready for loading on the sequencing gel.
The sequencing gel was made by mixing 50g urea and 15 ml 40% acrylamide and
making up to 80 ml with water. One teaspoon of amberlite was added to this and the
mixture was heated gently until the urea dissolved. This was filtered to remove the
amberlite and then 10 ml of TBE added. The mixture was made up to 100 ml with
water and just prior to pouring 500pl 10% Ammonium persulphate (APS) and 45pl
65
RHN^Tetra-methylethylenediamine (TEMED) were added. The gel was then
poured between the glass plates with spacers in situ and allowed to set prior to
placing in the sequencer along with running buffer and loading with samples.
Sequencing was carried out using an Applied Biosystems 373 A automated
sequencer.
2.35 ISOLATION OF RNA BY LASER CAPTURE MICROSCOPY
The technique of laser capture microscopy (LCM) allows sampling of individual or
groups of cells from complex tissues, in such a way that mRNA and/or proteins
could be extracted from them and analysed. In the present study the LCM
microscope was used with the laser set to the smallest size available (7.5 pm) to
allow for sampling of single cells. Briefly, 5pm sections were cut from paraffin wax
embedded 19 wk human fetal testis samples and mounted on plain, uncoated, glass
slides. Sections were dewaxed in xylene, rehydrated then subjected to
immunostaining. Initially frozen sections were also used but resulted in very poor
tissue morphology. To visualise the cells within the seminiferous cords an Anti
Miillerian Hormone (AMH) polyclonal antibody was used as detailed in Chapter 3
except that the protocol was modified for short, typically 10 min, incubation times at
each step to reduce the chance of RNA degradation and RNase inhibitor was
included in all the immunohistochemical reagents. After colour development with
DAB the sections were dehydrated through graded alcohols and finally xylene.
Sections were stored in a vacuum dessicator for at least 30 min prior to capture. Care
was taken throughout to avoid RNase contamination of sections and all aqueous
solutions were prepared with diethylpyrocarbonate (DEPC) -treated water.
66
Individual cells were recovered from the stained sections by micro-dissection using
the PixCell II LCM system according to the manufacturer's instructions. Each
section was overlaid with a thermoplastic membrane mounted on optically
transparent caps and cells captured by focal melting of the membrane due to laser
activation. The parameters of the laser shot used in this study were: spot size 7.5pm
in diameter, power 45mW and duration time 0.5ms (Figure 2.1).
Total RNA was extracted from micro-dissected samples with the Micro RNA
Isolation Kit. After incubation with 200pl of denaturing buffer and 1.6pl of B-
mercaptoethanol at room temperature for 10 min, the sample was extracted with 20pl
of 2M sodium acetate, 220 pi phenol and 60 pi Chloroform:isoamyl alcohol (ratio
25:24:1). The aqueous phase was mixed with lpl of lOmg/ml carrier glycogen and
then precipitated with 200pl of isopropanol. After a 70% ethanol wash then drying in
air, the pellet was resuspended in lOpl of RNase free H20. The extracted RNA was
reverse transcribed using 1 Opmol random hexamer primers and 200U of Superscript
II reverse transcriptase according to the manufacturer's instructions. Initially, this
cDNA was then used in subsequent PCR reactions with primers for c-kit (set 1, Table
3.1) and AMH (set 1, Table 3.1). However, this method failed to successfully
amplify products and so was developed further by Dr T Gaskill. This was modified
by amplifying the cDNA prior to using nested primers in PCR for c-kit and AMH, as
detailed below.
An aliquot of cDNA was amplified using a modified degenerate oligonucleotide
primed polymerase chain reaction (DOP-PCR) protocol (Kasai et a/., 2000) using the
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primer UNI, 5'-CCGACTCGAGNNNNNNATGTGG-3' in a total volume of 25pl.
5 pi ofamplified cDNA was then used in subsequent PCR reactions using primer sets
for specific sequences which are detailed in Chapter 3.
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2.36 IN SITU HYBRIDIZATION
In situ hybridization techniques allow specific nucleic acid sequences to be detected
in morphologically preserved tissue sections. In combination with
immunohistochemistry in situ hybridization can relate microscopic topological
information to gene activity at the DNA, mRNA and protein level.
2.37 GENERATION OF RIBOPROBES FOR IN SITU HYBRIDIZATION
cDNA specific for human NT4 was generated by PCR using oligonucleotides
(forward primer: 5-CTT TCG GGA GTC AGC AGG TGC-3' and reverse primer: 5'-
CAG GCA GTG TCA ATT CGA ATC C-3') designed from the human NT4
sequence (Human NT4 sequence Accession no. NM006179). These primers were
predicted to amplify a 698 bp product (nucleotides 401-1099). Briefly, RNA was
extracted from snap-frozen human fetal ovary using a RNeasy mini kit. RNA was
treated with DNAse to eliminate any genomic DNA contamination and cDNA
synthesized using a first strand cDNA synthesis kit. PCR was then performed at an
annealing temperature of 55°C for 35 cycles in 75 mM Tris/HCl (pH 9.0), 20 mM
(NH4)2S04, 1.5 mM MgCl2, 200 gM each deoxynucleotide-5'-triphosphate, and
0.01% Tween-20 with 25 pmol of each primer and 1 25U AGSGold DNA
polymerase in a final volume of 50pl. A clear product of the expected size was
obtained which was then subcloned into a TA cloning vector (pGEM-T plasmid) and
the resulting clones sequenced to confirm that they were human NT4 cDNA
sequence. Riboprobes for in situ hybridization were then generated using a PCR
strategy to incorporate SP6 or T7 phage promotor sequences into NT4 PCR product.
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The pGEM-T plasmid containing human NT4 insert (see above) was used as a
template for the reaction. Briefly, for the antisense probe, the NT4 PCR product was
amplified using NT4 forward primer (as above) and NT4 reverse primer which had
the T7 promotor sequence added to its 5' end (5-TAA TAC GAC TCA CTA TAG
GGA GAC AGG CAG TGT CAA TTC GAA TCC-3'). For the sense probe, product
was amplified using the NT4 forward primer linked to the SP6 promotor sequence
(5-ATT TAG GTG ACA CTA TAG AAG TGC TTT CGG GAG TCA GCA GGT
GC-3') and NT4 reverse primer (as above). PCR was then performed as describe
above. Products were purified using High Pure PCR product purification kit and
used directly for transcription with T7 or SP6 RNA polymerase to generate antisense
and sense riboprobes, respectively. Probes were labelled with Digoxigenin (DIG)
using a commercially available kit. Briefly, DNA templates (300ng) were incubated
for 60 min at 37°C with transcription buffer, 10U ribonuclease inhibitor, 0.5 mM
each rATP, rCTP, rGTP, 0.33 mM rUTP, 0.17 mM digoxigenin-11-UTP and 30U of
appropriate RNA polymerase in a final volume of 20pl. After the addition of 2U
DNase I (RNase-ffee), the probes were incubated at 37°C for an additional 15 min
before being purified through Chromaspin columns.
2.38 IN SITU HYBRIDIZATION METHOD
Paraffin sections (5 pm) were cut over DEPC -treated water and transferred to super
frost plus coated slides within a baked glass dish containing ultra pure water at 55°C.
The sections were dried overnight at 50°C and then dewaxed in xylene and
rehydrated through a graded series of ethanol. All solutions were made up in DEPC
water. Slides were immersed in 0.4 M HC1 for 20 min, then washed twice in DEPC
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water for 5 min. Slides were then treated with 1.5 jag/ml Proteinase K at 37°C for 10
min in 0.1 M Tris/HCl and 0.05 M EDTA (pH 8.0), transferred to 0.2% glycine at
4°C for 10 min, acetylated with 0.25% acetic anhydride in 0.08 M triethanolamine
(pH 8.0) for 10 min and washed in 4 x SSC for 5 min. Sections were then incubated
with prehybridization buffer at 50°C for 2hours. The prehybridization buffer was
drained and excess dried off and 50pil hybridisation buffer added containing the
probe. This was coverslipped with Gel bond film (hydrophobic side down) and this
was incubated overnight at 50°C in a humid box.
Next day, sections were washed in 4 x saline-sodium citrate (SSC) for 10 min, then
incubated in RNase A buffer (0.02 mg/ml in 0.01 M Tris/HCl, 0.5 M NaCl and 0.1 M
EDTA, pH 8.0) at 37°C for 30 min, washed twice in 2 x SSC for 5 min, transferred to
0.1 x SSC with 30 % formamide at 37°C for 30 min, and washed in TBS, pH 7.4 for
5 min. For detection of DIG labelled probes, the sections were then incubated
sequentially at room temperature, with 2x5 min washes in TBS between steps, in: 1)
3% H2O2 in TBS for 30 min; 2) normal rabbit serum (NRS, 1:5 dilution in TBS
containing 5 drops/ml avidin block) for 30 min; 3) biotin block (8 drops/ml in TBS)
for 30 min; 4) Sheep Anti-Digoxigenin (1:100 in NRS/TBS) for 2h; 5) Biotinylated
rabbit anti-sheep IgG (1:500 in NRS/TBS) for 30 min; 5) ABComplex-HRP for 30
min and 6) 3, 3'-diaminobenzidine (DAB) liquid substrate-chromagen system for 2
min approximately. Sections were then counterstained in haematoxylin, dehydrated
and coverslip mounted with DPX.
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IMMUNOHISTOCHEMISTRY
2.4 IMMUNOHISTOCHEMISTRY: Background and general protocol
The technique of immunohistochemistry involves localisation of an antigen within a
section of tissue by a specific primary antibody. A variety of detection systems can
then be used to detect and visualise the specific staining.
Non-specific staining occurs when tissue other than at the site of the desired antigen
stains immunopositive and may be due to a variety of causes. The first of these is that
the primary antibody may bind non-specifically to epitopes in the tissue. Having a
good antibody is essential and the immunohistochemistry results were compared
with those obtained by Western Blotting to ensure that results were valid. Secondly,
tissues may contain endogenous peroxidase which may catalyse the enzymatic
detection thus producing DAB staining at the site of the endogenous enzyme. To
avoid this problem, prior to the addition of the primary antibody, tissues were
exposed to dilute H2O2 to saturate any endogenous peroxidase thus rendering it
inactive. Endogenous biotin can also cause a problem by binding to the primary
antibody. To overcome this, prior to adding the primary antibody, avidin was applied
to the tissue which binds to any endogenous biotin and then adding a biotin which
binds to the avidin and this then effectively blocks any endogenous activity. Lastly,
secondary antibody may bind to epitopes in the original tissue mimicking those from
the species it was raised against as well as to the primary antibody. This was
minimised by adding normal serum from the species from which the secondary
antibody was raised against prior to the addition of the secondary antibody.
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On each staining run the relevant positive control included contained the desired
antigen and was therefore expected to stain positively. To act as negative controls,
sections of tissue being stained were included which were treated in an identical
manner except the primary antibody was omitted. These sections were expected to
exhibit minimal, if any staining.
General protocol
Immunohistochemistry was performed on sections of fresh and cultured tissue.
Cultured pieces of tissue were fixed in Bouins fluid for 1 hour and fresh tissue was
fixed for 5 hours. They were then stored in 70% ethanol prior to routine paraffin
embedding.
Sections of tissue (5pm) were mounted on 3-aminopropyl-triethoxysilane (TESPA)
coated slides, dewaxed in histoclear and rehydrated through ascending grades of
ethanol to distilled water (2 minute washes) then washed in TBS (2 minutes). For
some antibodies, antigen retrieval using citrate (0.01M, pH 6.0, pressure cooked for
2.5 minutes) or glycine buffer was employed. The slides were immersed in the
boiling buffer in a pressure cooker for 2.5 minutes and then the pressure cooker was
removed from the heat and the slides left to stand in the buffer for 10 minutes buffer
being washed with tap water followed by a 5 minute wash in TBS. Endogenous
peroxidase activity was inhibited by incubation in 3% H2O2 in methanol for 30min.
After a wash in water, slides were transferred into TBS for 5 min and blocked for 30
min in blocking serum diluted 1:5 in TBS containing 5% bovine serum albumin.
Sections were then blocked with avidin (0.01M; 15min) and biotin (0.001M; 15min)
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with washes in TBS in between. The primary antibody, diluted in the appropriate
serum, was then added and this was incubated in a humidified atmosphere at 4°C
overnight. Optimal antibody concentrations were established in a series of
preliminary experiments. The following day, sections were washed and incubated for
30 min with a biotinylated secondary antibody 1:500 in the appropriate diluted
serum. Following washes in TBS, sections were incubated with ABC-HRP for 30
minutes. Slides were then rewashed in TBS and bound antibody was visualised using
the peroxidase substrate DAB which produces a brown stain. All sections were
counterstained with haematoxylin and dehydrated in graded ethanol
(2minutes/solution) and histoclear (5 minutes). They were then soaked in Xylene (5
minutes) and mounted with Pertex mounting medium. Images were captured using
an Olympus Provis microscope (Olympus Optical Co, London) equipped with a
Kodak DCS330 camera (Eastman Kodak).
2.41 Haematoxylin and Eosin stain (H & E stain)
Tissue sections were dewaxed in histoclear (5 minutes), rehydrated in graded
alcohols (absolute ethanol 20 seconds, 95% IMS 20 seconds and 70% IMS 20
seconds) and rinsed in tap water prior to staining in Haematoxylin (See Appendix II
for recipe) (5 minutes) . Next, slides were rinsed in 1% acid alcohol (5 seconds),
Scotts tap water (40 seconds) then Eosin (See Appendix II for recipe) (5-20 seconds)
being rinsed in tap water between each stage. Finally, slides were dehydrated in
graded alcohols (70% IMS 20 seconds, 95% IMS 20 seconds and absolute ethanol
20 seconds) steeped in histoclear (5 minutes), then Xylene (5 minutes) and Pertex
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mounted. H and E staining was utilised to check the morphology of tissue samples
and to count germ cells in time 0 samples in our analysis of cultured tissue.
PROTEIN EXTRACTION AND IMMUNOBLOTTING
2.5 WESTERN BLOT
Western blotting detects the presence of proteins, separated by electrophoresis, using
specific antibodies after transfer to a nitro-cellulose membrane. SDS polyacrylamide-
gel electrophoresis allows individual polypeptide chains to form a complex with
negatively charged molecules of SDS and therefore migrate as a negatively charged
SDS-protein complex through a porous gel of polyacrylamide. Since the speed of
migration under these conditions is greater the smaller the polypeptide, this can be
used to determine the approximate molecular weight of a polypeptide chain as well
as the subunit composition of a complex protein. See Appendix II for recipes.
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2.51 PROTEIN EXTRACTION FROM TISSUE
Tissue samples which had been stored at -70°C were kept on ice and then
homogenised in extraction buffer at room temperature. The samples were then
allowed to stand at room temperature for 1 hour, vortexing every 5 to 10 minutes
before being centrifuged at 10,000rpm for 30 minutes at RT. The pellet was
discarded and supernatant retained and stored as lOOpl aliquots at -70 °C. The
protein was quantified by diluting samples by factors of 10 and 20 and measuring
them in a spectrophotometer.
2.52 IMMUNOBLOTTING METHOD
PROTEIN SEPARATION
For recipes of buffers see Appendix II. Samples (20 pg protein) were diluted with an
equal volume of reducing loading buffer and boiled for 5 min. These were kept on
ice while the gel was being loaded. The combs were removed from a 4-20% gradient
Tris-glycine gel and the gel placed in the chamber. The chamber was then filled with
Tris-glycine sodium dodecyl sulfate (SDS) running buffer making sure air was
dislodged from all the wells. Samples were then loaded into wells in parallel with
prestained protein molecular weight markers and run at a constant 100V for « 2
hours.
After electrophoresis, the gels were removed from the apparatus and molecular
weight markers and dye front were measure and gels immersed in transfer buffer.
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2.53 BLOTTING
Eight pieces of filter paper and one polyvinylidene fluoride (PDF) membrane were
soaked in wet blot transfer buffer for 15 mins. The pads of the transfer apparatus
were soaked briefly in buffer and then one laid inside the cassette. The pad was
covered with 4 pieces of filter paper and the membrane. The stacking gel was cut off
and the remaining piece of gel placed over the membrane. The gel was covered with
the remaining filter paper and pad and the cassette closed. This was then placed in
the tank filled with buffer and run at a constant voltage of 25V overnight.
The next day, membranes were soaked for 5 min in methanol and washed briefly
several times in TBS. They were then blocked for 8 h at room temperature in 0.02 M
TBS (pH 7.6) containing 3% w/v BSA and 5% powdered milk. The membranes were
washed in TBS with 0.1% Tween-20 (TBST) and then incubate overnight with the
primary antibody. Antibodies used were against NT4, TrkB, and p75 NGFR. These
were used at dilutions of 1 in 500, 1 in 50 and 1 in 500 respectively (Table 2.2), in
TBST with 1% BSA at 4°C. Primary antibody was omitted as a negative control.
The following day, membranes were washed in TBST for three 5 minute washes and
then incubated with either anti-rabbit and anti-mouse HRP linked secondary
antibodies at 1:4000 in TBST with 1% BSA at room temperature for 1 hour. These
were then washed in TBST for 3 washes as before and the bound antibody detected








Table 2.2 Concentrations of antibody used for Western Blotting
EXPLANT CULTURE AND ZYMOGRAPH1C TECHNIQUES
2.6 EXPLANT CULTURE
Gonads from two fetuses of each sex (ovaries at 12 and 14 weeks gestation, and
testes at 17 weeks gestation) were cultured using the initial culture method as
described in Section 2.22. The medium comprised MEMa containing 3mg/ml BSA,
antibiotics, 2mM glutamine, 2mM pyruvate and ITS. The cultures were maintained
at 37°C in a humidified incubator under 5% CO2 in air. After 48 hours the tissue was
removed and fixed in Bouins fluid and the media was collected in a sterile container
and frozen at -20°C prior to analysis by zymography. Histological analysis of
cultured tissue confirmed that morphology was maintained and the tissue was viable.
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2.7 ZYMOGRAPHY
The technique of zymography detects activity of the latent and active forms of
MMPs. Samples are separated by electrophoresis on a sodium dodecyl sulphate-
polyacrylamide gel (SDS-PAGE) which has a substrate, in this case gelatin,
incorporated into it. The gels are then incubated overnight at 37°C and the latent
form of the enzyme, which is activated by the SDS, and the active form of the
enzyme digest the substrate within the gel at the site corresponding to their molecular
weight. The gel is then stained with Coomassie Blue then destained. The sites of
enzymatic gelatinase activity are manifest as a clear area of digestion within the gel.
The zymograms may then be semi-quantitated by densitometry.
Activities ofMMP-2 and MMP-9 in conditioned medium from gonadal cultures were
determined using gelatinase zymography (Riley et al 1999a) (See Appendix II for
recipes). Human amniotic fluid collected at term during labour was used a positive
control, which clearly demonstrates the latent forms of MMP-2 (72 kDa), MMP-9




Tissue culture incubation medium
• Freeze to -20°C prior to lyophilising samples by freeze drying. A medium
sample volume of 1.5 ml is resuspended in 50 pi ofwater.
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Plate preparation
• Clean (70% IMS) and assemble plates (8x10 cm) with spacers (0.75 mm)
between them.
• Prepare the resolving gel according to the recipe and pour immediately to 1.2
cm below top of plate (fill line), avoiding bubbles and leaks if possible.
• Overlay gel with water saturated sec-Butanol to burst any bubbles and give
an even level to top of gel.
• Leave to set (45 minutes, 23°C) and pour off the butanol. Wash with water
followed by several washes with Tris Buffer and leave with Tris buffer
(Stock B 1:4) overlay to allow polymerisation to occur (minimum of 2 hours,
23°C).
• Pour off buffer, rinse overlay with water and dry with paper. Clean (70%
IMS) combs (0.75 mm, 15 well) and position between the plates.
Plate preparation
• Clean (70% IMS) and assemble plates (8x10 cm) with spacers (0.75 mm)
between them.
• Prepare the resolving gel according to the recipe and pour immediately to 1.2
cm below top of plate (fill line), avoiding bubbles and leaks if possible.
• Overlay gel with water saturated sec-Butanol to burst any bubbles and give
an even level to top of gel.
• Leave to set (45 minutes, 23°C) and pour off the butanol. Wash with water
followed by several washes with Tris Buffer and leave with Tris buffer
(Stock B 1:4) overlay to allow polymerisation to occur (minimum of 2 hours,
23°C).
• Pour off buffer, rinse overlay with water and dry with paper. Clean (70%
IMS) combs (0.75 mm, 15 well) and position between the plates.
• Prepare the stacking gel according to the recipe, apply to the resolving gel as
before, remove any bubbles and leave to set (at least 90 minutes, 23°C).
Gel electrophoresis
• Remove the combs from the gels, take gels off the holder and attach to
electrophoresis apparatus.
• Place the assembled core in the tank and fill chamber with running buffer
(500 mis) to dislodge any trapped air bubbles.
• Load the samples (2.5 pi of the 50 pi of resuspended lyophilised medium, ie:
5%) into the wells, remove any air bubbles and top up the core chamber to
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about 3 mm below the top edges of the two plates. For the positive control, 1
pi of amniotic fluid at term is loaded.
• Run at a constant voltage, 100 V for 90 minutes at 23 °C.
• After electrophoresis measure molecular larkers and dye front.
• Remove gel from plate and immerse in Triton X 100 Wash buffer.
Wash, digestion and stain
• Wash the gels twice (15 minutes/wash, 23°C) in Triton wash buffer then
twice (~ 2 minutes/wash, 23°C) in wash buffer.
• Add digestion buffer and incubate at 37°C overnight. After incubation, decant
buffer, wash twice in wash buffer (~ 2 minutes/wash, 23°C) and add staining
solution (~ 3 hours, 23°C).
• Decant staining solution and replace with destaining solution (-30 minutes
then 60 minutes, 23°C). Store destained gels in air tight water-filled container
until ready to be photographed or scanned.
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2.71 REVERSE ZYMOGRAPHY
Reverse zmography detects activity of the TIMPs. In this technique, active MMP
incorporated into the gelatin sodium dodecyl sulphate-polyacrylamide gel binds to
TIMPs within the samples. When the electrophoresed gels are incubated overnight,
the MMPs within the gel become activated and digest the gelatin throughout the gel
apart from where it is bound to TIMPs within the sample. After staining, the TIMPs
are detected as a stained band on an otherwise clear background. (See Appendix II
for recipes). The activities of TIMP were detected by reverse zymography using a
commercially available kit with some minor adaptations (Riley et al 1999b).
REVERSE ZYMOGRAPHY
• Method for plate preparation and pouring gels, refer to Zymography protocol
Gel Electrophoresis
• Assemble apparatus and load samples on 12% gel containing gelatin (1
mg/ml) and a preparation of MMP-2 (conditioned medium from BHK-21
cells which constitutively express MMP-2; University Technologies Inc.)
using a minigel apparatus, as in Zymography protocol. The volume loaded for
the lyophilised samples is 7.5 pi (15% of the 50 pi of resuspended lyophilised
medium). The standards used are mouse TIMPs-1, -2 and -3, expressed by
transfected BHK-21 cells (University Technologies Inc.)
• Run at a constant voltage, 100 V for 90 minutes at 23°C
• After removing gel from apparatus place in container with Rinse Buffer
• Incubate at 23°C with gentle shaking for a 15 mins.
• Change Buffer and incubate with gentle shaking for a further 150 mins.
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• Discard Buffer and wash x 2 with deionised water
• Add Digestion Buffer and incubate at 37°C for 17 hrs.
• Discard Buffer, rinse in deionised water x 2.
• Stain and destain gel as in Zymography protocol.
The TIMPs inhibitory activity appeared as dark bands against a lighter background.
TIMPs were identified and characterised by comparison with molecular weight
markers, control standard solutions containing mouse TIMP-1, TIMP-2 and the
glycosylated and unglycosylated forms of TIMP-3 and human amniotic fluid, which
contain all TIMP isoforms (Riley et al 1999b). Analysis of samples by PAGE with
gelatine substrate omitted demonstrated no significant detectable underlying protein
staining at the molecular weights at which TIMP were observed, demonstrating the
specificity of the reverse zymography for the detection of TIMP activity.
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CHAPTER 3
GERM CELL SPECIFIC EXPRESSION OF C-KIT
IN THE HUMAN FETAL GONAD
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3.1 INTRODUCTION
The germ cells of vertebrate species do not initially form within the genital ridge but
originate in the extra embryonic mesoderm of the yolk sac. Primordial germ cells
increase by mitosis during migration and become associated with the cells within the
gonadal ridges at about 6 weeks (Byskov 1986). During fetal life, male germ cells
continue to proliferate until the late second trimester (Hilscher 1991). Within the
fetal ovary, following oogonial replication by mitosis, germ cells subsequently enter
meiosis only to arrest at diplotene of the first meiotic division (Hilscher 1991),
surrounding themselves with granulosa cells, thus forming primordial follicles.
Studies in rodents have highlighted the importance of the C-kit proto-oncogene
receptor and its ligand, the kit ligand (stem cell factor) in migration of germ cells
from the yolk sac to the developing gonad and their subsequent survival and
development (Godin et al 1991; Kierszenbaum et al 2001; Manova et al 1990; Pesce
et al 1993). For example, analysis in mice of the effects of mutations of the White
Spotting and Steel loci (encoding C-kit and the kit ligand respectively) has allowed
the demonstration of the importance of this ligand-receptor pair in multiple stem cell
lineages including melanogenesis and haematopoiesis as well as gametogenesis
(Ashman 1999; Besmer 1991). C-kit is predominantly expressed by germ cells in the
rodent testis although it has also been suggested to be expressed by Leydig cells
(Manova et al 1990), whereas K1 is expressed by a wider range of cell types. The
presence of a functional C-kit receptor has been implicated in spermatogonial
proliferation, survival and adhesion to Sertoli cells (Loveland et al 1997). Vincent et
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al have demonstrated expression of C-kit by pachytene spermatocytes and proposed
that the C-kit/Kl interaction is essential for meiosis (Vincent et al 1998).
Messenger KNA encoding C-kit and Kl have been detected in fetal mouse ovaries
between embryonic days 8 and 14.5 consistent with a role in germ cell migration and
proliferation (reviewed by (Driancourt et al 2000)). In their review Driancourt and
colleagues used ovaries from mice in which one copy of the kit gene was replaced by
a lac-z reporter construct (Bernex et al 1996) to demonstrate that C-kit mRNA is not
present in oogonia in fetal ovaries on day 15.5 but is transcribed in oocytes in
primordial and growing follicles at high levels. These results are in agreement with
the studies by Manova et al (Manova et al 1990) using in situ hybridisation.
Functional effects of kit ligand/c-kit in the ovary may persist into adult life, for
example in the regulation of persistence of meiotic arrest (Horie et al 1991; Ismail et
al 1997) and activation of primordial follicle growth (Parrott et al 1999; Yoshida et al
1997).
Studies identifying the sites of expression of C-KIT in the human fetus have been
very limited compared with those in rodents and there are inconsistencies between
the results so far reported. Horie and co-workers (Horie et al 1993) used specific
immunohistochemistry to detect C-KIT protein in frozen sections from a number of
human tissues and in their paper immunopositive staining of single sections from a
human fetal testis (18 weeks) and human fetal ovary (20 weeks) are shown.
However other investigators have suggested that C-KIT is not detectable in the fetal
testis after 15 weeks gestation (Rajpert-De Meyts et al 1996). It is notable that in the
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study by Rajpert-de-Meyts et al C-KIT remained detectable in intersex testes until
later in gestation and other studies from the same group have demonstrated that C-
KIT is a marker of carcinoma in situ (CIS) a pre-malignant lesion thought to be
associated with persistence of fetal-type germ cells in the adult testis (Rajpert-De
Meyts et al 1994). Consistent with the suggestion that signalling via c-kit is
important in normal male germ cell development and function, alterations C-KIT/KL
expression have also been demonstrated in some patients with defective
spermatogenesis (Mauduit et al 1999), with reduced expression associated with
increased germ cell apoptosis.
As the second trimester is the major time for the regulation of germ cell numbers in
the female (Baker 1963) and is a period of continuing testicular development
(Wartenberg 1989) we have examined the expression and localisation of C-KIT in
the human gonad between 13 and 20 weeks of development. Our studies have
demonstrated that C-KIT mRNA and protein are expressed specifically in germ cells
of both sexes during this critical period.
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3.2 MATERIALS AND METHODS
Tissues
Human fetal gonads were obtained following medical termination of pregnancy
(Section 2.21).
A total of 20 specimens were used for this study, divided equally between male and
female.
Isolation of RNA and synthesis of cDNA from whole tissues
Total RNA was extracted from snap frozen samples of fetal ovary (13-21 weeks,
n=10) and testis (14-19 weeks, n=6) and cDNA synthesis performed (Section 2.3).
Isolation of RNA by laser capture microscopy
RNA was extracted from gonocytes in paraffin wax embedded 19wk human fetal
testis samples using an anti-AMH polyclonal antibody to visualise the seminiferous
cords (Section 2.35). The extracted RNA was reverse transcribed and an aliquot of
cDNA was then amplified using a modified degenerate oligonucleotide primed
polymerase chain reaction (DOP-PCR) protocol (Section 2.35).
5pl of amplified cDNA was then used in subsequent PCR reactions using primer sets
for specific sequences.
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Amplification of specific cDNAs by polymerase chain reaction (PCR)
C-KIT
PCR was performed by incubating either lpl (whole tissue extracts) or 5pl (samples
from LCM) cDNA with Taq DNA polymerase in buffer containing 0.2 mM of each
dNTP and forward and reverse oligonucleotide primers. Two control tubes were run
in parallel, one in which water replaced the RNA and a second omitting reverse
transcriptase to ensure there was no genomic DNA contamination. PCR
amplification conditions consisted of an initial denaturation step at 95 for 2 min,
followed by 35 cycles of denaturation at 95°C for 30 sec, annealing at 50°C for 30
sec and extension at 72°C for 45 sec.; a final extension period at 72°C for 5 min
completed the amplification. Three sets of primers specific for human c-kit
(Vandenbark et al 1992) were used, one for cDNA from whole tissue extracts (set 1),
the other two following laser capture of samples (sets 2 and 3[nested]) (Table 3.1).
All three pairs of primers were designed to span an intron to ensure genomic DNA
was not amplified. Setl amplified a product of 345 bp; set 2 amplified a product of
232 bp; set 3 amplified a product of 138 bp from within the product of primer set 2.
Primers for the constitutively expressed gene GAPDH were used to confirm the
integrity of the RNA and efficacy of the PCR reaction. The identity of all PCR
products were confirmed by direct sequencing using an Applied Biosystems 373A
automated sequencer.
AMH
Specific primers were used to identify samples containing Sertoli cell mRNAs
recovered by LCM. All primers were based on the sequence of human AMH
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(accession no. NP000470). These primers are shown in Table 3.1 and set 1 amplify a
product of 238bp. Set 2 are nested and amplify a product of 117bp from within the



































Table 3.1 Primers used specific for human C-KITand AMH. Human sequences used:
SI = Accession no. U63834; S2 = Accession no. NP000470
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Immunohistochemistry
Immunohistochemistry was performed on paraffin embedded sections of fetal ovaries
and testes (Section 2.4) to localise the expression of C-KIT and AMH. A total of 6
ovaries and 6 testes were examined using immunohistochemistry.
C-KIT
Several C-KIT antibodies were used on both fetal ovaries and testes (Table 2.1,
Chapter 2). Non-specific binding was eliminated by pre-blocking with normal rabbit
serum (diluted 1:5 in TBS containing 5% bovine serum albumin) for 30 minutes at
23 °C. C-KIT (1) and C-KIT (2) primary antibodies were added at dilutions of 1: 300
and 1: 30 respectively (in diluted rabbit or swine serum, overnight at 4°C). The
secondary rabbit anti-goat and swine anti-rabbit biotinylated IgG antibodies for C-
KIT (1) and C-KIT (2) respectively were added at a dilution of 1: 500 (in dilute
rabbit or swine serum, for 30 minutes at 23°C).
AMH
Antigen retrieval was performed using citrate buffer (0.01M, pH 6.0, pressure
cooked for 2.5 minutes) prior to blocking tissue with 3% H2O2. Non-specific binding
was eliminated by pre-blocking with normal swine serum (diluted 1:5 in TBS
containing 5% bovine serum albumin) for 30 minutes at 23 °C. The rabbit polyclonal
primary antibody (Table 2.1 Chapter 2) was added at a dilution of 1: 500 (in diluted
swine serum, overnight at 4°C). Secondary swine anti-rabbit biotinylated IgG
antibody was added at 1: 500 (in dilute swine serum, for 30 minutes at 23°C).
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Immunoblotting
Immunoblotting was performed to detect C-KIT protein in fetal ovaries (n-2) and
testes (n=4) (Section 2.5-2.53).
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3.3 RESULTS
Expression of C-KIT mRNA
Following RT-PCR a single cDNA (345bp) was amplified from RNA extracted from
both fetal ovaries and testes at all gestations examined (13-21 weeks) (Figure 3.1 A);
although the PCR was not quantitative the amount of mRNA detected appeared
higher in samples from testis.
Analysis of cell populations recovered from fixed sections of a week 19 testis by
laser capture microscopy showed that at this age expression of C-KIT mRNA was
confined to the germ cell population (gonocytes) and was not expressed in either
Sertoli cells or within the interstitium (Figure 3.1 B-D).
Immunohistochemistry
C-KIT protein was detected by immunohistochemistry in all specimens examined,
across the gestational range 14-21 weeks (ovary) and 13-19 weeks (testis) (Figures
3.2 and 3.3, representative sections from a total of 6 ovaries and 6 testes). Both anti-
C-KIT antibodies tested gave similar staining patterns. In the ovary, positive
staining was seen in oogonia and oocytes (Figure 3.2 A-C labelled o), with the great
majority of germ cells being stained. The surface epithelium, the ovarian stroma and
the pregranulosa cells of primordial follicles were all immunonegative. This was
particularly apparent in the 21 week gestation specimen, in which there were a large
number of primordial follicles which were not present at earlier gestations (Figure
3.2 C, labelled pf). It was notable that although the C-KIT protein appeared to be
concentrated at the cell membrane of the oogonia at earlier gestational ages (Figure
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3.2 A, B, arrow o), at 21 weeks the protein was clearly spread throughout the
cytoplasm (Figure 3.2C, pf).
Within the testis, C-KIT protein was localised to gonocytes within the testicular
cords (Figure 3.3 A-C) consistent with the cell specific expression of C-KIT mRNA.
Although most gonocytes were immunopositive at all ages examined (13 to 19
weeks) some immunonegative cells were also present (e.g. 17 weeks, Figure 3.3C).
As with the ovary, immunohistochemical staining was concentrated at the germ cell
membrane (figure 3.3C arrow g). C-KIT immunoexpression was not detected in the
peritubular cells, interstitial cells (figure 3.3C) or the surface epithelium (not shown).
Sertoli cells were identified by immunostaining for AMH (Figure 3.3D). No staining
was seen on sections of ovary (Figure 3.2D) or testis (Figure 3.3D inset) in which the
primary antibody was not included.
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Figure 3.1 Expression of C-KIT mRNA in human fetal ovary and testis.
Panel A. RT-PCR analysis of samples extracted from whole ovaries obtained at 14,
16 and 21 weeks, and testis at 14, 17 and 19 weeks as indicated. Lanes labelled 'n'
contained samples in which reverse transcriptase was not included.
Panels B, C and D show results of RT-PCR analysis of cell fragments recovered
from a week 19 fetal testis by laser capture as described in Materials and Methods.
Tissues were immunostained for AMH to identify the positions of Sertoli cells and
gonocytes within the seminiferous cords. The mRNA for C-KIT (panel B) was
detected in gonocytes (G) and whole testis (T) but not in Sertoli cells (S) or the
interstitium (In). Likewise AMH (panel C) was only detected in S or T but not in G
or In. GAPDH (panel D) was detected in all samples. Lane bl denotes blank in
which reverse transcriptase was not included.
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A Ov Te
Figure 3.2 Immunohistochemical localisation of C-KIT in the human fetal ovary
(A) 14 week ovary; inset shows oocyte staining for C-KIT (B) 17 week ovary, (C) 21
week ovary, (D) Representative section of fetal ovary omitting anti C-KIT antibody.
Staining for C-KIT is brown, o, oocyte; pf, primordial follicles. Scale bar in A
represents 200pm and applies to D; scale bar on B is 50pm and also applies to A
inset; scale bar in C represents 25pm
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Figure 3.3 Immunohistochemical localisation of C-KIT (A-C) and AMH (D)
proteins to fixed tissue sections from human fetal testis.
(A) 14 week testis, (B) 16 week testis, (C) 17 week testis, (D) 17 week testis, AMH;
inset representative section of fetal testis omitting anti c-kit antibody. Staining for c-
kit and AMH is brown, g, gonocyte; i, interstitium; p, peritubular cells; s, Sertoli
cells; tc, tubules. Scale bar in A represents 200pm and applies to A, B, D, D inset;
scale bar in C represents 25pm.
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The presence of C-KIT protein in both fetal ovary and testis was confirmed by
immunoblotting. A prominent 145 kDa band corresponding to the size of the
transmembrane receptor protein was detected in samples from gonadal tissues of
both sexes (figure 3.4). There was no immunoreactivity in the absence of the primary
antibody. The experiment was repeated 3 times with similar results.
99
Figure 3.4 Western blot of C-KIT in human fetal ovary and testis.
Total protein samples (10pg) from ovary (14 weeks gestation) and testes (15 and 17
weeks gestation) were separated by SDS-PAGE, transferred to nylon membrane and
incubated with anti C-KIT antibodies. Positions of molecular weight markers are
indicated, the arrow marks the position of the single protein band which migrated
with an apparent molecular size of -110,000 kDa. No immunoreactive bands were






The results presented demonstrate unequivocally that the expression of C-KIT
mRNA and protein occurs in the germ cells of both ovary and testis in the human
fetus during the second trimester.
In the rodent ovary expression of the C-kit gene has been detected very early in
development and is high in proliferating germ cells (Manova et al 1991), however
expression stops when oogonia enter meiosis (Manova et al 1990). In the human
ovary, entry into meiosis occurs over a wide timescale, being detectable as early as
11 weeks gestation (Gondos et al 1986) although it is believed to be maximal at
approximately 20 weeks (Baker 1963). Thus over the range of gestations examined
in the present study, many oogonia will continue to proliferate by mitosis while an
increasing proportion enter meiosis. The absence of a closely-defined time at which
mitosis ceases and meiosis is initiated throughout the ovary is likely to account for
the detection of C-KIT mRNA in whole tissue samples at all gestations examined up
to 21 weeks, at which time many primordial follicles were present. The detection of
C-KIT protein in all specimens examined up to and including 21 weeks gestation is
consistent with a previous report in sheep in which C-KIT protein but not mRNA
was detected in oocytes undergoing meiosis (Tisdall et al 1999). It is possible that the
apparent change in intracellular localisation of C-KIT protein from the membrane to
the cytoplasm seen in human primordial follicles may be related to this underlying
change in gene expression. C-KIT protein has been previously localised to the
oocytes of a 20 week gestation fetus (Horie et al 1993) but in that study which was
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undertaken on frozen sections it was unclear whether C-KIT was localised to the
cytoplasm or cellular membrane.
The range of gestational ages examined in this study covers the period of definitive
histogenesis of the ovary, when the finite population of oocytes which will survive
within primordial follicles and thus determine reproductive potential is regulated. C-
KIT and its ligand, SCF or KL, may have an important role in these processes.
Mutations in the genes for these factors result in loss of primordial germ cells
(reviewed in Besmer (Besmer et al 1993)), and effects of KL/ C-KIT signalling on
germ cell survival and protection from apoptosis have been demonstrated in vivo and
in vitro (Godin et al 1991; Pesce et al 1993; Yee et al 1994). It has been suggested
that the pro-survival effects of c-kit in the ovary may be mediated by increased
expression of the anti-apoptotic factor Bcl-2 (Tilly 1996). Such studies have also
suggested a role for this pathway in regulation of the onset of primordial follicle
formation and growth of primary follicles (Yoshida et al 1997). KL/C-KIT may also
have a role in later folliculogenesis: both promotion of follicle development and
maintenance of arrest of meiosis have been suggested (Horie et al 1991; Ismail et al
1997; Parrott et al 1999). KL appears to have effects on surrounding stromal cells in
addition to the oocyte (Parrott et al 2000b). C-KIT is also present in the adult human
ovary, in both oocytes and granulosa cells (Tanikawa et al 1998) and has been
suggested to have an autocrine role in the ovarian surface epithelium (Parrott et al
2000a). C-KIT expression appeared to be confined to germ cells within the ovary in
the present study: no consistent staining of stromal cells was observed.
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The technique of laser capture microscopy (LCM) was developed at the National
Institutes of Health in the USA to allow sampling of individual, or groups of cells
from complex tissues in such a way that mRNA and/or proteins could be extracted
from them and analysed (Emmert-Buck et al 1996). The method has recently been
applied to the recovery of seminiferous tubules from frozen sections of mouse testis
(Suarez-Quian et al 2000). In the present study the LCM microscope was used with
the laser set to the smallest size available (7.5 pm) to allow for sampling of single
gonocytes. Recently the size of male germ cells in the human fetal testis (7 to 10
weeks) has been reported as being 9pm in diameter (Bendsen et al 2001). To enable
us to locate individual gonocytes, fixed tissue sections were used and these were
stained using a modified immunohistochemical technique. The use of fixed sections
meant that only short fragments of cDNA could be identified by RT-PCR
(Goldsworthy et al 1999) and we employed a nested PCR strategy to increase signal
intensity and specificity. We believe this is the first time LCM methodology has
been used to sample individual cell types from the human fetal testis and has allowed
us to show that C-KIT mRNA is expressed in fetal gonocytes at 19 weeks gestation.
In a previous study on human fetal testes C-KIT protein was not detected in the testis
beyond 15 weeks gestation using immunohistochemistry (Rajpert-De Meyts et al
1996). In another study presence of C-KIT in the human fetal testis was reported in
cells described as spermatogonia in a fetus of 18 weeks gestation (Horie et al 1991).
The results we have obtained using specific immunohistochemistry and Western
analysis all demonstrate that C-KIT protein is expressed in the fetal germ cells up to
and including 19 weeks of gestation. Gonocytes are believed to be the cell of origin
of gonadoblastomas (Rajpert-De Meyts et al 1996), and it has been suggested that
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prolonged expression of c-kit in germ cells in individuals with intersex conditions
may be a component of abnormal germ cell development in such individuals who are
at increased risk of testicular neoplasia (Rajpert-De Meyts et al 1996). Following
laser capture of cells from a 19 week fetus we failed to detect expression of C-KIT
mRNA in interstitial cells. Although this result is based on a single stage of
development it was in agreement with lack of immunostaining in the interstitium at
all ages examined and would not therefore be consistent with findings in the mouse
(Manova et al 1990). Studies of mice in which mutations in C-kit or its ligand have
been well documented and shown to result in a failure in migration of germ cells into
the genital ridge (reviewed by (Besmer et al 1993) however the use of a blocking
antibody against C-kit has led to the suggestion that C-kit is important in
proliferation of differentiated spermatogonia (Yoshinaga et al 1991) and protection
from apoptosis (Packer et al 1995). A role in spermatogonia! differentiation rather
than proliferation has also been suggested on the basis of experiments involving
transplantation of germ cells into testes of Steel mice (Ohta et al 2000) and the C-
kit/Kl genes shown to have a role in meiosis (Vincent et al 1998). Taken together
these data reinforce the importance of C-KIT and its ligand in multiple cell lineages
both during development and in adulthood.
In conclusion, this study demonstrates conclusively that C-KIT mRNA and protein
are expressed in oogonia during the transition from rapid proliferation by mitosis to
the formation of primordial follicles, and in gonocytes of the developing testis during
the second trimester. C-KIT has been demonstrated to be crucial for germ cell
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migration, survival and proliferation in the mouse: the present results suggest that C-
KIT is likely to be of similar importance in the human.
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CHAPTER 4
MATRIX METALLOPROTEINASES AND (MMPs)
TISSUE INHIBITORS OF
METALLOPROTEINASES (TIMPs) IN HUMAN
FETAL TESTIS AND OVARY
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4.1 INTRODUCTION
The development of the human fetal gonad is a complex process involving dramatic
structural changes, the control mechanisms of which remain unclear. In both fetal
ovary and testis, the ECM provides both the scaffold to which cells attach and also,
by binding to specific cell surface receptors, modulates their function (Woessner, Jr.
1991). Remodelling of the ECM may play an integral role in fetal gonadal
development, including cell migration, organisation, differentiation and function.
MMPs are essential for proteolytic degradation of the ECM and the extent of ECM
remodelling depends on the ratio of MMP to TIMP (Salamonsen 1996). Regulation
of ECM remodelling by MMPs and TIMPs is vital to provide an environment that
supports initiation ofgrowth, migration and differentiation by a range of mechanisms
(Behrendtsen et al 1997; Giannelli et al 1997; Li et al 2000). These proteins can act
from within the matrix and also at the cell surface, where for example MMP-2 and -9
are known to bind to heparin sulphate proteoglycans. They are thus positioned for
interaction with cell surface adhesion molecules or receptors and for regulating the
turnover of these molecules (Yu et al 2000b).
MMPs and TIMPs also regulate proliferation of a variety of cell types (Edwards et al
1996a) and are involved in the regulation of cytokines and their receptors both
directly and indirectly via effects on the ECM. Growth factors bound to ECM are
biologically inactive and must be liberated and in some cases activated before
binding to receptors (Vu et al 2000), for example MMP-9 proteolytically activates
latent transforming growth factor-P (TGF-P) (Yu et al 2000a). MMPs may also
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control bioavailability by cleaving binding proteins, thus MMP-1 can degrade
insulin-like growth factor binding proteins I and II (IGFBP I and II) into fragments
with low affinity for insulin growth factor I and II (IGF I and II), thus increasing the
bioavailability of IGF (Rajah et al 1995). Regulation of proteolytic degradation of the
ECM may therefore provide an important mechanism for controlling growth factor
availability and activity thus influencing tissue differentiation during organ
development. Secretion of MMPs and TIMPs is under the control of a wide range of
cytokines and growth factors (Nagase et al 1999), such as platelet derived growth
factor (PDGF) (Johnson et al 1999) and TGF-J3 (Edwards et al 1996b). Sex hormones
such as progesterone are also significant in ECM remodelling via inhibition of
MMPs-1, -3 and-7 synthesis and stimulation of TIMPs-1 and -2 production in
progesterone-dependent tissues (Imada et al 1994; Marbaix et al 1995). Signalling
pathways also lead to expression of particular MMP genes as in the case of MMP-1
which is mediated by the MAP kinase pathway (Reunanen et al 1998).
In the rat ovary MMPs are produced by a variety of cell types including mature
oocytes, granulosa cells and luteal cells (Bagavandoss 1998; Curry, Jr. et al 2001)
and in the bovine ovary MMP-9 and TIMP-1 have been associated with follicular
growth (Kaiura et al 2000; McCaffery et al 2000). TIMPs have also been identified
in the gonadal tissue of various species including adult human (Curry, Jr. et al 1990).
The objective of this study was to establish the secretion and localisation of a range
of MMPs and all TIMPs family members to determine their possible role in the
development of the fetal testis and ovary.
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4.2 MATERIALS AND METHODS
Collection of tissue samples
Gonadal tissue was collected from 21 fetuses after termination of pregnancy (Section
2.21). The gonads were removed and either placed in a sterile petri dish containing
a-MEM prior to culture or were immediately fixed in Bouins fluid for histological
analysis.
Explant culture
Gonads from 2 fetuses of each sex (ovaries at 12 and 14 week gestation, and testes at
17 weeks gestation) were cultured for 48 hours (Section 2.6) and the media was
collected in a sterile container and frozen at -20°C prior to analysis by zymography.
Detection of gelatinase activities by zymography
Activities of MMP-2 and MMP-9 were determined using gelatinase zymography
(Riley et al 1999a) (Section 2.7, Appendix II).
Detection of TIMPs by reverse zymography
The activity of TIMP-1, -2, -3 and -4 was detected by reverse zymography (Riley et
al 1999b) (Section 2.71, Appendix II).
Localisation of MMP-1, -2, and -9 and TIMPs by immunohistochemistry
Immunoreactive MMP-1, -2 and -9, and TIMP-1, -2, -3 and -4 were localised in
tissues using immunohistochemistry (Riley et al 1999b) (Section 2.4). The conditions
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for individual antibodies are described below. In each case term human fetal
membranes were used as a positive control.
MMP-1
Non-specific binding was eliminated by pre-blocking with normal horse serum
(diluted 1:5 in TBS containing 5% bovine serum albumin) for 30 minutes at 23°C.
The mouse monoclonal primary antibody was added at a dilution of 2pg/ml (in
diluted horse serum, overnight at 4°C). Secondary horse anti-mouse biotinylated IgG
antibody was added at 1: 500 (in dilute horse serum, for 30 minutes at 23°C).
MMP-2
Non-specific binding was eliminated by pre-blocking with normal horse serum
(diluted 1:5 in TBS containing 5% bovine serum albumin) for 30 minutes at 23°C.
The mouse monoclonal primary antibody was added at a dilution of 5pg/ml (in
diluted horse serum, overnight at 4°C). Secondary horse anti-mouse biotinylated IgG
antibody was added at 1: 500 (in dilute horse serum, for 30 minutes at 23°C).
MMP-9
Non-specific binding was eliminated by pre-blocking with normal horse serum
(diluted 1:5 in TBS containing 5% bovine serum albumin) for 30 minutes at 23°C.
The mouse monoclonal primary antibody was added at a dilution of lOpg/ml (in
diluted horse serum, overnight at 4°C). Secondary horse anti-mouse biotinylated IgG
antibody was added at 1: 500 (in dilute horse serum, for 30 minutes at 23°C).
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TIMP-1
Non-specific binding was eliminated by pre-blocking with normal goat serum
(diluted 1:5 in TBS containing 5% bovine serum albumin) for 30 minutes at 23°C.
The rabbit polyclonal primary antibody was added at a dilution of 2pg/ml (in diluted
goat serum, overnight at 4°C). Secondary goat anti-rabbit biotinylated IgG antibody
was added at 1: 500 (in dilute goat serum, for 30 minutes at 23°C).
TIMP-2
Non-specific binding was eliminated by pre-blocking with normal goat serum
(diluted 1:5 in TBS containing 5% bovine serum albumin) for 30 minutes at 23°C.
The rabbit polyclonal primary antibody was added at a dilution of 5pg/ml (in diluted
goat serum, overnight at 4°C). Secondary goat anti-rabbit biotinylated IgG antibody
was added at 1: 500 (in dilute goat serum, for 30 minutes at 23°C).
TIMP-3
Non-specific binding was eliminated by pre-blocking with normal goat serum
(diluted 1:5 in TBS containing 5% bovine serum albumin) for 30 minutes at 23°C.
The rabbit polyclonal primary antibody was added at a dilution of 5pg/ml (in diluted
goat serum, overnight at 4°C). Secondary goat anti-rabbit biotinylated IgG antibody
was added at 1: 500 (in dilute goat serum, for 30 minutes at 23°C).
TIMP-4
Non-specific binding was eliminated by pre-blocking with normal goat serum
(diluted 1:5 in TBS containing 5% bovine serum albumin) for 30 minutes at 23°C.
Ill
The rabbit polyclonal primary antibody was added at a dilution of 5pg/ml (in diluted
goat serum, overnight at 4°C). Secondary goat anti-rabbit biotinylated IgG antibody
was added at 1: 500 (in dilute goat serum, for 30 minutes at 23°C).
Analysis of immunohistochemistry
Immunostaining of tissue sections was assessed semi-quantitatively for both the
ovary and testis using + and - symbols as a measure of the intensity and amount of




No positive staining in any cell of this
type
+/- Some but not most of these cells have
stained
+ Pale staining in this cell type
++ Marked staining in this cell type
+++ Intense immunostaining
Table 4.1 Table showing semi-quantitative scoring of immunohistochemical staining
of fetal testes and ovaries.
4.3 RESULTS
Secretion of MMPs and TIMPs by the fetal testis
In culture medium conditioned by the fetal testis for 48 h, high levels of gelatinase
activity were detected at 120 kDa, 92 kDa, 72 kDa and 66 kDa. These molecular
weights correspond to the MMP-9 lipocalin complex, the active form of MMP-9,
MMP-2 activated protein in the latent form and the active form of MMP-2
respectively (Figure 4.1). The predominant gelatinase activity detected was ofMMP-
2, the latent form. MMP-2 and -9 were studied in particular because these MMPs
break down collagen IV which is a major component of basement membranes, and
so a good candidate and marker for important remodelling events.
The examination of TEMP activity in the testis using reverse zymography showed
predominant gelatinase inhibitory activity at 27-30 kDa, which corresponds to the
molecular weights of TIMP-1, glycosylated TIMP-3, and TIMP-4 (Figure 4.2).
Bands of activity were also present at 24 kDa (corresponding to unglycosylated
TIMP-3) and 21 kDa (corresponding to TIMP-2). These bands aligned with
standards to TIMP-1, TIMP-2 and glycosylated and unglycosylated TIMP-3. Reverse
zymography is unable to distinguish precisely between the TIMP isoforms of 27-30
kDa molecular weight. The presence of these TIMPs of similar molecular weights,
including TIMP-4, was therefore confirmed by immunohistochemistry.
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Figure 4.1 Gelatin zymography gel showing gelatinase activity (visualised as lighter
bands) in conditioned medium from explant cultures of fetal ovary and testis. Ovary
1, 14 weeks; ovary 2, 12 weeks; testis 1 and 2, 17 weeks. The predominant gelatinase
activity is due to MMP-2 (latent form; 72 kDa). Molecular weight markers are as












Figure 4.2 Reverse zymography gel demonstrating the secretion of TIMPs
(visualised by darker bands) into culture medium from explant cultures of fetal ovary
and testis. Ovary 1, 14 weeks; ovary 2, 12 weeks; testis 1 and 2, 17 weeks. Three
predominant bands of TIMP activity are observed at 27-30 kDa, 24 kDa and 21kDa.
The standards (stds) of TIMP-1 and TIMP-2 (1+2; TIMP-1 as a broad band at 27-30
kDa; TIMP-2 at 21 kDa) and TIMP-3 (3; glycosylated TIMP-3 at 28-30 kDa and
unglycosylated TIMP-3 form at 24 kDa) are indicated by arrows. Molecular weight





















Localisation of MMPs and TIMPs in the fetal testis
Sections of human testis from ten fetuses between 13 and 19 weeks gestation were
used for analysis. Table 4.2 shows the spatial and cellular localisation of MMPs and
TIMPs immunoreactivity and relative intensity of staining found and Figure 4.3
shows representative photomicrographs. MMP-1 was found in abundance in the
cytoplasm of the interstitial cells and to a lesser extent in the surface epithelium
(Figure 4.3A). MMP-1 was also distributed among some of the peritubular cells and
within the tubules, particularly in Sertoli cells. MMP-2 was predominantly localised
to the interstitium of the testis and also found within the cytoplasm of some of the
tubular cells, being more prevalent in gonocytes than Sertoli cells (Figure 4.3B). It
was also present in the surface epithelium but absent in the peritubular cells. MMP-9
was present chiefly within the tubules and was also present in some of the interstitial
cells and surface epithelium (Figure 4.3C). Like MMP-2, MMP-9 was not observed
in the peritubular cells.
TIMPs-1, -2, -3 and -4 were also immunolocalised within the fetal testis. TIMP-1
was localised to the cytoplasm of the interstitial cells and also within the tubules,
staining in particular Sertoli cells (Figure 4.3D). TIMP-2 was predominantly
localised to the interstitium, with very little within the tubules and no
immunoreactivity in the peritubular cells or surface epithelium (Figure 4.3E).
Staining for TIMP-3 was very intense within the interstitium and was also present
although to a lesser degree in some of the peritubular cells (Figure 4.3F). There was
no TIMP-3 immunostaining within the tubules and surface epithelium. TIMP-4 was
present mainly in the interstitial cells but there was also strong positive staining
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within the Sertoli cell and gonocyte cytoplasm (Figure 4.3G). It was absent from
both the peritubular cells and the surface epithelium. Immunostaining was also
observed in the vascular endothelium for MMPs-1, -2, -9 and TIMPs-1, -2, -3 and -4
(Table 4.2). No major changes were seen in immunostaining for any MMP or TIMP
examined over the gestational range examined. Sections incubated without primary








MMP-1 +/- + ++ +++ + +
MMP-2 - + +/- ++ +/- +
MMP-9 - ++ ++ ++ - +
TIMP-1 +/- + ++ ++ +/- +
TIMP-2 - +/- +/- ++ - +
TIMP-3 +/- - - +++ - +
TIMP-4 - ++ ++ ++ - +
Table 4.2 Semi-quantitative analysis of cellular and spatial localisation of MMP-1, -
2, -9 and TIMPs -1, -2, -3 and -4 using immunohistochemistry in the fetal testis
between 13 and 19 weeks gestation.
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Figure 4.3 Localisation of MMP-1, -2, -9 and TIMPs -1, -2, -3 and -4 in human fetal
testis. (A) Shows MMP-1 in fetal testis at 13 wks. Arrow denotes surface epithelium.
(B) MMP-2 in 15 wk. fetal testis (C) MMP-9 in 17 wk. fetal testis (D) TIMP-1 in 19
wk. fetal testis. Arrow indicates peritubular cells. (E) TIMP-2 in 13 wk. fetal testis.
The arrow denotes the surface epithelium. (F) TIMP-3 in 15 wk. fetal testis (G)
TIMP-4 in 15 wk. fetal testis (H) Representative section of fetal testis omitting
primary antibody, i, interstitium; tc, tubules. Scale bar in A represents 100 pm and












\r-1mw-r\t- (1sMrr £j ,
/fi* ; •; '.* ^l|/''»■*JL;
SgfllOTi IS
£• ?£««• -Mri S











* ^SfCTfc^>iViA '.«•- 3S#Y
tclv-
> ■*• T«x .H^ i-W il ■ si -■







*jrU- . -r •W&2s2
*ng v»;f »*< v"




• ?• fr *Ar ;V£P*8P
II />/jP Im
f^HLsfltev■■ •: .' ••fcCTtk , .i;1 - 2rv% ■
(w^a ••I ( .*> 4. j J» «
'[V,\ G^'7Ai
V #>» £ a-kl£^Sv. --f>
tc
Secretion of MMPs and TIMPs by the fetal ovary
Analysis using zymography of culture medium conditioned by the fetal ovary for 48
h, demonstrated in the two samples examined that the predominant gelatinase
activity was identified at 72 kDa molecular weight, corresponding to the latent form
of MMP-2 (Figure 4.1). The active form ofMMP-2, which has a molecular weight of
66 kDa, was also detected but at a lower level. Gelatinase activity was also
detectable at 92 kDa, corresponding to latent MMP-9 and a less intense band of
activity was observed at 120 kDa, corresponding to the MMP-9 lipocalin complex. In
one sample, MMP-2 (latent and active) and MMP-9 were identified in much smaller
amounts.
A broad spectrum of TIMP activity was detected in culture medium conditioned by
the fetal ovary for 48 h by reverse zymography (Figure 4.2). Three bands of
gelatinase inhibitory activity were present at 27-30 kDa (corresponding to the
molecular weight of TIMP-1, glycosylated TIMP-3 and TIMP-4), 24 kDa
(corresponding to unglycosylated TIMP-3) and 21 kDa (corresponding to TIMP-2).
As with zymography, one of the samples showed very low levels of TIMPs activity.
Localisation of MMPs and TIMPs in the fetal ovary
Sections of fetal ovaries from 11 fetuses between 13 and 21 weeks gestation were
used for analysis. Table 4.3 and Figure 4.4 describe and demonstrate the spatial and
cellular localisation of MMPs and TIMPs and relative intensity of immunostaining
121
found. As with the fetal testis, no major or systematic variation in immunostaining
was seen for any MMP or TIMP examined with increasing gestational age.
MMP-1 was abundantly present in the cytoplasm of the oocytes throughout the
ovarian cortex and was also localised to some of the cells of the ovarian stroma and
the surface epithelium, although this immunoreactivity was less intense (Figure
4.4A). MMP-2 was predominantly found in the oocyte cytoplasm and was also
present in some of the cells of the surface epithelium but was absent from the ovarian
stroma (Figure 4.4B). A similar staining pattern in the oocyte cytoplasm and surface
epithelium was found with MMP-9 (Figure 4.4C).
All four members of the TEMP family were also localised within the fetal ovary.
TIMP-1 was found chiefly in the cytoplasm of the oocytes but was also present in the
surface epithelium (Figure 4.4D). TIMP-2 was weakly associated with the oocyte
cytoplasm but was more localised to the ovarian stroma and was absent from the
surface epithelium (Figure 4.4E). TIMP-3 was widely distributed, immunostaining
some of the oocyte cytoplasm, ovarian stroma and cells of the surface epithelium
(Figure 4.4F). Immunostaining for the TIMP-4 antibody was restricted to the oocyte
cytoplasm (Figure 4.4G). MMPs-1, -2, -9 and TIMPs-1, -2, -3 and -4 were also
localised to the vascular endothelium (Table 4.3). No immunostaining was observed










MMP-1 ++ +/- +/- +
MMP-2 ++ - +/- +
MMP-9 ++ - +/- +
TIMP-1 +++ - +/- +
TIMP-2 +/- +/- - +
TIMP-3 +/- +/- +/- +
TIMP-4 ++ - - +
Table 4.3 Semi-quantitative analysis of cellular and spatial localisation of MMP-1, -
2, -9 and TIMPs -1, -2, -3 and -4 by immunohistochemistry in the fetal ovary
between 13 and 21 weeks gestation.
123
Figure 4.4 Localisation of MMP-1, -2, -9 and TIMPs -1, -2, -3 and -4 in human fetal
ovary (A) MMP-1 in fetal ovary at 21 wks. Inset demonstrates primordial follicles
stained with MMP-1 in same ovary (B) MMP-2 in fetal ovary at 21 wks. Inset shows
primordial follicles with staining for MMP-2 in oocyte cytoplasm in same ovary. (C)
MMP-9 in fetal ovary at 13 wks. Inset shows oocytes stained with MMP-9 in 16 wk
ovary (D) TIMP-1 in 15 wk. fetal ovary (E) TIMP-2 in 17 wk. fetal ovary. Inset
shows oocytes and rete ovarii staining with TIMP-2 in same ovary. (F) TIMP-3 in 13
wk. fetal ovary. Arrow denotes surface epithelium. (G) TIMP-4 in 15 wk. fetal
ovary. Arrow denotes primordial follicle. Inset shows oocyte staining for TIMP-4 in
same ovary. (H) Representative section of fetal ovary omitting primary antibody, os,
ovarian stroma; pf, primordial follicle; o, oocyte. Scale bar in A represents 50 pm
and applies to panels B-H and scale bar in A inset represents 12 pm and applies to
insets in B, C, E and G.
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This study demonstrates the presence of MMP-1, -2, -9 and all four TIMP family
members in the human fetal ovary and testis during mid-gestation. MMP-2 appears
the predominant gelatinase matrix metalloproteinase secreted by the gonads, being
most abundant in its latent form. All of the TIMP family were secreted by both the
testis and ovary. These data therefore indicate the likely involvement of MMPs and
TIMPs during this time of gonadal development.
Using zymographic techniques, we are unable to comment on absolute amounts of
MMPs and TIMPs present as they are not quantitative but they do allow relative
intensities of activity to be established. However, one of the ovarian samples
analysed (at 14 weeks gestation) appeared to be producing much lower levels of
MMPs and TIMPs than the other samples tested. This may be due to a change in
secretion levels over gestation or to a delay in receiving the tissue after termination.
Immunolocalisation does not specifically identify the cellular site of production of
these TIMPs and MMPs as they are secreted and may bind to the ECM or directly to
the cell, however it is likely that the MMPs and TIMPs have been directly secreted at
these sites to mediate specific functions (Vu et al 2000). The drugs used to induce
termination included mifepristone and a prostaglandin El analogue. Mifepristone is a
potent anti-progestin and anti-glucocorticoid, which also has anti-oestrogenic effects
(Teutsch et al 1994). Although concentrations of mifepristone reaching the chorionic
villi are low compared with those in serum and decidua (Wang et al 1994) it may
have some effect on the fetal gonadal tissue, although the nature and extent of any
such effects are currently unknown. Exogenous prostaglandin El is also used to
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induce uterine contractions and promote cervical dilatation at termination.
Prostaglandins are involved in many aspects of normal ovarian function and it is
uncertain whether these concentrations used in the termination procedure might cross
the placenta to the fetus and then have an effect on the fetal gonadal tissue
(Greystoke et al 2000).
Both MMPs and TIMPs are likely to be involved in the tissue remodelling that
accompanies the rapid growth, differentiation and structural changes of the fetal
gonads in the second trimester. Interactions between MMPs and TIMPs are probably
important in controlling both fibrillar collagen remodelling by MMP-1, an important
structural matrix component and also collagen IV, by MMP-2 and -9, a major
component of basement membranes. Thus, cells can be permitted to grow,
differentiate and undergo mitosis. Cell migration may also be allowed (Giannelli et al
1997), as seen for instance in the formation of primordial follicles in the ovary that
occurs at this time in development and the movement of gonocytes from a central
location within the testicular tubule to lying adjacent to the basement membrane.
MMPs and TIMPs influence many cellular functions (Salamonsen 1996; Vu et al
2000) and may play other roles within the gonads. The interaction between a cell and
its surrounding matrix, for instance via integrins and focal adherins, is a vital
regulator of cell function (Brooks et al 1996) (Giancotti 1997; Steffensen et al
1998)and studies on roles of MMPs at the cell surface have shown that they can
stimulate cell proliferation through interaction with cytokines (Edwards et al 1996a).
MMPs-1, -2 and -9 bind to heparin suphate proteoglycans on the cell surface (Fisher
et al 1994; Yu et al 2000b) which may prevent diffusion of the MMP and confer a
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high degree of local control for tissue remodelling, cell matrix interactions and local
modulation of cytokine shedding or degradation. The binding of MMP-2 and -9 to
heparin sulphate proteoglycan therefore may have an effect on processes involving
excessive tissue breakdown, such as angiogenesis. As we have observed vascular
staining in both testis and ovary for MMP-1, -2 and -9 and all TIMPs, it is likely that
these proteins are involved in angiogenesis within the gonadal tissue (Yu et al
2000b). MMP-1 may also have another role in angiogenesis as it enhances smooth
muscle cell migration within the vessel wall by degrading collagen to gelatin, leaving
this available for the action of gelatinases such as MMP-2 (Pilcher et al 1997).
MMPs and TIMPs may also regulate cell cycle progression or death (Boudreau et al
1996). TIMP-3 induces apoptosis of colon carcinoma cells (Smith et al 1997), and in
mammary cells inhibition of MMP activity rescues cell apoptosis (Schedin et al
2000). The number of germ cells within the ovary reaches a peak at approximately
20 weeks gestation (Baker et al 1974) with a parallel though lesser increase in the
number of atretic cells. The rapid increase and subsequent loss of germ cell numbers
at this time is likely to have a major impact on the compliment of primordial
follicles. The regulatory mechanisms involved are fundamental to the determination
of reproductive lifespan but are poorly understood. The presence of MMP-1, -2, -9,
TIMP-1 and -4 in the oocytes suggests that they may potentially regulate survival
signals and so possibly affecting cell proliferation. MMPs also regulate growth factor
activity by cleaving the proteins that bind them, including IGF I and II. MMP-1 and -
2 both can degrade IGFBPs I and II allowing IGF I and II to become active (Rajah et
al 1995; Vu et al 2000). IGF I and II, its receptor and binding proteins I and II are
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expressed in the human ovary and testis and have been implicated germ cell
development (Zhou et al 1993a; Zhou et al 1993b). In addition, TIMPs also stimulate
proliferation directly in other cell systems (Hayakawa et al 1994) and MMP activity
and its control by TIMPs regulates activation of cytokines such as tumour necrosis
factor a (TNF a) (McGeehan et al 1994) at the cell matrix interface. The TIMP-1-
procathepsin L complex has been previously suggested to be a potent activator of
steroidogenesis in the rat testis, and was secreted by Sertoli cells (Boujrad et al
1995). The present data suggest that TIMP-1 is mainly localised to the Sertoli cells
within the tubules, thus it may play a similar steroidogenic role in the human fetal
testis.
In conclusion, this study demonstrates that MMPs and TIMPs are secreted by the
human fetal gonad during mid gestation and are localised with discrete cellular and
spatial distributions within the fetal testicular and ovarian tissue. These results
suggest that MMPs and TIMPs are involved in ECM remodelling at this time and
may also play a role in paracrine regulation including germ cell proliferation by
regulating growth factor availability and action, and possibly also steroidogenesis in
the testis. This study provides a basis from which to work towards further assessment
of the functions of MMPs and TIMPs within the human fetal gonad during this
period of structural change and development.
128
CHAPTER 5
EXPRESSION OF NEUROTROPHINS AND
THEIR RECEPTORS IN THE HUMAN FETAL




Mammalian ovarian development is characterised by a sequential pattern of mitotic
proliferation of oogonia, initiation then arrest of meiosis, and primordial follicle
formation. As reproductive lifespan is determined by the continuing presence of
primordial follicles, the regulation of germ cell proliferation and survival in the form
of primordial follicles is central to reproductive potential. Waves of atresia of
oogonia have been identified at particular stages of development (Baker 1963; Speed
1988) but the factors and pathways involved are largely unknown, particularly in the
human. The neurotrophin family are known to have a critical role in cell
proliferation, migration, differentiation and survival within the nervous system
(Davies 1994; Henderson et al 1993; Snider 1994). However they also have
important functions in non neuronal tissue (Brill et al 1995; Dissen et al 1995;
Mitsiadis et al 1995; Ojeda et al 1992; Sariola et al 1991; Wheeler et al 1992; Yaar et
al 1991) and have been demonstrated in the mammalian ovary (Berkemeier et al
1991; Dissen et al 1995; Ernfors et al 1990b; Ibanez et al 1992; Klein et al 1989;
Lara et al 1990; Timmusk et al 1993). There they appear to be involved in follicular
formation (Dissen et al 1995; Dissen et al 2001) and ovulation (Dissen et al 1996;
Mayerhofer et al 1996). More recently, neurotrophins have been shown to promote
germ cell survival in the mouse ovary (Spears 2003). There is therefore increasing
evidence that the various neurotrophins may have specific roles in ovarian
development and function, but no data are currently available on their presence in the
normal human ovary. We have therefore investigated the presence and distribution of
the neurotrophins and their receptors in the developing human ovary during the
period leading up to the formation of primordial follicles. Following this, we
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examined the effect blocking neurotrophin action in organ culture had on germ cell
survival and proliferation.
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5.2 MATERIALS AND METHODS
Tissue samples
Human fetal ovaries aged between 13 and 21 weeks of gestation were obtained
following medical termination of pregnancy (Section 2.21).
Isolation of RNA and RT-PCR
Total RNA was extracted from snap frozen samples of fetal ovary and cDNA
synthesised (Section 2.3). RT-PCR was performed (Section 2.31) using primers
specific for human neurotrophins and their receptors. All products were purified
(Section 2.33) and their identities confirmed by direct sequencing (Section 2.34).
Amplification of specific neurotrophins and receptors by PCR
NGF
Specific primers were used to identify human NGF and are detailed in Table 5.1. The
PCR programme used was as follows: samples were denatured at 95°C for 2
minutes; samples were then heated to 95°C for 30 seconds, 50°C for 30 seconds, and
72°C for 45 seconds for 35 cycles. A final extension step at 72°C for 15 minutes
completed the programme and amplified a PCR product of 167 bp.
BDNF
Specific primers were used to identify human BDNF and are detailed in Table 5.1.
The PCR programme used was as follows: samples were denatured at 95°C for 2
minutes; samples were then heated to 95°C for 30 seconds, 50°C for 30 seconds, and
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72°C for 45 seconds for 35 cycles. A final extension step at 72°C for 15 minutes
completed the programme and amplified a PCR product of 222 bp.
NT3
Specific primers were used to identify human NT3 and are detailed in Table 5.1. The
PCR programme used was as follows: samples were denatured at 95°C for 2
minutes; samples were then heated to 95°C for 30 seconds, 55°C for 30 seconds, and
72°C for 45 seconds for 35 cycles. A final extension step at 72°C for 15 minutes
completed the programme and amplified a PCR product of 334 bp.
NT4
Specific primers were used to identify human NT4 and are detailed in Table 5.1. The
PCR programme used was as follows: samples were denatured at 95°C for 2
minutes; samples were then heated to 95 °C for 30 seconds, 57°C for 30 seconds, and
68°C for 45 seconds for 35 cycles. A final extension step at 68°C for 15 minutes
completed the programme and amplified a PCR product of 400 bp.
TRKA
Specific primers were used to identify human TRKA and are detailed in Table 5.1.
The PCR programme used was as follows: samples were denatured at 95°C for 2
minutes; samples were then heated to 95°C for 30 seconds, 55°C for 30 seconds, and
72°C for 45 seconds for 35 cycles. A final extension step at 72°C for 15 minutes
completed the programme and amplified a PCR product of 229/247 bp.
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TRKB
Specific primers were used to identify full-length human TRKB and are detailed in
Table 5.1. The PCR programme used was as follows: samples were denatured at
95°C for 2 minutes; samples were then heated to 95°C for 30 seconds, 57°C for 30
seconds, and 68°C for 45 seconds for 35 cycles. A final extension step at 68°C for 15
minutes completed the programme and amplified a PCR product of 525 bp.
trTRKB
Specific primers were used to identify human trTRKB and are detailed in Table 5.1.
The PCR programme used was as follows: samples were denatured at 95°C for 2
minutes; samples were then heated to 95°C for 30 seconds, 57°C for 30 seconds, and
68°C for 45 seconds for 35 cycles. A final extension step at 68°C for 15 minutes
completed the programme and amplified a PCR product of 430 bp.
TRKC
Specific primers were used to identify human TRKC and are detailed in Table 5.1.
The PCR programme used was as follows: samples were denatured at 95°C for 2
minutes; samples were then heated to 95°C for 30 seconds, 57°C for 30 seconds, and
68°C for 45 seconds for 35 cycles. A final extension step at 68°C for 15 minutes
completed the programme and amplified a PCR product of 228/204 bp and an extra
band of 300bp. This band persisted despite changing the PCR conditions so a gel
extraction technique was used to confirm the separate sequences for each band.
Samples were run on a 1.5% agarose gel and the resulting 3 bands cut out. GenElute
Agarose Spin Columns were used to extract the DNA. Briefly, the columns were
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prewashed with 100 pi of H2O and centrifuged for 5 - 10 seconds at maximum
speed. The elute was discarded and a gel slice loaded onto the column and
centrifuged at maximum speed for 10 seconds. The DNA yield was measured using a
spectrophotometer and then products were directly sequenced using the method
described.
P75
Specific primers were used to identify human P75 and are detailed in Table 5.1. The
PCR programme used was as follows: samples were denatured at 95°C for 2
minutes; samples were then heated to 95°C for 30 seconds, 55°C for 30 seconds, and
72°C for 45 seconds for 35 cycles. A final extension step at 72°C for 15 minutes
completed the programme and amplified a PCR product of 489 bp.
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Table 5.1 Table listing the sequences for specific primers for human neurotrophins
and their receptors. Human sequences used: S3 = Accession no. NM002506; S4 =
Accession no. X91251; S5 = Accession no. NM002527; S6 = Accession no.
NM006179; S7 = Accession no. NM002529; S8 = Accession no. NM006180;

































Forward TCTTCACTGAGTTCCTGGAG 229/247- spliced variants
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In situ hybridization for NT4
Riboprobes were generated using a PCR strategy to incorporate SP6 or T7 phage
promoter sequences into NT4 PCR product (Section 2.37). In situ hybridisation was
then performed for NT4 (Section 2.38).
Immunohistochemistry
Immunohistochemistry was performed on paraffin embedded sections (Section 2.4)
to localise the expression of NGF, NT3, NT4, the receptors TRKB and P75 and
BrdU.
NGF
Non-specific binding was eliminated by pre-blocking with normal swine serum
(diluted 1:5 in TBS containing 5% bovine serum albumin) for 30 minutes at 23°C.
The rabbit polyclonal primary antibody was added at 1: 30 (in diluted swine serum,
overnight at 4°C) and secondary swine anti-rabbit biotinylated IgG antibody added at
1: 500 (in dilute swine serum, for 30 minutes at 23°C). A NGF peptide block was
used as a negative control. The peptide block (concentration 200pg/ml ) was added
to the antibody in a ratio of 10:1. This solution of peptide and antibody was then




Non-specific binding was eliminated by pre-blocking with normal swine serum
(diluted 1:5 in TBS containing 5% bovine serum albumin) for 30 minutes at 23°C.
The rabbit polyclonal primary antibody was added at 1: 50 (in diluted swine serum,
overnight at 4°C) and secondary swine anti-rabbit biotinylated IgG antibody added at
1: 500 (in dilute swine serum, for 30 minutes at 23°C).
NT4
Non-specific binding was eliminated by pre-blocking with normal swine serum
(diluted 1:5 in TBS containing 5% bovine serum albumin) for 30 minutes at 23°C.
The rabbit polyclonal primary antibody was added at 1: 100 (in diluted swine serum,
overnight at 4°C) and secondary swine anti-rabbit biotinylated IgG antibody added at
1: 500 (in dilute swine serum, for 30 minutes at 23°C).
TRKB
Several TRKB antibodies were used on both fetal ovaries and testes. After dewaxing
and rehydrating, antigen retrieval was carried out. The tissue was immersed in
boiling 0.01M citrate buffer pH 6.0 for 2.5 mins and then left to stand in the buffer
for 10 minutes. Non-specific binding was eliminated by pre-blocking with normal
swine serum in the case of TRKB (1) and TRKB (3) and donkey serum in the case of
TRKB (2) (diluted 1:5 in TBS containing 5% bovine serum albumin) for 30 minutes
at 23°C. Primary antibodies were added at serial dilutions of 1: 25, 1:50 and 1:100
(in diluted donkey or swine serum, overnight at 4°C). The secondary swine anti-
rabbit and donkey anti-chicken biotinylated IgG antibodies for TRKB (1) and (3) and
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TRKB (2) respectively were added at a dilution of 1: 500 (in dilute donkey or swine
serum, for 30 minutes at 23°C).
P75
After dewaxing and rehydrating, antigen retrieval was carried out. The tissue was
immersed in boiling 0.01M citrate buffer pH 6.0 for 5 mins and then left to stand in
the buffer for 20 minutes. Non-specific binding was eliminated by pre-blocking with
normal rabbit serum (diluted 1:5 in TBS containing 5% bovine serum albumin) for
30 minutes at 23°C. The mouse monoclonal primary antibody was added at dilutions
of 1: 25 to ovarian tissue and 1:50 to testicular tissue (in diluted rabbit serum,
overnight at 4°C). Secondary rabbit anti-mouse biotinylated IgG antibody was added
at 1: 500 (in dilute rabbit serum, for 60 minutes at 23°C).
BrdU
After dewaxing and rehydrating, antigen retrieval was carried out. The tissue was
immersed in boiling 0.01M citrate buffer pH 6.0 for 2.5 mins and then left to stand in
the buffer for 10 minutes. Non-specific binding was eliminated by pre-blocking with
normal rabbit serum (diluted 1:5 in TBS containing 5% bovine serum albumin) for
30 minutes at 23 °C. The mouse monoclonal primary antibody was added at a dilution
of 1: 30 to sections of cultured tissue (in diluted rabbit serum, overnight at 4°C).
Secondary rabbit anti-mouse biotinylated IgG antibody was added at 1: 500 (in dilute
rabbit serum, for 60 minutes at 23°C).
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Immunoblotting
Protein was extracted from snap frozen fetal ovaries and immunoblotting performed
for NT4, TRKB and P75 (Sections 2.51-2.53).
Ovary Culture
Ovaries from 5 fetuses ranging from 13 to 16 weeks gestation were dissected free of
adherent tissues using sterile technique, bisected longitudinally and then cut into
slices ~0.5mm thick. Samples of fresh tissue were fixed for histological analysis. The
remaining tissue fragments were cultured for 48 hours in (i) control media, (ii)
control media + basic fibroblastic growth factor (bFGF) (iii) media containing
K252a, the neurotrophin tyrosine kinase receptor inhibitor (Section 2.23), and (iv)
media containing K252a + bFGF. At the end of the culture period, tissue was fixed
for 1 hr in Bouins fluid and then transferred to 70% ethanol before embedding in
paraffin wax for histological analysis. The tissue was sectioned at 5 pm thickness
and using immunohistochemistry, stained for BrdU .
Analysis of cultured tissue
Sections of uncultured control and cultured tissue were analysed to investigate the
effects of culture and of K252a and bFGF on the number and proliferation of germ




After RT-PCR, cDNA was amplified from RNA extracted from fetal ovaries for each
of the neurotrophins, NGF, NT3, NT4, and BDNF (Fig. 5.1). cDNA for each of the
receptors, TRKA, full-length TRKB, the truncated form of TRKB, TRKC and P75,
were also identified (Fig. 5.1). Positive results were found at all gestations examined
for each of these neurotrophins and their receptors over the range 13-21 wk. Products
of 228 and 204 bp were detected for TRKC (Fig. 5. ID), representing spliced variants
of the gene (Labouyrie et al 1999), both confirmed by direct sequencing. In some
samples an additional PCR product of 300 bp was detected; sequence analysis
showed that it was unrelated to the tyrosine kinase receptor family.
In situ hybridization for NT4
Hybridization histochemistry demonstrated that the germ cells were the predominant
site of expression ofNT4 mRNA within the ovary before the formation of primordial
follicles (Fig. 5.2 A and B). The pattern of expression clearly demarcated the ovarian
stroma, within which some cells showed NT4 mRNA expression, from the more
uniformly and intensely stained clusters of oogonia(Fig. 5.2A). No marked change in
the level or pattern of expression was detected before the formation of primordial
follicles. However, at that stage of development, intense staining was detected in the
flattened granulosa cells surrounding the enlarged oocytes (Fig. 5.2C), in which NT4
expression was reduced, but still present. Less mature oogonia, situated more
peripherally in the ovary, continued to express NT4 mRNA as in the earlier gestations
examined. The cells of the ovarian surface epithelium did not express NT4 mRNA.
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Figure 5.1 Expression of mRNA for neurotrophins and their receptors in human fetal
ovary. RT-PCR analysis of samples extracted from whole ovaries obtained from 13
to 21 weeks gestation, as indicated above each panel. Panels (a)-(h) and (j) show
mRNA expression for various neurotrophins and their receptors as labelled. In panel
(d) products of 228 and 204 bp size were detected for TrkC representing spliced
variants of the gene and in some samples an additional PCR product of 300 bp was
detected: sequence analysis showed that it was unrelated to the tyrosine kinase
receptor family. Panel (i) demonstrates GAPDH expression in these samples. Lanes
marked RT- contained samples in which the reverse transcriptase was not included.
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Immunohistochemical localization of NT4, TrkB, and P75
Expression of NGF, NT3, NT4, TrkB, and P75 proteins was detected by
immunohistochemistry in all specimens examined across the gestational range 13-21
wks. Oogonia showed weak cytoplasmic immunostaining for NT4 at all gestations
(Fig. 5.2 D-F), but marked staining was detected in epithelioid cells among and
immediately surrounding the nests of germ cells, consistent with early differentiation
of pregranulosa cells (Fig. 5.2D). This pattern strikingly outlined the germ cells, both
individually and in clusters. Generally, cells of the ovarian stroma showed only slight
staining, although individual cells at the edge of the stroma, thus in close proximity
to oogonial clusters, showed more marked staining (Fig. 5.2D). The most intense
expression of NT4 protein was, however, seen in the cytoplasm of flattened
granulosa cells of primordial follicles at later gestations. This pattern of staining very
clearly demarcated formed primordial follicles predominantly located in the
medullary region of the ovary from the more peripheral oogonia; thus, a
medullary/cortical gradient was observed (Fig. 5.2 E and F). The pattern of
distribution of NT4 protein therefore differed from that of NT4 mRNA at earlier
gestations, but was similar once primordial follicles were formed. No staining of the
ovarian surface epithelium was detected. NGF protein was found in both stromal
cells and oogonia (Fig 5.3A) throughout the gestations examined. The ovarian
epithelium also expressed NGF. NT3 was localised to stromal cells and clearly seen
in the cell streams (Fig 5.3C). At later gestations granulosa cells were also found to
express NT3 (Fig 5.3D). Using an antibody specific to full-length TRKB, the protein
was immunolocalized to the cytoplasm of ovarian germ cells across the gestational
range examined (Fig. 5.4A and B). In particular, clear staining of the cytoplasm of
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oocytes in primordial follicles was observed (Fig. 5.4B), with faint staining of the
cytoplasm of pregranulosa cells.
The distribution of expression of P75 protein was very different. P75 was
predominantly localized to cells of the ovarian stroma at all gestations examined
(Fig. 5.4C and D), thus clearly demonstrating the branching pattern of the stroma
from the medulla toward the surface of the ovary, surrounding, but not becoming
intermixed with, the clusters of oogonia. P75 immunostaining was not detected in
germ cells at any gestation examined. In contrast to the expression of NT4, the
flattened granulosa cells of primordial follicles clearly did not express P75, although
it was present in the immediately adjacent cells of the ovarian stroma (Fig. 5.4C and
D). P75 was not expressed by the ovarian surface epithelium.
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Figure 5.2 In situ hybridisation and immunolocalisation of NT4 in the human fetal
ovary: (A) localisation of NT4 mRNA expression in a 16 week ovary (antisense
probe). Inset shows results for sense RNA probe; (B) NT4 mRNA expression in 16
week ovary at higher magnification; (C) NT4 mRNA localisation in 21 week
gestation ovary. Immunohistochemistry: (D) 13 week ovary stained for NT4, arrow
indicates positively stained stromal cells; inset representative section of fetal ovary
omitting primary antibody (E) 21 week ovary stained for NT4; (F) 21 week ovary at
higher magnification, stained for NT4. Positive staining in all panels is brown, and
sections are counterstained with haematoxylin. Labels: Oo, oogonia; o, oocyte; pf,
primordial follicle; gc, granulosa cell; os, ovarian stroma. Scale bar in A represents
1000 microns and applies to E; scale bar in D insert represents 250 microns and
applies to D and A insert; scale bar in C represents 50 microns and applies to B; scale
bar in F represents 100 microns.
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Figure 5.3 Immunohistochemical localisation of NGF and NT3 in the human fetal
ovary: (A) 14 week ovary stained for NGF; (B) 14 week ovary treated with peptide
block against NGF (C) 16 week ovary stained for NT3, inset negative control for
NT3; (D) 21 week ovary stained for NT3 at higher magnification. Positive staining in
all panels is brown, and sections are counterstained with haematoxylin. Labels: o,
oocyte; pf, primordial follicle; gc, granulosa cell; os, ovarian stroma; se, surface
epithelium. Scale bar in A represents 250 gm and applies to B, C inset and D. Scale
bar in C represents 500 pm.
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Figure 5.4 Immunohistochemical localisation of TRKB and P75 in the human fetal
ovary (A) 18 week ovary stained for TRKB, A inset shows representative section of
fetal ovary omitting primary antibody; (B) 21 week ovary stained for TRKB, inset
shows same ovary at higher magnification; (C) 17 week ovary stained for P75; (D)
21 week ovary stained for P75 at higher magnification; Positive staining in all panels
is brown, and sections are counterstained with haematoxylin. Labels: o, oocyte; pf,
primordial follicle; gc, granulosa cell; os, ovarian stroma. Scale bar in A represents
250 microns and applies to B and A inset; scale bar in B inset represents 100 microns




The presence of NT4, TRKB, and P75 proteins in the fetal ovary was confirmed by
immunoblotting. NT4 protein expression was detected as a single band of 21 kDa
(Fig. 5.5A), also observed in the positive control (rat cerebral cortex). Two
immunoreactive bands of 110 and 95 kDa were observed for TRKB (Fig. 5.5B). As
the antibody specifically detects full-length TRKB, these bands may represent
variously glycosylated forms of the full-length molecule (Klein et al 1990), rather
than the truncated form. A band of 110 kDa was also detected in the positive control
of rat cerebral cortex. Differences in lower mol wt forms may reflect differences in
the pattern ofglycosylation between the two tissues (Fig. 5.5B). A prominent 75-kDa
band representing the P75 protein was observed (Fig.5.5C). An additional 65-kDa
band was also detected, representing another form of the molecule as detected by
others, (Russo et al 1999; Scharfmann et al 1994). A similar band was detected in the
positive control tissue. The intensity of expression was comparable among the
samples used (13-21 wk gestation) for the three proteins, although insufficient
samples were available for rigorous quantitative analysis. A negative control was also
performed for all three proteins by omitting the primary antibody, and in all cases
immunoreactivity was abolished.
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Figure 5.5 Western blot ofNT4, TRKB and P75 NGFR in human fetal ovary.
Total protein extracts (20pg) from whole ovaries at 13-21 weeks gestation as
indicated were separated by SDS-PAGE, transferred to PVDF membrane and
incubated with anti-NT4, -TRKB and -P75 antibodies. (A) NT4: a protein band
which migrated with apparent molecular size of 21 kDa size is indicated. (B) TRKB:
protein bands of apparent molecular size 110 kDa and 95 kDa are indicated,
representing two forms of full length TRKB. (C) P75: protein band of apparent
molecular size 75 kDa, and an additional band of approximately 65 kDa. Control
tissue was rat cerebral cortex in each case. Positions of molecular weight markers
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Ovarian culture
After 48 hours of culture there was a small decrease in germ cell number in
comparison to the time 0 samples which was not significant (p=0.13) (Fig 5.7).
K252a treatment resulted in a marked decrease in germ cell number from 59.9±3.4 to
27.6 ±4.2 per grid (p=0.01) (Figs 5.6, 5.7). Consistent with this 54% decrease in
germ cells, there was a significant fall in the number of proliferating germ cells (ie:
BrdU positive cells) in samples treated with K252a in comparison to the control
samples (Figs 5.6, 5.8). Proliferating germ cell numbers fell by 66% between the two
groups, from 12.8±2.3 to 4.3±1.5 per grid (p=0.001).
In the 3 of the 5 experiments we added FGF to some of the tissue during culture to
act as a control for any effect of K252a on other tyrosine kinase receptors. A very
small fall in germ cell number was seen in tissue cultured in FGF compared to
control tissue (Fig 5.6, Fig 5.9) (p=0.5) and a small increase was noted in germ cell
number between tissue treated with K252a and that with K252a and FGF (Figs 5.6,
5.9) (p=0.7). Similarly there was little effect of FGF on cell proliferation (Figs 5.6,
5 .10). There was small increase of 11% in the total number of germ cells in tissue
cultured with FGF compared to tissue cultured in control media alone (p=0.6). In
contrast there was a small decrease in the number of proliferating germ cells in tissue
cultured in K252a and FGF compared to that treated with K252a alone, from
3.87±2.76 to 3.04±0.96. This did not reach statistical significance (p=0.7). Although
not quantified, some stromal cell and particularly surface epithelial cell proliferation
was noted in the cultures (Fig 5.6).
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Figure 5.6. Immunohistochemical staining for BrdU of a 13 weeks human fetal
ovary, marking proliferating cells (A) control sample; (B) sample cultured in K252a;
(C) control sample at higher magnification; (D) sample cultured in K252a at higher
magnification; (E) control sample cultured with FGF; (F) sample cultured in K252a
and FGF. Positive staining in all panels is brown, and sections are counterstained
with haematoxylin. Labels: o, oocyte; se, surface epithelium. Scale bar in A
represents 500 pm and applies to B; scale bar in C represents 250 pm and applies to
D, E and F.
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Figure 5.7 Number ofgerm cells present per frame in the human fetal ovaries (13-16
wks.) in fresh and cultured tissue. The shaded columns represent uncultured, time 0
samples, the white columns represent control samples cultured for 48 hours and the
black columns represent tissue treated in culture with K252a neurotrophin receptor










Figure 5.8 Number of proliferating (BrdU immunopositive) germ cells present per
frame in the human fetal ovary (13-16 wks.) after 48 hours of culture. The white
columns represent control samples and the black columns represent tissue treated






Figure 5.9 Number of germ cells present per frame in the human fetal ovaries (13-16
wks.) in cultured tissue. The white column represents control samples cultured for 48
hours; the vertically shaded column represents tissue cultured in control media and
FGF; the black column represents tissue cultured in K252a; the horizontally shaded
column represents tissue cultured in K252a and FGF. Mean ±sem, n=3.
20 n
<1)
Total proliferating germ cells
Figure 5.10 Number of proliferating germ cells present per frame in the human fetal
ovaries (13-16 wks.) in cultured tissue. The white column represents control samples
cultured for 48 hours; the vertically shaded column represents tissue cultured in
control media and FGF; the black column represents tissue cultured in K252a; the




The present results demonstrate the expression of all neurotrophins and both high
affinity TRK receptors and the non selective P75 receptor within the developing
human ovary. In addition, blockade of high-affinity neurotrophin receptors using
K252a markedly decreases germ cell survival and proliferation. These data therefore
indicate that neurotrophins may play a major role in ovarian development and germ
cell regulation in the human, as has been suggested in the rodent.
Localization ofNT4 mRNA confirmed that the germ cells are the predominant site of
expression of this neurotrophin before the formation of primordial follicles.
Expression was, however, developmentally regulated, thus after the formation of
primordial follicles, the predominant site of expression of NT4 mRNA and protein
was the flattened granulosa cell, whereas its cognate high affinity receptor TRKB
protein was localized to the oocyte. These data therefore indicate the involvement of
neurotrophins in this crucial step in ovarian development, i.e. in the formation of the
essential structures of the ovary.
Tissue specimens were obtained after medical termination of pregnancy, induced by
administration of the antigestogen mifepristone and PGEi. It is possible that the
administration of these drugs, directly or indirectly, might have affected the
expression of neurotrophins in the fetal ovary, in which there is some expression of
steroidogenic enzymes at these gestations (Voutilainen et al 1986). Hypoxia has also
been demonstrated to modify expression of neurotrophins and their receptors in
several tissues (Hiltunen et al 2001; Kokaia et al 1998). Although the results
presented here are in broad agreement with the limited data obtained in the
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developing rodent ovary (see below), it would be appropriate to corroborate the
present data in specimens obtained by other methods.
Neurotrophins, specifically NGF, were originally identified on the basis of their role
in the regulation of neuronal survival (Levi-Montalcini et al 1968).
Trk-mediated cell survival requires protein synthesis, and neurotrophins are
predominantly believed to act by suppression of apoptosis. Neurotrophins may also
regulate cell migration (Behar et al 1997) and differentiation (Polak et al 1993). In
addition to these prodevelopment roles, neurotrophins can promote cell death. This
had been suggested to be a function of the p75 receptor when present without the
coexistence of Trk receptors, whereas in their presence p75 promotes cell survival
(Casaccia-Bonnefil et al 1999). Differential effects ofp75 activation on Trk receptor
autophosphorylation dependent on both ligand and Trk subtype have been previously
described (Vesa et al 2000). It has also been demonstrated that the immature form of
NGF, termed proNGF has a greater affinity for p75 than the mature form of NGF
(Lee et al 2001). There is thus the potential for complex interplay between the
different receptor pathways.
There are no previous data on the presence of neurotrophins in the human ovary, but
their expression has been demonstrated in the rat ovary (Dissen et al 1995; Dissen et
al 2001; Timmusk et al 1993). The immediate postnatal period in the rat is the time
of primordial follicle formation, and increased expression of NT4 and its high
affinity receptor TrkB, but not other neurotrophins/Trk receptors, was demonstrated
at that time (Dissen et al 1995). NT4 expression has been localized to the germ cell in
both rodent and Xenopus (Dissen et al 1995).(Ibanez et al 1992) The present results
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are therefore in broad agreement with the limited previous data in other species. NT4
protein was not, however, predominantly localized to the germ cells. The main site of
localization was granulosa cells surrounding oocytes in primordial follicles and, at
earlier developmental stages, in epithelioid stromal cells within clusters of oogonia. It
appears likely that these cells are the precursors of the granulosa cells. This is similar
to the pattern of development demonstrated in the rodent, where these cells are
derived from the cells of the rete ovarii, which, in turn, derive from the mesonephros
(reviewed in (Byskov 1986). The rete ovarii is also recognized to be of central
importance in the regulation of the onset of meiosis (Byskov 1974) and of the
cortical/medullary pattern in the rodent ovary (Byskov et al 1997; Hirshfield et al
1995). The neurotrophins may therefore be involved in the regulation of development
of the oocyte in the human ovary at a number of levels.
A central component of the mechanism of action of neurotrophins in the nervous
system is that they are produced and released by the target cell in proportion to the
final innervation density, taken up by the innervating neuron, and transported to the
nucleus where they mediate their pro-survival effects (Davies et al 1987; Korsching
et al 1983). The predominant localization ofNT4 mRNA and protein in different cell
types before primordial follicle formation is consistent with a similar pattern of
secretion/uptake by germ cells and somatic cells, respectively, suggesting that NT4 is
involved in the intercellular communication between these cells types. The change in
pattern of expression of NT4 mRNA, being low in the oocyte and high in the
granulosa cell after primordial follicle formation, indicates that the signals mediated
by this pathway may vary according to the developmental status of the germ
cell/somaticcell.
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Both NGF and NT3 proteins were localised within the human fetal ovary and
although we did not attempt to localise it, BDNF was detected. NGF appeared to be
expressed in both somatic and germ cells throughout the second trimester. This is
similar to the distribution in the rat ovary (Dissen et al 1995). NT3 had a more
selective distribution as it was expressed exclusively in the stromal cells and later the
granulosa cell populations. The localisation of NT3 suggests it may be involved in
the formation and development of primordial follicles and its presence in the stromal
cells suggests a possible paracrine effect on the germ cell population. NGF is likely
to be involved in somatic cell proliferation as seen in the developing rat ovary
(Dissen et al 2001) which in turn affects germ cell survival (Romero et al 2002).
NGF levels drop in the rodent at the time of follicular assembly (Dissen et al 1995),
suggesting it is involved in earlier ovarian histogenesis and it is possible it has a
similar role in the human.
The localization of TRKB to the germ cells suggests that these are a major site of
NT4 action, whereas P75 was localized to the ovarian stroma and was not present in
the granulosa cells of primordial follicles. The distribution of P75 in the human fetal
ovary is therefore very similar to that in the neonatal rat ovary (Dissen et al 1995).
The differential distribution of the several receptors may contribute to the regulation
of neurotrophin signalling in the immediate environment of the forming primordial
follicle. The localization of other TRK receptors has not been investigated. In the
newborn rat, TrkB mRNA appeared to be localized to presumptive pregranulosa cells
(Dissen et al 1995). Whether this is a species difference or reflects a particular
developmental stage is unclear at present. Developmental changes in the requirement
for specific neurotrophins during neuronal differentiation and survival have been
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described (Davies 1996). It has long been recognized that oocytes must interact with
somatic cells to form primordial follicles and survive (McLaren 1991). The
intermingling ofNT4-immunopositive epithelioid cells within the clusters of oogonia
may indicate a crucial role for oogonial-derived neurotrophins in determining germ
cell survival by enhancing the movement and differentiation of somatic cells and thus
promoting primordial follicle development.
Three Trk receptors with high affinity for specific neurotrophins have been identified
as well as the low affinity p75 receptor (Barbacid 1994; Chao 1994). Truncated
isoforms of TrkB and TrkC resulting from alternative splicing have also been
described (Barbacid 1994; Klein et al 1990; Strohmaier et al 1996). The present
results demonstrate that mRNA for both full-length and truncated isoforms of TRKB
is expressed in the human fetal ovary. The truncated isoforms of the Trk receptors
lack the intracellular, tyrosine kinase domain, but retain the ligand-binding domain,
and may be found in both neuronal and nonneuronal cell types, although the
truncated form may be more abundant in the latter (Klein et al 1990; Wetmore et al
1995). Changing patterns of expression of full-length vs. truncated forms have been
demonstrated during tissue repair in certain regions of the nervous system (Beck et al
1993). TrkB-truncated isoforms have recently been suggested to be involved in
neurotrophin endocytosis (Alderson et al 2000) and in regulation of specific patterns
of dendritic growth distinct from those mediated by the full-length isoform
(Yacoubian et al 2000). Conversely, several neurotrophins and their receptors may
require to be coexpressed by specific cell types (Fan et al 2000; Miller et al 2000).
The relevance of Trk splice variants to ovarian development and function remains to
be investigated.
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In this study K252a was used to investigate the functional activity of neurotrophin
signalling in ovarian tissue. K252a is an indole carbazole, widely used as a potent
and selective inhibitor of the intracellular protein kinase domain of Trk receptors
without affecting other serine/threonine kinases at the concentrations used here
(Koizumi et al 1988; Levine et al 2000b; Tapley et al 1992). K252a blocks the
activity of all high-affinity Trk receptors, so we cannot interpretate which
neurotrophin(s) and receptor(s) might be involved in the effects observed. bFGF acts
as a survival and mitogenic factor for germ cells (Dissel-Emiliani et al 1996; Han et
al 1993; Lynch et al 2000) and although FGF acts via tyrosine kinase receptors, their
actions do not appear to be inhibited by K252a. Treating ovarian tissue with K252a
resulted in a decrease in germ cell number of 54% and a 66% fall in germ cell
proliferation. There was no significant effect of adding bFGF to the culture,
indicating that bFGF receptors are not inhibited by K252a. This data agrees with the
effect of Trk receptor inhibition in the mouse and neonatal rat ovaries, where it has
been shown to reduce oocytes survival and primordial follicle development (Spears
2003). Although from this data we cannot identify specific neurotrophins or
receptors responsible for this effect, it seems that NT4 and TrkB are likely
candidates, as indicated by the TrkB -/- mice (Spears 2003).
Although the present study does not comprehensively localize within the ovary all
identified members of the neurotrophin family and their receptors, the differential
localization of NGF, NT3, NT4, TRKB and P75 may indicate multiple roles for
neurotrophin signalling. Indeed, neurotrophins have been implicated in several
processes in the rodent ovary. Increased NT4/TrkB mRNA expression was associated
with primordial follicle formation (Dissen et al 1995), whereas increased NGF/TrkA
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expression was induced by the LH surge during first ovulation (Dissen et al 1996)
and is involved in the regulation of intercellular gap junction integrity between thecal
cells (Mayerhofer et al 1996). Increased NGF production within the ovary resulted in
disruption of oestrous cyclicity (Dissen et al 2000). It therefore appears that
individual neurotrophin/receptor pathways are involved in the regulation of specific
intraovarian processes. Direct evidence for the importance of neurotrophins in
ovarian development is scanty. Recent studies of mice with an inactivating mutation
of TrkB are consistent with this pathway having an important role in primordial
follicle formation (Spears 2003), although transgenic NT4 knockout mice appear to
be normally fertile (Liu et al 1995). The ovaries of neonatal MTF-knockout mice also
show reduced proliferation of mesenchymal cells and reduced primordial follicle
growth, suggesting that both cell populations are targets for NGF action (Dissen et al
2001), consistent with our localisation of NGF. Mice carrying a null mutation of the
p75 gene appear to have normal numbers of ovarian follicles, but this receptor may
be involved in the reduction in mesenchymal cell proliferation found in the NGF-
knockout mouse (Dissen et al 2001), as this is the site of expression of p75. Later
stages of ovarian development in neurotrophin/7)-£ knockout models have not been
studied in detail, as they are generally nonviable (Snider 1994).
These results therefore demonstrate the presence of neurotrophins and their receptors
in the developing human ovary. Differential patterns of expression between cell types
and developmental changes, particularly associated with primordial follicle
formation, suggest multiple roles for them in the regulation of germ cell and somatic
cell proliferation, survival, and differentiation. The effect of neurotrophin blockade
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has revealed that neurotrophins are essential for germ cell survival and proliferation
in the human fetal ovary.
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CHAPTER 6
EXPRESSION OF NEUROTROPHIC AND
THEIR
RECEPTORS IN THE HUMAN FETAL TESTIS




Development of the human fetal testis involves differentiation, maturation and
proliferation of several cell types. The first sign of male gonadal development is the
appearance of Sertoli cells at 6-7 weeks gestation (Byskov 1986), initiated by the
expression of the testis-determining gene Sry (Tilmann et al 2002). Following
migration from the yolk sac to the nephrogonadoblastic ridge, PGCs associate with
Sertoli cells to form the seminiferous cords. The peritubular cell population
originates from the mesonephros. While their migration is also determined by Sry
and is central to cord formation (Buehr et al 1993), the factors mediating these
crucial intercellular signals are poorly understood (Capel et al 1999; Tilmann et al
1999). At the same time there is considerable proliferation of germ cells and Leydig
cells (Bendsen et al 2003; Hilscher 1991; Murray et al 2000; Voutilainen 1992). This
period of development is believed to be central to the establishment of adult
testicular function and is also the point at which the cellular abnormalities that later
manifest as testicular malignancies may arise (Sharpe 2001). This study investigates
the possibility that neurotrophins may be involved in these intercellular interactions
in the developing human testis.
A number of paracrine factors controlling migration, differentiation and proliferation
of PGCs and Sertoli cells have been described in the rodent, including members of
the transforming growth factor P (TGFP) family (Cupp et al 1999; Dissel-Emiliani et
al 1996; Levine et al 2000a; Olaso et al 1998). Neurotrophins are members of the
nerve growth factor family and related to TGFp. They regulate neuronal survival
and differentiation in nervous tissue (Levi-Montalcini 1987) (Snider 1994)and their
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effects are mediated via Trk and p75 receptors. Neurotrophins may also function in
non-neuronal tissues (Sariola 2001), including the developing gonads of both sexes.
For example several members of the neurotrophin family and their receptors have
been identified in the developing rodent testis (Campagnolo et al 2001; Cupp et al
2000; Levine et al 2000b; Russo et al 1999) and roles in testicular cord formation
(Levine et al. 2000b) have been suggested in addition to later involvement in the
function and interaction of germ cells and Sertoli cells (Djakiew et al 1994;
Lonnerberg et al 1992; Onoda et al 1991). Preliminary data suggest that members of
the neurotrophin family and their receptors may also be expressed in the developing
human testis (Cupp et al 2000). Recent studies have shown that NT4 and its cognate
high-affinity receptor TrkB may be of particular importance in the interaction
between germ cells and somatic cells in the developing ovary of both rodent and
human (Anderson et al 2002; Dissen et al 1995; Spears 2003). In order to determine
whether neurotrophins could influence development and maturation of the human
fetal testis we have examined the cell-specific expression and distribution of several
members of the neurotrophin family and their receptors during the second trimester,
with particular emphasis on NT4 and TrkB.
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6.2 MATERIALS AND METHODS
Tissues
Human fetal testes (13-19 weeks gestation) were obtained following medical
termination of pregnancy (Section 2.21). A total of 15 specimens were used for this
study (13 weeks, 2; 14 weeks, 3; 15 weeks, 2; 16 weeks, 2; 17 weeks, 4; 19 weeks,
2). Testes were dissected free, and either fixed for immunohistochemical analysis or
snap frozen and stored at -70°C. Fixation was carried out in Bouins for 5 hours,
followed by transfer to 70% ethanol prior to processing into paraffin using standard
methods.
Isolation of RNA and RT-PCR
Total RNA was extracted from snap frozen samples of fetal testis and RT-PCR
performed using primers specific for human neurotrophins and their receptors (Table
6.1) (Sections 2.3, 2.31, 5.2). All products were purified (Section 2.33) and their
identities confirmed by direct sequencing (Sections 2.34).
In situ hybridization for NT4
Riboprobes were generated using a PCR strategy to incorporate SP6 or T7 phage
promoter sequences into NT4 PCR product (Section 2.37). In situ hybridisation was
then performed for NT4 (Section 2.38).
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Immunohistochemistry
Immunohistochemistry was performed on paraffin embedded sections (Section 2.4)
to localise the expression of NGF, NT3, NT4, the receptors TRKB and P75, and
BrdU (Section 5.2).
169
Table 6.1 Sequence ofprimers used for detection ofneurotrophins and their
receptors. Human sequences used: S3 = Accession no. NM002506; S4 = Accession
no. X91251; S5 = Accession no. NM002527; S6 = Accession no. NM006179; S7 =
Accession no. NM002529; S8 = Accession no. NM006180;













































Protein was extracted from snap frozen fetal testes and immunoblotting performed
for NT4, TRKB and P75 (Sections 2.5-2.53).
Testis Culture
Testes from 3 fetuses of 14, 16 and 19 weeks gestation were dissected free of
adherent tissues using sterile technique, bisected longitudinally and then cut into
slices ~0.5mm thick. Samples of fresh tissue were fixed for histological analysis. The
remaining tissue fragments were cultured for 48 hours in control media and media
containing K252a, the neurotrophin tyrosine kinase receptor inhibitor (Section 2.23).
At the end of the culture period, tissue was fixed for 1 hr in Bouins fluid and then
transferred to 70% ethanol before embedding in paraffin wax for histological
analysis. The tissue was sectioned at 5 p.m thickness and using
immunohistochemistry, stained for BrdU.
Analysis of cultured tissue
Sections of uncultured control and cultured tissue were analysed to investigate the
effects of culture and of K252a on the number and proliferation of gonocytes, Sertoli
cells and peritubular cells present (Section 2.24).
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6.3 Results
Expression of mRNAs for neurotrophins and their receptors
Expression of mRNAs was detected by RT-PCR using RNA extracted from fetal
testes (Figure 6.1). RT-PCR for the constitutively expressed gene GAPDH was used
to confirm the integrity of the RNA. Human fetal brain and placenta were used as
positive controls. mRNA for the neurotrophins NGF (a), NT3 (b), NT4 (c) and BDNF
(d), and the receptors TRKA (f), TRKB (h), TRKC (g) and P75 (j) was detected in all
specimens at all gestations examined. Both full-length and the truncated forms of
TRKB were detected (h and i). Products of 228 and 204 bp size were detected for
TRKC (g), representing spliced variants of the gene (Labouyrie et al 1999),
confirmed by sequencing. In some samples an additional PCR product of 300 bp
was noted and the sequence found to be unrelated to the tyrosine kinase receptor
family.
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Figure 6.1. Expression of mRNA for neurotrophins and their receptors in human
fetal testis.
RT-PCR analysis of samples extracted from whole testes obtained from 13-19 wk
gestation, as indicated above each panel, (a-d and f-j), mRNA expression for the
neurotrophins and their receptors as indicated. Products of 228 and 204 bp were
detected for TRKC (panel g) representing spliced variants of the gene, and in some
samples an additional PCR product of 300 bp was detected: sequence analysis
showed that it was unrelated to the tyrosine kinase receptor family, (e) GAPDH




In situ hybridisation for NT4
Cell specific patterns of expression of NT4 were further investigated by non¬
radioactive in situ hybridisation on fixed tissue sections. NT4 mRNA expression was
predominantly localised to the peritubular cells (Figure 6.2A and B). NT4 mRNA
was also detected in Sertoli cells but no mRNA appeared to be expressed in
gonocytes (Figure 6.2B). A low level of expression was detected in the interstitium
with the exception of the endothelial cells of small blood vessels which showed more
clearly positive expression. There was no apparent change in the pattern or intensity
of expression of NT4 mRNA over the gestational range examined (14-19 wk).
Tissue sections incubated with the sense riboprobe showed no staining (Figure 6.2A
inset) confirming the specificity of the probe.
Immunohistochemical localisation of neurotrophins and receptors
Expression of NT4, NGF, NT3 and P75 proteins were detected by
immunohistochemistry in all specimens examined across the gestational range 13-19
wk. Expression of NT4 was confirmed by immunolocalisation of the protein to the
cytoplasm of the peritubular cells and Sertoli cells within the seminiferous tubules;
gonocytes were immunonegative (Figure 6.2C and D). Very little immunostaining
was noted in the interstitial cells, but endothelial cells within small blood vessels
were immunopositive for NT4. The most intense immunopositive reaction for NGF
was in Sertoli cells (Figure 6.3A) although some gonocytes also appeared
immunopositive. Weak staining was noted in the interstitial cells (Figure 6.3A). NT3
protein was also immunolocalised mainly to the Sertoli cells with some interstitial
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staining (Figure 6.3B and C). Very few gonocytes stained positively for NT3 and no
protein was detected in the peritubular cells.
Immunolocalisation of P75 was most intense in the peritubular cell compartment
(Figure 6.3D and E) but it was also present in the interstitial cells. Neither Sertoli
cells nor gonocytes showed any P75 immunoreactivity. Despite the use of three
different antibodies, specific staining for TRKB receptor protein was not detectable.
No change in pattern or intensity of staining for any of the proteins detected was
noted over the gestational range examined. Control experiments conducted by
omitting the application of the primary antibody or using a specific blocking peptide
in the case ofNGF showed no staining (Figure 6.3A inset and F).
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Figure 6.2 In situ hybridization and immunohistochemical localization of NT4 in
human fetal testis.
In situ hybridization: (A) localisation of NT4 mRNA expression in a 19 wk testis
(antisense probe). Inset shows results for sense RNA probe; (B) NT4 mRNA
expression in 16 wk testis at higher magnification.
Immunohistochemistry: C, NT4 in 17 wk testis; D, NT4 in 13 wk testis at higher
magnification. C inset shows representative section of fetal testis omitting primary
antibody. Positive staining is brown, and sections are counterstained with
haematoxylin. g, gonocyte; s, Sertoli cell; p, peritubular cell; i, interstitium; tc,
testicular cord. The scale bar in A represents 500 pm. The scale bar in B represents
250 pm and applies to A inset, C and C inset. The scale bar in D represents 50 pm.
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Figure 6.3 Immunohistochemical localisation of NGF, NT3 and P75 in human fetal
testis.
(A) 15 wk testis stained for NGF, inset shows section of testis treated with peptide
block for NGF antibody; (B) 17 wk testis stained for NT3; (C) 17 week testis stained
for NT3 at higher magnification; (D) 19 wk testis stained for p75; (E) 17 wk testis
stained for p75 at higher magnification; (F) A representative section of fetal testis
omitting primary antibody. Positive staining in all panels is brown, and sections are
counterstained with hematoxylin, g, gonocyte; s, Sertoli cell; p, peritubular cell; i,
interstitium; tc, testicular cord. The scale bar in A represents 250 pm and also applies
to A inset, C, E and F. The scale bar in B represents 500 pm and applies to D.
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Immunoblotting
The presence of NT4, TRKB and P75 proteins in the fetal testis was confirmed by
immunoblotting; a positive control of rat cerebral cortex was run on all gels (Figure
6.4). The immunoblot of NT4 protein expression detected a single band of 21 kDa
molecular mass in all samples of fetal testis (Figure 6.4A). For detection of TRKB,
the antibody used was directed against the full-length protein. Two immunoreactive
bands of 110 kDa and 80 kDa molecular masses were detected (Figure 6.4B). These
bands are reported to represent the glycosylated and unglycosylated forms of the
TRKB protein respectively. Two immunoreactive bands were also detected for the
P75 receptor, at 75kDa and 65 kDa in all samples of fetal testis (Figure 6.4C). In all
cases the sizes of the proteins detected were identical to those in the positive control
tissue. These immunoblots were repeated three times using different samples: no
consistent changes with gestation were noted. A negative control was also performed
for all three proteins by omitting the primary antibody and in all cases
immunoreactivity was abolished.
179
Figure 6.4 Western blot ofNT4, TRKB, and P75 in human fetal testis.
Total protein extracts (20 pg) from whole testes at 13-19 wk gestation, as indicated,
were separated by SDS-PAGE, transferred to PDF membrane and incubated with
anti-NT4, -TRKB, and -P75 antibodies. A, NT4, a protein band that migrated with an
apparent molecular size of 21 kDa is indicated. B, TRKB, protein bands with
apparent molecular sizes of 110 and 95 kDa are indicated, representing two forms of
full-length TRKB. C, p75, a protein band with an apparent molecular size of 75 kDa
and an additional band of approximately 65 kDa. Control tissue was rat cerebral
cortex in each case. The positions of molecular mass markers are indicated. No
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After 48 hr of culture there was a small increase in the number of gonocytes in
comparison to the time 0 samples (p=0.02) (Figure 6.5A) and a decrease in the
number of interstitial cells (p=0.05). The numbers of Sertoli cells and peritubular
cells did not change significantly during this period of culture. Consistent with this
increase in gonocyte number an average of 12% of that cell type were
immunostained with BrdU, compared to less than 2% of Sertoli cells and peritubular
cells.
K252a treatment resulted in a consistent decrease in the number of gonocytes present
in the tissue (p < 0.01, Figure 6.5B-D). There was also a significant fall in the
number of peritubular cells (p=0.006), and a small but statistically significant
(p=0.04) reduction in the number of Sertoli cells (Figure 6.5B). In contrast there was
an increase in the number of interstitial cells, but this did not reach statistical
significance. The number of proliferating (i.e. BrdU immunopositive) gonocytes was
reduced by an average of 58% from 2.4±0.6 to 0.9±0.2 per grid (Figure 6.5C and D),
very similar to the reduction in the number of gonocytes (54%). The number of
proliferating peritubular cells was also reduced, by a mean of 71% from 1.9±0.8 to
0.5±0.1 per grid, compared to a reduction in the number of peritubular cells of 30%.
There was thus a mean fall of 26% in the proportion of gonocytes that were BrdU
immunopositive, compared to a fall of 71% for peritubular cells. However these
decreases did not reach statistical significance. There was also a reduction in the
number of proliferating Sertoli cells from 0.8±0.5 to 0.3±0.0 per grid, which again
did not reach statistical significance.
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Comparable results were obtained in the 3 experiments, without clear evidence of a
change with increasing gestational age.
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Figure 6.5 Testis tissue culture data
A. Number of each cell type present per frame in the human fetal testis in fresh and
cultured tissue. The shaded columns represent uncultured, time 0 samples, the white
columns represent control samples cultured for 48 hours and the black columns
represent tissue treated in culture with K252a neurotrophin receptor inhibitor. Mean
±sem, n=3 * p < 0.05 and ** p < 0.001 vs control 48 hr cultures.
B Number of proliferating (BrdU immunopositive) cells of each type present per
frame in the human fetal testis after 48 hours of culture. The white columns represent
control samples and the black columns represent tissue treated with K252a
neurotrophin receptor inhibitor. Mean ±sem, n=3.
C and D Sections of a 19 week fetal testis stained using immunohistochemistry for
Brdu. C shows tissue cultured for 48 hours in control media; D shows tissue cultured
for 48 hours with K252a neurotrophin receptor inhibitor. Positive staining is brown,
g, gonocytes; s, Sertoli cell; p, peritubular cell; tc, testicular cord; i, interstitium. The




The gestational age range examined in this study follows the period of testicular cord
differentiation and is a time of gonocyte and Sertoli cell proliferation and active
steroidogenesis (Bendsen et al 2003; Byskov 1986; Hilscher 1991; Murray et al
2000; Voutilainen 1992). These data demonstrate the gene expression and presence
of neurotrophins and their receptors in the human fetal testis at this time, and that
blockade of high-affinity neurotrophin receptors reduced gonocyte and peritubular
cell survival and proliferation while having little effect on Sertoli or interstitial cells.
The striking localisation of expression of NT4 (at both mRNA and protein levels)
and the p75 neurotrophin receptor to the peritubular cells may indicate that these
cells are central to the functions of neurotrophins in the developing testis. The
formation of cords is crucial to Sertoli cell and Leydig cell differentiation and
inhibition of germ cell meiosis (Tilmann et al 2002) and is thus not only the main
morphological feature distinguishing the developing testis from the ovary, but is also
of paramount functional importance. These features of normal development have in
the mouse been clearly linked to Sry expression (Capel et al 1999) which also
induces stimulation of cell migration from the mesonephros into the gonad inducing
testis cord formation (Tilmann et al 1999). Peritubular cells originate in the
mesonephros (Buehr et al 1993), and their precursors have been demonstrated to
express the p75 receptor (Campagnolo et al 2001). Trk receptor knock-out models
also provide evidence for the involvement of neurotrophins in the cell migration
associated with testicular cord formation (Cupp et al 2002), supporting earlier studies
using K252a treatment of organ cultures (Levine et al 2000b). The present results
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therefore support the hypothesis that neurotrophin expression in the human testis is
important in the regulation of normal development.
Neurotrophins are small, secreted proteins related to the TGF(3 superfamily,
originally identified on the basis of their role in the regulation of neuronal survival.
However, neurotrophins may also regulate cell migration (Behar et al 1997) and
differentiation (Polak et al 1993). In addition to signalling through high-affinity Trk
receptors, neurotrophins also signal through the low-affinity p75 receptor and the
pattern of expression of the different receptor types influences the response (Barker
et al 1994; Casaccia-Bonnefil et al 1999). Further complex interaction is suggested
by the demonstration that the immature form of NGF, termed proNGF has a greater
affinity for p75 than the mature form of NGF (Lee et al 2001). Thus neurotrophin
signalling is a complex interaction between the ligands and the Trk/p75 receptor
compliment present. In addition to the full length TRKB we have identified mRNA
for truncated TRKB in the developing testis. The truncated form lacks the tyrosine
kinase domain and is predominantly expressed in non-neuronal cells (Klein et al
1990; Wetmore et al 1995). Although the function of truncated receptors remains
elusive, it has been postulated that these isoforms have a role as cell adhesion
molecules acting as a selective barrier preventing the diffusion of neurotrophin and
promoting elimination by internalisation (Biffo et al 1995; Zhou et al 1997).
There are increasing data regarding the expression of neurotrophins and their
receptors in the developing rodent testis, but very little data in the human. In the
rodent testis expression has been detected from very early in development (Cupp et
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al 2000; Levine et al 2000b). The present data suggest a cell-specific distribution of
the neurotrophins although some cell types, such as Sertoli cells, expressed more
than one neurotrophin. Expression of multiple neurotrophins may be required for
normal development of some neuronal cell types (Fan et al 2000). We were unable to
localise TRKB using immunohistochemistry although using RT-PCR and Western
analysis expression of both full length and truncated TRKB mRNA and the full-
length protein was demonstrated. Previous reports of the cellular localisation of p75
in the rat (Campagnolo et al 2001; Levine et al 2000b; Russo et al 1999) are in
agreement with our findings in the human, being predominantly localised to the
peritubular cells. This pattern of expression shows some parallels with that seen in
the rodent and human fetal ovary (Dissen et al 1995) (Anderson et al 2002)where
P75 is localised to the stromal cells surrounding clusters of replicating germ cells.
Functional roles for the neurotrophins in morphological sex determination, cell
migration and testicular cord formation have been suggested (Levine et al 2000b;
Russo et al 1999). Treatment of organ cultures of El 3 rat testis with K252a inhibited
cord formation (Levine et al 2000b). In the present studies we have also used K252a
to investigate the functional activity of neurotrophin signalling in the developing
human testis. K252a is an indole carbazole, widely used as a potent and selective
inhibitor of the intracellular protein kinase domain of Trk receptors without affecting
other serine/threonine kinases at the concentrations used here (Koizumi et al 1988;
Levine et al 2000b; Tapley et al 1992). K252a blocks the activity of all high-affinity
Trk receptors, so these data do not permit interpretation in terms of which
neurotrophin(s) and receptor(s) might be involved in the effects observed. While the
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investigation of selective blockade of specific Trk receptors has been attempted in
the investigation of many models including the developing testis (Levine et al
2000b), the effects are generally much less marked that those of K252a consistent
with considerable redundancy in neurotrophin signalling, as also demonstrated by the
phenotypes of knock-out animals (Snider 1994). In this culture system, the integrity
of the tissue was well maintained and cell proliferation was detected. This was noted
to be at a much higher rate in gonocytes that in other cell types. The major effect of
K252a on the testicular cords was on gonocyte survival with relatively little effect on
Sertoli cells. Sertoli cells were the primary site of expression of NGF and NT3, and
although the site of expression of TRK receptors was not demonstrated in the present
study, TrkA has been previously reported to be expressed by rat Sertoli cells between
E16 and P0 (Cupp et al 2000). These results suggest that neurotrophins are critical
for gonocyte survival and replication, but their effects may be mediated indirectly via
Sertoli cells. This is the classic pattern of Sertoli cell/germ cell interaction with
paracrine signalling between these two cell populations, most clearly exemplified by
the mediation of the effects of FSH and androgen. It is also apparent that the relative
number of gonocytes and Sertoli cells is maintained during early testicular
development despite a 10-fold increase in the number of gonocytes between 6 and 9
weeks gestation (Bendsen et al 2003): the present data suggest that neurotrophin
signalling may contribute to the regulation of this ratio. Selective gonocyte loss has
not previously been reported as a result of neurotrophin blockade but cord formation
is certainly affected, inevitably involving gonocyte survival (Levine et al 2000b).
These data may be compared to the recent demonstration that neurotrophins are
involved in germ cell survival in the human fetal ovary at a comparable stage of
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development (Anderson et al 2002; Spears 2003), although in the ovary it appears
that germ cells are a direct site of neurotrophin action. While that may also be the
case in the testis, direct evidence is thus far lacking.
While K252a resulted in a marked loss of gonocytes, there was also a reduction in
the number of peritubular cells. There was also a striking reduction in gonocyte and
peritubular cell proliferation. As the fall in the number of BrdU immunopositive
peritubular cells was much greater that the fall in the total number of that cell type
(71% vs 30%) whereas the comparable figures for gonocytes were similar (58% vs
54%), these data may suggest a specific effect of neurotrophin on peritubular cell
proliferation in addition to survival, consistent with those cells being the major site
of expression of NT4 and the P75 receptor. The importance of neurotrophins and
their receptors in rat testicular cord formation (Cupp et al 2000; Levine et al 2000b)
may also reflect a major site of action on the peritubular cell population. As the p75
receptor may promote apoptosis in the absence of Trk receptor signalling (Casaccia-
Bonnefil et al 1999; Chao et al 1995) relatively unopposed p75 signalling may
contribute to the decrease in peritubular cell proliferation and survival in the
presence of K252a.
We have recently demonstrated the expression of oestrogen receptor (ER) p within
the human fetal testis (Gaskell et al 2003). Sertoli and peritubular cells were
demonstrated to express both ERp 1 and 2 isoforms, whereas gonocytes expressed
only ERp2, indicating that Sertoli and peritubular cells in particular may be sites of
estrogen action. Oestrogen and neurotrophins interact in neural development
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selectively enhancing neuronal growth and development (Simerly 2002), and ER
mRNA may be co-expressed with neurotrophins (Miranda et al 1994; Toran-
Allerand 1996). Some of these effects of oestrogen may be mediated by the ER|3
rather than the classical ERa (Toran-Allerand et al 1999). The expression of both
neurotrophins and their receptors and ER(3 in Sertoli cells and peritubular cells
suggest that these pathways may interact in a wide variety of cell types.
In conclusion, this study demonstrates that neurotrophins and their receptors are
expressed in the developing human testis during the second trimester. Neurotrophins
have been demonstrated to be crucial for cellular migration, germ cell survival and
proliferation (Campagnolo et al 2001; Cupp et al 1999; Cupp et al 2000; Cupp et al
2002; Levine et al 2000b; Russo et al 1999) in the rodent testis: the present results
suggest that they are likely to be of similar importance in the human with a major






This thesis provides support for the hypothesis that the various factors studied,
namely c-kit receptor, neurotrophins and their receptors and MMPs and TIMPs, play
an essential role in the development and differentiation of the human fetal testis and
ovary during the second trimester.
7.1 C-kit receptor and ligand
The studies in Chapter 3 investigating the role of C-kit receptor and its ligand in
human fetal gonadal development demonstrated expression of these factors in both
ovary and testis at all gestational ages examined. The expression of C-KIT mRNA
and protein is germ cell specific in human fetal gonads and suggests an important
role for the C-KIT/KL signalling system in germ cell proliferation and survival in the
developing human gonad. There is evidence that mutations in the genes for these
factors result in loss of primordial germ cells (Besmer et al 1993) and that these
factors are important for germ cell survival and protection from apoptosis, possibly
via the increased expression of Bcl-2 (Pesce et al 1993; Tilly 1996; Yee et al 1994).
The present results support this evidence and also that of studies in animal models
showing that C-kit is important for folliculogenesis in the ovary (Horie et al 1991;
Ismail et al 1997; Parrott et al 1999) and may play a role in spermatogonial
proliferation, germ cell migration and protection from apoptosis (Besmer et al 1993;
Packer et al 1995; Yoshinaga et al 1991). This has furthered our limited knowledge
of the factors controlling germ cell development in human fetal gonads and has
clarified conflicting reports on the existence of C-KIT in germ cells in the human
fetal testis. Further work could be done to block C-KIT/KL signalling in vitro to
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examine the resultant effect on germ cell survival and proliferation as has been done
in mice. In addition to evaluating proliferation using BrdU staining, a method for
detecting apoptotic cells such as TUNEL could be employed. If possible, studying
earlier gestations could be helpful regarding the role C-KIT may play in germ cell
migration in the human.
7.2 MMPs and TIMPs in human fetal testis and ovary
The studies described in Chapter 4 investigated the role of MMPs and TIMPs in the
development of the human fetal gonads. These demonstrated that MMPs -1,-2-9 and
all TIMP family members are secreted by the developing fetal human ovary and
testis and are localised to specific cell and tissue sites, MMP-2 being the most
abundant gelatinase. These findings support the hypothesis that MMPs and TIMPs
are involved in ECM remodelling during fetal gonadal development. The localisation
of these factors in the vasculature within the gonads suggests a role in angiogenesis
thereby correlating with findings in other tissues (Pilcher et al 1997; Yu et al 2000b).
MMP and TIMP expression in the fetal gonads in the second trimester also
corroborates with their possible role regulating germ cell proliferation by modifying
growth factor availability and action and also activating steroidogenesis in the testis
(Boujrad et al 1995; Edwards et al 1996a). In summary, MMPs and TIMPs are likely
to play a role in ECM remodelling during fetal gonadal development and also in the
cell and matrix interactions that control a range of cellular functions. This provides a
basis from which to work towards further assessment of the functions of MMPs and
TIMPs within the human fetal gonad. Further studies investigating the inhibition
and/or promotion of MMP and TIMP activity on gonadal tissue in vitro should be
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carried out, for example investigating the effect of TIMP-1 on TNFa secretion.
Further work should also be done regarding the action of TIMP-1 on steroidogenesis
as this could be quantitatively measured after organ culture.
7.3 The role of neurotrophins in human fetal ovarian and testicular
development
These studies in Chapters 5 and 6 have demonstrated the presence of neurotrophins
and their receptors in the developing human ovary and testis during the second
trimester. This was a novel finding in the ovary and clarified previous studies
investigating their presence in the testis. Following this, neurotrophin action was
blocked in organ culture and the resulting effect on germ cell survival and
proliferation was examined.
In both ovary and testis this markedly decreased germ cell survival and also
produced a significant decrease in oocyte proliferation. There was a significant
decrease also noted in peritubular cell proliferation and survival in the testis. These
results support our hypothesis that neurotrophins are present in the human fetal
gonads and have an essential role to play in cell proliferation and survival, in
particular in the regulation of germ cell number. These findings correlate with the
expression of neurotrophins and receptors in rodent gonads (Dissen et al 1995)
(Timmusk et al 1993) (Campagnolo et al 2001; Cupp et al 2000; Dissen et al 2001;
Levine et al 2000b; Russo et al 1999)and also on germ cell number in the ovary
(Spears 2003). Previous studies have suggested neurotrophin involvement in rat
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testicular cord formation (Cupp et al 2000; Levine et al 2000b; Russo et al 1999)
indicating similar action on gonocytes and peritubular cells.
The information generated from these studies should be extended by adding
neurotrophins to organ culture in an attempt to identify the roles of individual
neurotrophic factors. Alternatively, it may be feasible to block individual Trk
receptors using chimeric fusion proteins. Neurotrophin effects on steroidogenesis in
the testis should also be investigated as testosterone production could be measured.
From organ culture, the effects on factors such as TGFa and TGF(3 could be assessed
and also the effect of manipulation of neurotrophins on the expression of ERa and
ERp in fetal ovaries. After studying these factors in vitro the research should be
continued in animal models in vivo. This could provide a possible clinical application
for neurotrophins, in manipulating germ cell number and hence ovarian follicular
development and spermatogenesis.
The main limitation throughout this research was the relative scarcity of tissue
samples. In addition to this was the unpredictability of the timing of the arrival of
samples and therefore inevitably some delay in processing them. By building a bank
of frozen and fixed tissue samples over a longer period of time it should be possible
to advance these studies and gain further knowledge concerning the role of these
factors in human gonadal development.
In summary, this research has demonstrated that the various factors studied in the
preceding chapters are unequivocally present in the human fetal ovaries and testis
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during the mid-trimester. These results alone imply essential roles in gonadal tissue
proliferation and development. The discovery that neurotrophins are required for
germ cell and peritubular cell development furthers our understanding as to the
processes affecting the regulation of development of human gonadal tissue. To date,
very little research into human fetal gonadal development has been carried out due to
the scarcity and difficulty obtaining tissue and most information regarding this
subject has been extrapolated from animal models. By carrying out these studies, the
mechanisms of development during this time period in the human have been clarified
and factors directly contributing to germ cell and peritubular cell development have
been identified. This forms a base for further research looking at ways of
manipulating these factors in vitro. From this conditions for in vitro maturation of
gonadal tissue may be optimised and thereby the lifespan of the tissue may be
altered, offering therapeutic applications for this research.
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The sources of all the reagents used for the experiments described in the preceding
chapters are detailed below.
TISSUE CULTURE MATERIALS - SOURCE
GENERAL
24 well culture plates Costar Ltd., High Wycombe, UK
Milliceil CM filters Millipore, Bedford MA
Minimal essential medium alpha (MEMa) Gibco, Paisley, UK
Bovine serum albumin (BSA), Fraction V,
electrophoresis grade
Sigma, Poole Dorset
Penicillin Sigma, Poole Dorset
Streptomycin sulphate Sigma, Poole Dorset
Amphotericin Sigma, Poole Dorset
ITS Sigma, Poole Dorset
Glutamine Sigma, Poole Dorset
Pyruvate Sigma, Poole Dorset
Trk kinase inhibitor, K252a, Nocardiopsis
sp. Acts as a potent inhibitor (IC5o = 3 nM)
of the tyrosine protein kinase activity of the
TrkA as well as the kinase activity of its
transforming alleles, the Trk oncogenes,
and of the related neurotrophin receptors
TrkB and TrkC. Induces apoptosis and cell
cycle arrest by inhibiting Cdkl and
Cdc25c.
Calbiochem, Nottingham, UK
Basic Fibroblast growth factor (bFGF)
Human. ED50 = 100-250 pg/ml
Gift from Amgen Inc,
California
Dimethylsulfoxide (DMSO) Sigma, Poole Dorset
Bromodeoxyuridine (Brdu) Sigma, Poole Dorset
Bouins fluid Triangle Biomedical Sciences,
Lancashire





0.2 ml eppendorf tubes Ambion, Huntingdon, UK
Deoxynucleotide triphosphate Roche Diagnostics, Lewes, UK
Taq DNA polymerase AGS Gold, Hybaid, Ashford, UK
Complete buffer AGS Gold, Hybaid, Ashford, UK
TBE buffer See Appendix 1 for recipe
Agarose Sigma, Poole Dorset
dNTPs Boehringer Mannheim, Lewes, UK
Ethidium Bromide Sigma, Poole Dorset
Gel tank Biorad, CA, USA
DNA Hi Pure Purification kit Boehringer Mannheim, Lewes, UK
GenElute Agarose Spin Columns Sigma, Poole Dorset
Primer sequences Sigma Genosys
ISOLATION OF RNA, SYNTHESIS SOURCE
AND AMPLIFICATION OF cDNA
RNeasy mini kit Quiagen, Crawley, UK
DNAase Gibco, Paisley, UK
First strand cDNA synthesis kit Roche Diagnostics, Lewes, UK
Deoxynucleotide triphosphate Roche Diagnostics, Lewes, UK
Taq DNA polymerase AGS Gold, Hybaid, Ashford, UK
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GENERATION OF RIBOPROBES SOURCE
FOR IN SITU HYBRIDIZATION
Tris/HCl See Appendix II for recipe
(NH4)2S04 See Appendix II for recipe
pGEM-T Vector Promega
MgCl2 See Appendix II for recipe
Tween-20 Sigma, Poole, Dorset
RNeasy mini kit Qiagen, Crawley, UK
DNAse Invitrogen Ltd, Paisley, UK
First strand cDNA synthesis kit Roche Diagnostics, Lewes, UK
High Pure PCR product purification kit Roche Diagnostics, Lewes, UK
Digoxigenin labelling kit Maxiscript, Ambion
RNA Polymerase Maxiscript, Ambion
Ribonuclease inhibitor Promega
DNase I Sigma, Poole, Dorset
Chromaspin columns (DEPC-100), Clontech, Palo Alto, CA, USA
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IN SITU HYBRIDIZATION SOURCE
Super frost plus coated slides Menzel-Glaser, Germany
Gel bond film FMC Bioproducts, Maine, USA
Proteinase K Sigma, Poole, Dorset
EDTA ICN Biochemicals Inc., Aurora, Ohio
Glycine Sigma, Poole, Dorset
Acetic anhydride Sigma, Poole, Dorset
0.08 M triethanolamine Sigma, Poole, Dorset
Prehybridization buffer See Appendix II for recipe
Hybridization buffer See Appendix II for recipe
SSC See Appendix II for recipe
RNase A Sigma, Poole, Dorset
TBS See Appendix II for recipe
Formamide Sigma, Poole, Dorset
Hydrogen Peroxidase Sigma, Poole, Dorset
Normal swine/rabbit serum (NSS/NRS) Diagnostics Scotland, Carluke, UK
Avidin block Vector, Peterborough, UK
Biotin block Vector, Peterborough, UK
Sheep Anti-Digoxigenin Roche Diagnostics, Lewes, UK




DAB liquid substrate-chromagen system Dako, Cambridge, UK
SEQUENCING SOURCE
ABI 377 Sequencer Perkin Elmer
Big Dye Terminators Perkin Elmer
Sequencing reaction mix Applied Biosystems Utd, Cheshire
Vz Term See Appendix II for recipe
Formamide Sigma, Poole, Dorset
EDTA ICN Biochemicals Inc., Aurora, Ohio
Urea Sigma, Poole, Dorset
Aery 1 amide Northumbria Biologicals Ltd.,
Cramlington UK
Amberlite Sigma, Poole, Dorset
Filter unit Nalgene
TEMED Biorad, CA, USA
APS Biorad, CA, USA
TBE See Appendix II for recipe
Running Buffer See Appendix II for recipe
DNA Hi Pure Purification kit Boehringer Mannheim, Lewes, UK
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LASER CAPTURE MICROSCOPY SOURCE
PixCell II LCM system Arcturus Engineering Inc., Mountain
View, CA
B-mercaptoethanol Sigma, Poole, Dorset
Micro RNA Isolation Kit Stratagene, La Jolla
AMH
Rabbit polyclonal antibody Gift from Dr R. Rey
Chloroform:isoamyl Sigma, Poole, Dorset
Phenol Sigma, Poole, Dorset
Sodium Acetate Sigma, Poole, Dorset
Glycogen Sigma, Poole, Dorset
lsopropanol Sigma, Poole, Dorset




TESPA coated slides Sigma, Poole, Dorset
Histoclear National Diagnostics, Atlanta,
Georgia, USA
Hydrogen Peroxide (H2O2) Merck Ltd (BDH), Lutterworth,
UK
Methanol Merck Ltd (BDH), Lutterworth,
UK
Tris base Sigma, Poole, Dorset
Tris-buffered saline (TBS) See Appendix 11 for recipe
Blocking serum Diagnostics Scotland, Carluke,
UK
Glycine buffer See Appendix 11 for recipe
Citrate buffer See Appendix II for recipe
Bovine serum albumin, Fraction V,
electrophoresis grade
Sigma, Poole, Dorset
Avidin block Vector, Peterborough, UK
Biotin block Vector, Peterborough, UK
Biotinylated secondary antibodies Dako, Cambridge, UK
Biotinylated anti chicken secondary antibody Jackson Laboratories, Bar
Harbor, Maine, USA
Avidin-Biotin Complex-Horse radish peroxidase Dako, Cambridge, UK
DAB liquid substrate-chromagen system Dako, Cambridge, UK
Haematoxylin See Appendix II for recipe




Rabbit polyclonal antibody Santa Cruz, CA, USA
NGF peptide block Santa Cruz, CA, USA
NT3
Rabbit polyclonal antibody Santa Cruz, CA, USA
NT4
Rabbit polyclonal antibody Santa Cruz, CA, USA
TrkB(l)
Rabbit polyclonal antibody Santa Cruz, CA, USA
TrkB (2)
Chicken polyclonal antibody Promega, Southampton, UK
TrkB(3)
Rabbit polyclonal antibody Oncogene, San Diego, CA, USA
p75
Mouse monoclonal antibody Neomarkers, Fremont, Ca, USA
Brdu
Mouse monoclonal antibody Roche Diagnostics, Lewes, UK
c-kit (1)
Goat polyclonal antibody Santa Cruz, CA, USA
c-kit (2)
Rabbit polyclonal antibody Dako, Cambridge, UK
AMH
Rabbit polyclonal antibody Gift from Dr. R Rey, Buenos
Aires, Argentina
MMP-1
Mouse monoclonal antibody Chemicon International Inc.,
Flarrow, UK
MMP-2
Mouse monoclonal antibody Calbiochem, Nottingham, UK
MMP-9
Mouse monoclonal antibody Insight, Biotechnology,
Wembley, Middlesex, UK
TIMP-1
Rabbit polyclonal antibody Sigma, Poole, Dorset
TIMP-2
Rabbit polyclonal antibody Triple Point Biologies, Forest
Grove, OR, USA
TIMP-3
Rabbit polyclonal antibody Sigma, Poole, Dorset
TIMP-4
Rabbit polyclonal antibody Chemicon International Inc.,
Harrow, UK
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WESTERN BLOT AND PROTEIN
EXTRACTION
SOURCE
Protein extraction buffer See Appendix 11 for recipe
Gel tank Gibco, Paisley, UK
Homogenisation/denaturing buffer See Appendix 11 for recipe
Reducing loading buffer See Appendix 11 for recipe
Tris-glycine gel Novex, Invitrogen, The Netherlands
Tris-glycine SDS running buffer Novex, Invitrogen, The Netherlands
Molecular weight markers Biorad, CA, USA
PDF membrane Amersham Life Science,
Buckinghamshire, UK
Wet blot apparatus Biorad, CA, USA
Wet blot buffer See Appendix II for recipe
BSA Sigma, Poole, Dorset
Tween-20 Sigma, Poole, Dorset
NT4
Rabbit polyclonal antibody Santa Cruz, USA
TrkB
Rabbit polyclonal antibody Oncogene, San Diego, CA, USA
p75
Mouse monoclonal antibody Neomarkers, Ca, USA
Anti-rabbit HRP linked secondary antibody Amersham Life Science,
Buckinghamshire, UK
Anti-mouse HRP linked secondary- antibody Amersham Life Science,
Buckinghamshire, UK
ECL Reagent Amersham Life Science,
Buckinghamshire, UK
ZYMOGRAPHY SOURCE
Minigel apparatus Biorad, Hemel Hempstead, Herts, UK
Stacking gel buffer (Stock B) See Appendix II for recipe
Stock wash buffer X 10 See Appendix II for recipe
Resolving gel See Appendix 11 for recipe
Stacking gel See Appendix 11 for recipe
Triton-X-100 Wash See Appendix II for recipe
Digestion buffer See Appendix II for recipe
Destaining solution See Appendix II for recipe
Staining solution See Appendix II for recipe
Butanol Sigma, Poole, Dorset, UK
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REVERSE ZYMOGRAPHY SOURCE
Reverse zymography kit University Technologies Inc., Calgary,
Canada
BHK-21 cells University Technologies Inc., Calgary,
Canada
Wash buffer/Rinse buffer See Appendix II for recipe
Incubation buffer/Digestion buffer See Appendix II for recipe
All other reagents/solutions as for
Zymography
See Appendix II for recipe
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APPENDIX II
All chemicals were from Sigma-Aldrich, Poole, UK unless otherwise stated
IMMUNOHISTOCHEMISTRY SOLUTIONS
CITRATE BUFFER (0.1M) pH 6.0
42.02 g Citric Acid (monohydrate)
1900mls distilled water
Add conc.NaOH to solution to pH 5.5
Make up to 2 litres and pEI to 6.0
Use as 0.01M, diluting in distilled water
GLYCINE/0.1%EDTA (0.5M) pH 3.5
Glycine 75.07g
1900mls distilled water
Add conc. HC1 to solution to pH 4.0. Make up to 2 litres and pH to 3.5
Add 2g EDTA





Absolute alcohol 150 mis
Potassium Alum * 300 g
Distilled Water 3 litres
Mercuric Oxide 7.5 g
Glacial Acetic Acid 120 mis
Haematoxylin is dissolved in Absolute Alcohol and added to the Alum, which has
been dissolved in warm water. Bring to the boil and add Mercuric Oxide slowly.
Cool by plunging in ice. Acetic Acid ** is added after filtering into staining dish
* Potassium Alum - Aluminium Potassium Sulphate
** 4 mis Acetic Acid per 100 mis Haematoxylin
EOSIN
1 % solution in water 1500 mis (15 g)
1% solution in Methanol 500 mis (5 g)
Mix 3 parts (1500 mis) aqueous solution with one part (500 mis) spirit solution.








1 x Denhardts solution
10 mM dithiotreitol (DTT)
125 gg Salmon Testes DNA





1 x Denhardts solution
10 mM Dithiotreitol (DTT)
125 gg Salmon Testes DNA
125 gg yeast tRNA
10% dextran sulphate
2gl appropriate riboprobe per 50gl hybridization buffer
TRIS BUFFERED SALINE (TBS)
0.05M Tris
0.85% NaCl pH 7.4
IN HCL
36 mis cone HCL
9964 mis H2O
PROTEINASE K BUFFER
100 mis 1M Tris, pH 8.0




800 mis H20, pH to 8.0 using NaOH,
make up to 1 litre with H2O
5 X RNase BUFFER
100 mis 1M Tris
20 mis 0.5M EDTA, pH 8.0
1000 mis 5M NaCl
880 mis H20
ICN Biochemicals Inc., Ohio





800 mis H2O pH to 7.0 then make up to 1 litre with H2O
20 X STE
17.5g NaCl
10 mis 0.5M pH 7.4
1 ml 0.5M EDTA ICN Biochemicals Inc, Ohio
pH to 7.4, make up to 100 mis with H2O
3M Na ACETATE
24.6g Na-Acetate
100 mis H20 pH to 6.0 or 7.0 with acetic acid
0.1 SSC/30% FORMAMIDE
1.75 mis 20x SSC
105 mis formamide
H2O to 350 mis
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TEA BUFFER / ACETIC ANHYDRIDE
850jLtl acetic anhydride added To 350 mis TEA just
before use.
PROTEIN EXTRACTION BUFFER




1 protease inhibitor tablet
Mix all ingredients adding the protease
inhibitor last and leave it to dissolve.
Use immediately or store at -20 °C.
WESTERN BLOT SOLUTIONS
HOMOGENISATION BUFFER













Adjust pH with 5 N HC1
Store in aliquots at -20°C




Add dH20 to make a volume of 2.5L.
Use for a maximum of 3 times and then discard
TBS
0.02M Tris, 1.5M NaCl pH 7.6
4.85g Tris
17.53g NaCl
Make up to 2 litres with dH20 and pH to 7.6.
Adjust pH with 5 N HC1.
BioRad, Hemelhempstead, UK
Merck Ltd, Lutterworth, UK
BLOCKING SOLUTION




0.02 M TBS pH 7.6
0.1% Tween-20
1% BSA
GEL FOR PCR ELECTROPHORESIS
For minigel:
1 % AGAROSE GEL
50 mis TAE
0.5 g agarose
Mix in conical flask and heat for 2 minutes in
Microwave until agarose dissolved. Allow to
cool for a few minutes and then add 10 pi
ethidium bromide. Pour gel into gel cast with comb
in situ and allow to set.
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For 150ml gel:
1 % AGAROSE GEL
150 mis TAE
1.5 g agarose




To make up 1 litre:
175.3g NaCl, 3M
88.2g Citric Acid
800 ml Deionised Water
Make up and check pH using pH paper.
Adjust pH using NaOH (5M) or HC1.
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10X TBE
To make up 1 litre:
108g Tris Base
55g Boric Acid
3.77g EDTA ICN Biochemicals Inc, Ohio
Add deionised water to a final volume of
1 litre.
For sequencing, pH to 8.4.
10X Running Buffer
To make up 1 litre:
41.8g MOPS
3.72g Sodium Acetate
4.1g EDTA ICN Biochemicals Inc, Ohio
Add deionised water to 800 ml before adjusting
pH to 7.0 and then make to final volume.
7z TERM





10 mis 20 % v/v glycerol
lg 2 % w/v SDS BioRad, Hemelhempstead, UK
20 mg 0.04 % w/v bromophenol blue BioRad, Hemelhempstead, UK
Dissolve in 50 mis Elgastat x 1 purified H2O
Store in 1 ml aliquots at 5°C




Dissolve in 1 litre Elgastat x 1 purified H2O
Dilute 1:10 with Elgastat x 1 purified H2O
for use.
RESOLVING GEL BUFFER: STOCK A pH 8.8
1.5 M Tris
Dissolve in ~50 mis Elgastat x 1 purified H20.
pH with 5 N HCL.





STACKING GEL BUFFER: STOCK B pH 6.8
0.5 M Tris
Dissolve in ~50 mis Elgastat x 1 purified H2O.
pH with 5 N HCL.
Make up volume to 100 mis with Elgastat x 1
purified H20.
STOCK WASH BUFFER X 10 (TBS X 10)
0.5 M Tris
1.5 MNaCl
Dissolve in ~750 mis Elgastat x 1 purified H20,
adjust pH with 5 N HCL.
Make up volume to 1 litre with Elgastat x 1
purified H20.
Dilute 1:10 with Elgastat x 1 purified H20 for
use (TBS).
RESOLVING GEL (LOWER GEL)
2.35 mis Elgastat xl purified H20
1.0 ml gelatin 10 mg/ml Elgastat xl purified H20
Bovine Skin Type III Bloom 225
2.5 mis Stock A Buffer




50 pi 10% ammonium persulphate
4.0 mis acrylamide/bis
acrylamide/bis-acrylamide 37.5:1 (30% solution) BioRad, Hemelhempstead, UK
Mix by gently swirling. Degas via water
Pressure for 5-10 minutes.
5 pi TEMED
Add TEMED, swirl to mix gently.
STACKING GEL (UPPER GEL)
3.05 mis Elgastat xl purified H20
1.25 mis stock B buffer
50 pi 10% SDS
50 pi 10% ammonium persulphate
0.65 mis acrylamide/bis
Mix by gentle swirling. Degas by vacuum
for 5 - 10 minutes.
5 pi TEMED
Swirl to mix gently.
TRITON-X-100 WASH





DIGESTION BUFFER pH 7.6
50 mM Tris
0.2 M NaCl
5mM CaCh Merck Ltd, Lutterworth, UK
1 pM ZnCl2 Merck Ltd, Lutterworth, UK
0.02 % Brij-35
Dissolve in ~750 mis Elgastat xl purified
H20, adjust pH with 5N HCL.
Make up to 1 litre with Elgastat xl purified
H20. Store at 5°C.
DESTAINING SOLUTION
30 % Methanol Merck Ltd, Lutterworth, UK
10 % glacial acetic acid Merck Ltd, Lutterworth, UK
750 mis Elgastat xl purified
H20
STAINING SOLUTION




RESOLVING GEL (LOWER GEL)
1.69 mis Elgastat xl purified H20
1.0 ml gelatin 10 mg/ml Elgastat xl purified H20
2.5 mis Stock A Buffer
100 pi 10% SDS
50 pi 10% ammonium persulphate
4.0 mis acrylamide/bis
0.66 mis Solution A
Mix by gentle swirling.
Degas via water pressure/dissector
vacuum for 10 minutes.
5 pi TEMED
Swirl to mix gently.
STACKING GEL (UPPER GEL)
2.89 mis Elgastat xl purified H20
1.25 mis stock B buffer
50 pi 10% SDS
50 pi 10% ammonium persulphate
0.812 mis acrylamide/bis
Mix by gentle swirling. Degas by vacuum
12 % Acrylaniide/Bis






for 5 - 10 minutes.
5 |j.l TEMED
Swirl to mix gently.
WASH BUFFER/RINSE BUFFER pH 7.5
6.05 g 50 mM Tris
735 g 5mM CaCl2 Merck Ltd, Lutterworth, UK
25 mis 2.5 % Triton-X-100 Merck Ltd, Lutterworth, UK
Dissolve in ~750 mis Elgastat xl purified
H20, adjust pH with 5N HCL.
Add 25 mis Triton-X-100, allow to dissolve
completely — 1 — 1.5 hours on magnetic stirrer.
Make up to 1 litre with Elgastat xl purified
H20
INCUBATION/DIGESTION BUFFER
As rinse buffer but without the Triton-X-100.
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The Human Fetal Testis Is a Site of Expression of
Neurotrophins and Their Receptors: Regulation of the
Germ Cell and Peritubular Cell Population
LYNNE L. L. ROBINSON, JULIE TOWNSEND, and RICHARD A. ANDERSON
Medical Research Council Human Reproductive Sciences Unit, Centre for Reproductive Biology. Edinburgh EH16 4SB,
United Kingdom
In the fetal testis, organization of the tissue into two com¬
partments consisting of cords containing Sertoli and germ
cells surrounded by peritubular cells and of other cells within
the intcrstitium is essential for subsequent function. Neuro¬
trophins (NTs) act as survival and differentiation factors in
the nervous system and have been detected in the developing
rodent testis. Expression of mRNA for nerve growth factor:
NTs 3 and 4 and brain-derived neurotrophic factor: the high-
affinity receptors TrkA, TrkB, and TrkC; and the low-affinity
p75 receptor were detected in the human testis between 14
and 19 wk gestation. NT4 mRNA and protein were predomi¬
nantly localized to the peritubular cells. These cells were also
the site of expression of p75. By contrast, nerve growth factor
and NT3 were mainly expressed in Sertoli and interstitial
cells. Treatment of testis organ cultures with the Trk-specific
kinase inhibitor K252a resulted in a marked decrease in both
gonocyte and peritubular cell number and proliferation with
little effect on Sertoli cells. These data demonstrate the ex¬
pression of NTs and their receptors in the human fetal testis
during the second trimester and indicate possible roles in the
regulation ofproliferation and survival ofgerm cells and peri¬
tubular cells. (J Clin Endocrinol Metab 88: 3943-3951, 2003)
DEVELOPMENT OF THE human fetal testis involvesdifferentiation, maturation, and proliferation of sev¬
eral cell types. The first sign of male gonadal development
is the appearance of Sertoli cells at 6-7 wk gestation (1),
initiated by the expression of the testis-determining gene Sri/
(2). After their migration from the yolk sac to the nephro-
gonadoblastic ridge, primordial germ cells associate with
Sertoli cells to form the seminiferous cords. The peritubular
cell population originates from the mesonephros. Peritubu¬
lar cell migration is also determined by Sri/ and is central to
cord formation (3-5), however, the factors mediating these
crucial intercellular signals are poorly understood. At the
same time, there is considerable proliferation of genu cells
and Leydig cells (6-9). This period of development is be¬
lieved to be central to the establishment of adult testicular
function and is also the point at which the cellular abnor¬
malities that later manifest as testicular malignancies may
arise (10). This study investigates the possibility that neu¬
rotrophins may be involved in these intercellular interactions
in the developing human testis.
A number of paracrine factors controlling migration, dif¬
ferentiation, and proliferation of primordial germ cells and
Sertoli cells, including members of the TGE/3 family, have
been described in the rodent (11-14). Neurotrophins are
members of the nerve growth factor (NGE) family and are
related to TGE/3. They regulate neuronal survival and dif¬
ferentiation in nervous tissue (15, 16) and include NGE,
Abbreviations: BDNF, Brain-derived neurotrophic factor; BrdU, bro-
modeoxy uridine; ER, estrogen receptor; HRP, horseradish peroxidase;
NGF, nerve growth factor; NRS, normal rabbit serum; NT, neurotrophin;
SSC, sodium saline citrate; TBS, Tris-buffered saline; Trk, high-affinity
tyrosine kinase.
brain-derived neurotrophic factor (BDNF), neurotrophin
(NT) 3, NTT (also known as NT5), and NT6 (16). Many of the
effects of the neurotrophins are mediated via high-affinity
tyrosine kinase (Trk) receptors, which have specificity for the
various neurotrophins (17). Three members of the Trk re¬
ceptor family have been described: TrkA, the receptor for
NGE; TrkB, the receptor for BDNE and NTT; and TrkC, the
receptor for NT3. Truncated forms of the TrkB and TrkC
receptors, which lack the intracellular tyrosine kinase do¬
mains, have also been described, although their function is
unknown (16-18). All neurotrophins are also recognized by
a more widely expressed receptor known as p75, which is a
member of the TNE receptor family (19).
Neurotrophins also may function in nonneuronal tis¬
sues (20), including the developing gonads of both sexes.
For example, several members of the neurotrophin family
and their receptors have been identified in the developing
rodent testis (21-2T), and roles in testicular cord formation
(23) have been suggested in addition to later involvement
in the function and interaction of germ cells and Sertoli
cells (25-27). Preliminary data suggest that members of the
neurotrophin family and their receptors may also be ex¬
pressed in the developing human testis (2T). Recent stud¬
ies have shown that NTT and its cognate high-affinity
receptor TrkB may be of particular importance in the in¬
teraction between germ cells and somatic cells in the de¬
veloping ovary of both rodent and human (28, 29). To
determine whether neurotrophins could influence devel¬
opment and maturation of the human fetal testis, we have
examined the cell-specific expression and distribution of
several members of the neurotrophin family and their
receptors during the second trimester, with particular em¬
phasis on NTT and TrkB.
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Materials and Methods
Tissues
Human fetal testes (13—1*5 wk gestation) were obtained after medical
termination of pregnancy. Women gav e consent according to national
guidelines (30), and the study was approved by the Lothian Paediatrics/
Reproductive Medicine Research Ethics Sub-Committee. Termination of
pregnane)' was induced by treatment with mifepristone (200 mg orally),
followed bv 1 mg prostaglandin El analog (Gemeprost, Beacon Phar¬
maceuticals, Tunbridge Wells, UK) administered every 3 h per vaginum.
None of the terminations were for reasons of fetal abnormality, and all
fetuses appeared morphologically normal. Gestational age was deter¬
mined bv ultrasound examination before termination and confirmed by
subsequent direct measurement of foot length. A total of 15 specimens
were used for this study (13 wk, two specimens; 14 wk, three; 15 wk, two;
16 wk, two; 17 wk, four; and 19 wk, two specimens).
Testes were dissected free and either fixed for immunohistochemical
analysis or snap frozen and stored at —70 C. Fixation was carried out in
Bourn's fixative for 5 h, followed by transfer to 70'%. ethanol, before
processing into paraffin, using standard methods.
Isolation ofRNA and RT-PCR
Total RNA was extracted from snap-frozen samples of fetal testis
using the RNeasy mini kit (Quiagen, Crawley, UK). RNA was treated
with DNAase (Life Technologies, Inc., Paisley, UK), and reverse tran¬
scription was performed using a first-strand cDNA synthesis kit (Roche
Diagnostics, Lewes, UK) on aliquots containing 1 /eg. Subsequently, PCR
was performed as described previously (29). Two control tubes were run
in parallel, one in which water replaced the RNA and a second omitting
reverse transcriptase to ensure there was no genomic DNA contamina¬
tion. Primers specific for human neurotrophins and their receptors were
used and designed to span an intron in the case of the Trks, to prevent
amplification of any contaminating DNA (Table 1). Primers for the
constitulively expressed gene CArDH were used to confirm the integrity
of the RNA and efficacy of the PCR reaction. The identity of all PGR
products was confirmed by direct sequencing using an Applied Bio-
systems (Foster City, CA) 373A automated sequencer.
In situ hybridization for NT4
Riboprobes were generated using a PCR strategy to incorporate SP6
or T7 phage promoter sequences into NTT PCR product (29). Probes
were labeled with digoxigenin using a commercially available kit
(Maxiscripl, Ambion Inc., Huntingdon, UK). Briefly, DNA templates
(300 ng) were incubated for bll min at 37 C with transcription buffer; 10
U ribonuclease inhibitor; 0.5 mm each of rATP, rCTP, rGTP; 0.33 mu
TABLE 1. Sequence of primers used for detection of
ncurolrophins and their receptors















































rUTP; 0.17 mM digoxigenin-ll-UTP; and 30 U of appropriate RNA
polymerase in a final volume of 20 pi. After the addition of 2 U DNAase
I (RNAase-free), the probes were incubated at 37 C for an additional 15
min before being purified through Chromaspin columns (DEPC-lflfl,
Clontech, Palo Alto, CA).
In situ hybridization was carried out as described previously (29).
Briefly, 5-pm sections were cut and mounted before immersion in 0.4 m
HCl for 20 min. Slides were then washed and treated with 1.5 pg/ml
proteinase K at 37 C for 10 min in 0.1 m Tris/HCl and 0.05 m EDTA (pH
8.0), transferred to 0.2'%. glycine at 4 C for 10 min, acetylated with 0,25'%.
acetic anhydride in 0.08 m triethanolamine (pH 8.0) for 10 min, and
washed in 4x sodium saline citrate (SSC) for 5 min. Sections were
incubated with prehybridization buffer at 50 C for 2 h and then hy¬
bridized at 50 C ov ernight with hybridization buffer.
On the next day, sections were washed in 4X SSC for 10 min, then
incubated in RNAase A at 37 C for 30 min, washed twice in 2X SSC for
5 min, transferred to 0.1 X SSC with 30'%. formamide at 37 C for 30 min,
and washed in Tris-buffered saline (TBS, pH 7.4) for 5 min. For detection
of digoxigenin, labeled sections were then incubated sequentially at
room temperature, with 2X 5 min washes in TBS between steps, in: 1)
3'%. H202 in TBS for 30 min; 2) normal rabbit serum (NRS), 1:5 dilution
in TBS containing 5 drops/ml avidin block (Vector Laboratories, Peter¬
borough, UK) for 30 min; 3) biotin block (Vector Laboratories) 8
drops/ml in TBS for 30 min; 4) sheep antidigoxigenin (1:100 in NRS/
TBS; Roche Diagnostics) for 2 h; 5) biotinylated rabbit antisheep IgC
(1:500 in NRS/TBS; Vector Laboratories) for 30 min; 6) ABComplex-
horscradish peroxidase (HRP) (DAKG Corp., Cambridge, UK) for 30
min; and 7) diaminobenzidine liquid subs Ira te-chromagen system
(DAKO Corp.) for approximately 2 min. Sections were then counter-
stained in hematoxylin, dehydrated, and coverslip mounted with Pertex
mounting medium (Cellpath, Newtown, UK).
Im in unoh istochem istry
Immunohistochcmistry was performed to localize the expression of
NGF, NT3, NTT, the receptors TrkB and p75, and bromodeoxyuridine
(BrdU), as described previously (29). Briefly, 5-/cm sections were
mounted, devvaxed, and rehydrated. Antigen retrieval was used for
TrkB only by immersion of slides in boiling 0.01 m citrate buffer (pH 6.0)
for 2.5 min, then leaving them to stand in the buffer for 10 min. In all
cases, endogenous peroxidase activity was inhibited bv incubation in 3'%.
H202 in methanol for 30 min. After a wash in water, slides were trans¬
ferred into TBS [0.05 m Tris and 0.85'%. NaCl (pH 7.4)] for 5 min and
blocked for 30 min in the appropriate diluted serum. Sections were then
blocked with avidin (0.01 m, 15 min) and biotin (0.001 m, 15 min) (both
from Vector Laboratories), with washes in TBS in between. The follow¬
ing primary antibodies were used; NGF, NTT, NT3 (all rabbit polyclonal;
Santa Cruz Biotechnology, Santa Cruz, CA), p75 (mouse monoclonal;
Neomarkers, Fremont, CA), anti-BrdU (mouse monoclonal; Roche Di¬
agnostics). These were applied at dilutions of 1:30,1:100,1:50,1:25, and
1:30, respectively. Three antibodies against TrkB were used [rabbit poly¬
clonal (Oncogene, San Diego, CA), rabbit polyclonal (Santa Cruz Bio-
technology), and chicken polyclonal (Promega, Southampton, UK)] in
serial dilutions of 1:25, 1:50, and 1:100 in the appropriate serum at 4 C
overnight.
Sections were then washed and incubated for 30 min with a biotin¬
ylated secondary antibody diluted 1:500 in the appropriate serum. For
NGF, NTT. and NT3, a biotinylated antirabbit secondary antibody was
used; for p75 and anti-BrdU (both DAKOCorp.), biotinylated antimouse
was applied; and for TrkB, both biotinylated antirabbit (DAKO Corp.)
and antichicken (Jackson Laboratories, Bar Harbor, ME) secondary an¬
tibodies were used. After washes in TBS, sections were incubated with
avidin biotin HRP-linked complex (DAKO Corp.) according to the man¬
ufacturer's instructions, and bound antibody was visualized using 3,3'-
diaminobenzidine telra-hvdrochloride (DAKO Corp.). Primary antibod¬
ies were omitted as negative controls, except for NGF, in which the
primary antibody was preabsorbed with the blocking peptide (Santa
Cruz Biotechnology).
All sections were counterstained with hematoxylin, dehydrated,
mounted, and visualized by light microscopy. Images were captured
using an Olympus Prov is microscope (Olympus Optical Co., London,
UK) equipped with a Kodak DCS330 camera (Eastman Kodak, Roch-
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ester, NY) and assembled using Photoshop 6.0 (Adobe, Mountain
View, CA).
Immunoblotting
Immunoblotting was carried out according to the protocol described
previously (20). Briefly, fetal lesles were homogenized in denaturing
buffer, and samples (20 /xg protein) were diluted with an equal volume
of reducing loading buffer and boiled for 5 min. Proteins were separated
by SDS-PAGE on a 4-20% gradient Tris-glycine gel using Tris-glycine
SDS running buffer (both from Novex, Invitrogen, Amsterdam, The
Netherlands) in parallel with prestained protein molecular weight mark¬
ers (Bio-Rad, Hercules, CA) and blotted onto polyvinvlidene difluoride
membranes (Amersham Life Sciences, Buckinghamshire, UK) overnight
using a wet-blot apparatus (Bio-Rad).
Thereafter, membranes were soaked tor 5 min in methanol and
washed briefly several times in TBS. They were then blocked for 8 h at
room temperature in 0.02 m TBS (pH7.6) containing 3% weight/\ olume
BSA (Sigma) and 8",. powdered milk. Membranes were washed in TBS
with (1.1% Tween 20, and then incubated for overnight with the primary
antibody. Antibodies to NT4 (rabbit polyclonal; Santa Cruz Biotechnol¬
ogy), full-length TrkB (rabbit polyclonal; Oncogene), and p75 (mouse
monoclonal; Neomarkers) were applied at dilutions of 1:500, 1:50, and
1:500, respectively, in TBS with 0.1% Tween 20 and 1% BSA at 4 C.
Primary antibody was omitted as a negativ e control. Bound antibody
was detected using either antirabbit or antimouse HRP-linked second¬
ary antibodies (1:4000; Amersham Life Sciences) and the enhanced
chcmiluminesccnce visualization system (Amersham Life Sciences)
according to the manufacturer's instructions.
Testis culture
Testes from three fetuses of 14,16, and 19 wk gestation were dissected
free of adherent tissues using sterile technique, bisected longitudinally,
and then cut into slices approximately 0.5 mm thick under a dissecting
microscope. Samples of fresh tissue were fixed for histological analysis.
The remaining tissue fragments were cultured on 0.4 pm pore Millicell
CM filters (Millipore, Bedford MA) in a 24-well plate (Tramswell, Costar,
Lligh Wycombe, UK). To each well 0.4 ml ofmedium was added, enough
to just cover the tissue fragments. Any remaining wells were partially
filled with medium to maintain humidity in the culture vessel.
The medium comprised MEMa (Life Technologies, Inc., Paisley, UK)
containing 3 mg/ml BSA, antibiotics (100 IU/ml penicillin, 100 peg/'ml
streptomycin sulfate, and 0.125 prg/ml amphotericin), 5 pig /mI insulin,
5 pig/ml transferrin, and 5 pig/nil sodium sclenitc, 2 mmol/liter glu-
tamine, and 2 mmol/liter pyntvate (all chemicals supplied by Sigma).
To some wells the Trk inhibitor K252a (Calbiochem, Nottingham, UK)
was added, at a concentration of 100 nmol/liter. Dimethylsulfoxide was
used as the solvent for K252a and was added to control wells at the
appropriate dilution. The cultures were maintained at 37 C in a humid¬
ified incubator, under 5%, COz, in air for 48 h. After 24 h, the medium
was removed and replaced with fresh medium containing 30 pimol/liter
BrdU (Sigma) to label proliferating cells. At the end of the culture period,
tissue fragments were fixed for 1 h in Bouin's fluid, and then transferred
to 70% ethanol before embedding in paraffin wax for histological anal¬
ysis. The tissue was sectioned at 5 pun thickness and immunostained for
BrdU, using the protocol described above.
Sections of uncultured control and cultured tissue were analyzed to
investigate the effects of culture and of K252a on the number and
proliferation of the various cell types present. Analysis was carried out
blind using the Area Fraction Probe in the Stereologer software program
(Systems Planning and Analysis Inc., Alexandria, VA), as described
prev iously (31). Tissue was serially sectioned, and sections greater than
20 pirn apart were counted, ensuring the same cells were not counted
more than once. The counting was performed using a 121-poinl grid in
the eyepiece of the microscope. Only cells whose nuclei lay beneath the
intersections on the grid were counted. The number of germ cells, Sertoli
cells, peritubular cells, and interstitial cells present per randomly chosen
grid were recorded, with the number of each cell type that was immu¬
nostained for BrdU. Between 25 and 73 grids were counted for each testis
piece, as determined by the program. The number of points lying outside
the tissue in any grid was also recorded and the total cell numbers
counted were corrected for this. The average number of each cell type
present per grid was calculated for each experimental condition, and
data were analyzed using paired t tests.
Results
Expression of mRNAs for neurotrophins and their receptors
Expression of mRNAs was detected by RT-PCR using
RNA extracted front fetal testes (Fig. 1). RT-PCR for the
constitutively expressed gene GAPDH was used to confirm
the integrity of the RNA. Human fetal brain and placenta
were used as positive controls (data not shown). rnRNA for
the neurotrophins NGF (Fig. la), NT3 (Fig. lb), NT4 (Fig. lc),
and BDNF (Fig. Id) and the receptors TrkA (Fig. If), TrkB
(Fig. lh), TrkC (Fig. lg), and p75 (Fig. lj) was detected in all
specimens at all gestations examined. Both full-length and
the truncated forms of TrkB were detected (Fig. 1 h and i).
Products of 228- and 204-bp size were detected for TrkC (Fig.
1 g), representing spliced variants of the gene (32) confirmed
by sequencing. In some samples at all gestations an addi¬
tional PCR product of 300 bp was noted and the sequence
found to be unrelated to the tyrosine kinase receptor family.
In situ hybridization for NT4
Cell-specific patterns of expression of NT4 were further
investigated by nonradioactive in situ hybridization on fixed
tissue sections. NT4 mRNA expression was predominantly
localized to the peritubular cells (Fig. 2, A and B). NT4 mRNA
was also detected in Sertoli cells but no mRNA appeared to
be expressed in gonocytes (Fig. 2B). A low level of expression
was detected in the interstitium, with the exception of the
endothelial cells of small blood vessels, which showed more
clearly positive expression. There was no apparent change in
the pattern or intensity of expression of NT4 mRNA over the
gestational range examined (14-19 wk). Tissue sections in¬
cubated with the sense riboprobe showed no staining (Fig.
2A, inset) confirming the specificity of the probe.
Immunohistochemical localization of neurotrophins
and receptors
Expression of NT4, NGF, NT3, and p75 proteins was de¬
tected by immunohistochemistry in all specimens examined
across the gestational range of 14-19 wk. Expression of NT4
was confirmed by immunolocalization of the protein to the
cytoplasm of the peritubular cells and Sertoli cells within the
seminiferous tubules; gonocytes were immunonegative (Fig.
2, C and D). Very little immunostaining was noted in the
interstitial cells, but endothelial cells within small blood ves¬
sels were immunopositive for NT4 (data not shown). The
most intense immunopositive reaction for NGF was in Sertoli
cells (Fig. 2E), although some gonocytes also appeared im¬
munopositive. Weak staining was noted in the interstitial
cells (Fig. 2E). NT3 protein was also immunolocalized mainly
to the Sertoli cells, with some interstitial staining (Fig. 2F).
Very few gonocytes stained positively for NT3, and no pro
tein was detected in the peritubular cells.
Immunolocalization of p75 was most intense in the peri¬
tubular cell compartment (Fig. 2, G and H), but it was also
present in the interstitial cells. Neither Sertoli cells nor gono¬
cytes showed any p75 immunoreactivity. Despite the use of
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Flo. 1. Expression ol'mRNA for ncuro-
irophins and their receptors in human
fetal testis. RT-PCR analysis of mRNA
expression of the neurotrophins and
their receptors, as shown above each
panel, in samples extracted from whole
testes from 13-19 wk gestation. Prod¬
ucts of 228 and 204 bp were detected for
TrkC (g), representing spliced variants
of the gene, and in some samples an ad-
dilional PGR product of 300 bp was de¬
tected. e, GAPDII expression is shown.
Lanes marked RT- contained samples
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three different antibodies, specific staining for TrkB receptor
protein was not detectable.
Mo change in pattern or intensity of staining for any of the
proteins detected was noted over the gestational range ex¬
amined. Control experiments conducted by omitting the ap¬
plication of the primary antibody or using a specific blocking
peptide, in the case of MGF, showed no staining (Fig. 2, C and
E, insets).
Immunoblolting
The presence of MT4, TrkB, and p75 proteins in the fetal
testis was confirmed by immunoblotting; a positive control
of rat cerebral cortex was run on all gels (Fig. 3). The im-
munoblot of MT4 protein expression detected a single band
of 21 kDa molecular mass in all samples of fetal testis (Fig.
3A). For detection of TrkB, the antibody used was directed
against the full-length protein. Two immunoreactive bands
of 110 kDa and B0 kDa molecular mass were detected (Fig.
3B). These bands are reported to represent the glycosylated
and unglycosylated forms, respectively, of the TrkB protein
(33). Two immunoreactive bands were also detected for the
p75 receptor, at 75 kDa and 65 kDa, in all samples of fetal
testis (Fig. 3C). In all cases, the sizes of the proteins detected
were identical to those in the positive control tissue. These
immunoblots were repeated three times using different sam¬
ples; no consistent changes with gestation were noted. A
negative control was also performed for all three proteins by
omitting the primary antibody, and in all cases immunore-
activity was abolished.
Testis culture
After 48 h of culture, there was a small increase in the
number of gonocytes in comparison with the time 0 samples
(P = 0.02) (Fig. 4A) and a decrease in the number of inter¬
stitial cells (P = 0.05). The numbers of Sertoli cells and peri¬
tubular cells did not change significantly during this period
of culture. Consistent with this increase in gonocyte number,
an average of 12% of gonocytes were immunostained with
BrdU, compared with less than 2% of Sertoli cells and peri¬
tubular cells.
K252a treatment resulted in a consistent decrease in the
number of gonocytes present in the tissue (P < 0.01) (Fig. 4).










Fl(i. 2. /» g/fii hybridization and iinmunohistochemical localization of neurotrophins and their receptors in human fetal testis. In situ
hybridization: A, localization of NT4 mRNA expression in a 19-wk testis (antisense probe). Inset shows results for sense RNA probe; B, NT4
mRNA expression in 16-wk testis at higher magnification.Immunohistochemistry: C, NT4 in 17-wk testis; D, NT4 in 13-wk testis at higher
magnification; E, 15-wk testis stained for NGF; F, 17-wk testis stained forNT3; G, 19-wk testis stained for p75; II, 17-wk testis stained for
p75 at higher magnification. Insets in A, C, and E show negative controls. Positive staining in all panels is brown, and sections are countcrstained
with hematoxylin, g, Gonocytc; s, Sertoli cell; p, peritubular cell; i, inlerstilium; tc, testicular cord. Scale bars: A, C, and G, 500 /em (magnification,
X200); B, E, F, and II, 250 fim (magnification, X400); D, 100 /xm (magnification, X1000); insets, magnification, X400.
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Fl«. 3. Western blot of NT4, TrkB, and p75 in human fetal testis.
Total protein extracts (20 pg) from whole testes at 13-19-wk gesta¬
tion, as shown, were separated by SDS-PAGE. transferred to PDF
membrane, and incubated withanti-NT4, -TrkB, and -p75 antibodies.
A. NT4, a protein band that migrated with an apparent molecular size
of21 kDa. B, TrkB protein bands with apparent molecular sizes of 110
and 95 kDa, representing two forms of full-length TrkB. C, p75, a
protein band with an apparent molecular size of 75 kDa and an
additional band of approximately 65 kDa. Control tissue was rat
cerebral cortex in each case. The positions of molecular mass markers
arc indicated. No immunoreactive bands were detect ed in the absence
of primary antibody (data not shown).
There was also a significant fall in the number of peritubular
cells (P = 0.0(16) and a small but statistically significant (P =
0.04) reduction in the number of Sertoli cells (Fig. 4A). In
contrast, there was an increase in the number of interstitial
cells, but this did not reach statistical significance. The num¬
ber of proliferating (i.e. BrdU immunopositive) gonocytes
was reduced by an average of 58%, from 2.4 ± 0.6 to 0.9 ±
0.2 per grid (Fig. 4, B-D), very similar to the reduction in the
number of gonocytes (54%). The number of proliferating
peritubular cells was also reduced, by a mean of 71%, from
1.9 ± 0.8 to 0.5 ±0.1 per grid, compared with a 30% reduction
in the number of peritubular cells. Thus, there was a mean
fall of 26% in the proportion of gonocytes that were BrdU
immunopositive, compared with a fall of 71% for peritubular
cells. However these decreases did not reach statistical sig¬
nificance. There was also a reduction in the number of pro¬
liferating Sertoli cells, from 0.8 ± 0.5 to 0.3 ± 0.0 per grid,
which again did not reach statistical significance.
Discussion
The gestational age range examined in this study follows
the period of testicular cord differentiation and is a time of
gonocyte and Sertoli cell proliferation, and active steroido¬
genesis (1, 6-9). These data demonstrate the gene expression
and presence of neurotrophins and their receptors in the
human fetal testis at this time. Data also show that blockade
of high-affinity neurotrophin receptors reduced gonocyte
and peritubular cell survival and proliferation while having
little effect on Sertoli or interstitial cells. The striking local¬
ization of expression of NTT (at both mRNA and protein
levels) and the p75 neurotrophin receptor to the peritubular
cells may indicate that these cells are central to the functions
of neurotrophins in the developing testis. The formation of
cords is crucial to Sertoli- and Leydig-ccll differentiation and
inhibition of germ cell meiosis (2) and, thus, is not only the
main morphological feature distinguishing the developing
testis from the ovary but is also of paramount functional
importance. In the mouse these features of normal develop¬
ment have been clearly linked to the Sri/ expression (4), which
also induces stimulation of cell migration from the mesone-
phros into the gonad, and thus testis cord formation (5).
Peritubular cells originate in the mesonephros (3), and their
precursors have been demonstrated to express the p75
receptor (22). Trk receptor knock-out models also provide
evidence for the involvement of neurotrophins in the cell
migration associated with testicular cord formation (34),
supporting earlier studies using K252a treatment of organ
cultures (23). The present results, therefore, support the
hypothesis that neurotrophin expression in the human testis
is important in the regulation of normal development.
Neurotrophins are small, secreted proteins related to the
TGF/3 superfamily, originally identified on the basis of their
role in the regulation of neuronal survival. However, neu¬
rotrophins also may regulate cell migration (35) and differ¬
entiation (36). In addition to signaling through high-affinity
Trk receptors, neurotrophins also signal through the p75
receptor, and the pattern of expression of the different re¬
ceptor types influences the response (37, 38). Further inter¬
action is suggested by the demonstration that the immature
form of NGF, termed pro.NGF, has a greater affinity for p75
than the mature form of NGF (39). Thus, neurotrophin sig¬
naling is a complex interaction between the ligands and the
Trk/p75 receptor compliment present. In addition to the
full-length TrkB, we have identified mRNA for truncated
TrkB in the developing testis. The truncated form lacks the
tyrosine kinase domain and is predominantly expressed in
nonneuronal cells (33, 40). Although the function of trun-
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Fit). 4. Testis tissue culture data. A. Number of each cell type present per 121-point grid in the human fetal testis, in fresh and cultured tissue.
Tissue from testes of 14. 16, and 19 wk gestation was used in three separate experiments. H, Uncultured, time 0 samples; □, control samples
cultured for 48 h; ■. tissue treated in culture with K252a ncurotrophin receptor inhibitor. Mean ± sem; P < 0.05 ex. control 48 h cultures.
B, Number of proliferating iBrdU immunopositivel cells of each type present per grid in the human fetal testis allcr 48 h of culture. □, Control
samples: ■, tissue treated with K252a ncurotrophin receptor inhibitor. Mean ± sem; n = 3. % P < 0.05; *4:, P < 0.001 vs. control cultures. C
and D, Sections of a 19-wk fetal testis stained using immunohistochemistry for BrdU. C. Tissue cultured for 48 h in control medium; bar, 250
fun. D, tissue cultured lor 48 h with K252a neurotrophin receptor inhibitor; bar, 250 jun. Positive staining is brown, g, Gonocyte; s, Sertoli cell;
p, peritubular cell; tc. testicular cord; i, interstitium.
catcd receptors remains elusive, it has been postulated that
these isoforms have a role as cell adhesion molecules acting
as a selective barrier preventing the diffusion of neurotro¬
phin and promoting elimination by internalization (41, 42).
There are increasing data regarding the expression of neu¬
rotrophins and their receptors in the developing rodent testis
but very little data in the human. In the rodent, testis ex¬
pression has been detected from very early in development
(21, 23). The present data suggest a cell-specific distribution
of the neurotrophins, although some cell types, such as Ser¬
toli cells, expressed more than one ncurotrophin. Expression
of multiple neurotrophins may be required for normal de¬
velopment of some neuronal cell types (43). We were unable
to localize TrkB using immunohistochemistry although, us¬
ing RT-PCR and Western blotting analysis, expression of
both full-length and truncated TrkB mRNA and the full-
length protein was demonstrated. Previous reports of pre¬
dominant localization of p75 in the peritubular cells in the rat
(22-24) are in agreement with our findings in the human.
This pattern of expression shows some parallels with that
seen in the rodent and human fetal ovary (28, 29) in which
p75 is localized to the stromal cells surrounding clusters of
replicating germ cells.
Functional roles for the neurotrophins in morphological
sex determination, cell migration, and testicular cord forma¬
tion have been suggested (23, 24). Treatment of organ cul¬
tures of E13 rat testis with K252a inhibited cord formation
(23). In the present studies, we have also used K252a to
investigate the functional activity of neurotrophin signaling
in the developing human testis. K252a is an indole carbazole,
widely used as a potent and selective inhibitor of the intra¬
cellular protein kinase domain of Trk receptors without af¬
fecting other serine/threonine kinases at the concentrations
used here (23, 44, 45). K252a blocks the activity of all high-
affinity Trk receptors, so these data do not permit interpre¬
tation in terms of which neurotrophin(s) and receptor(s)
might be involved in the effects observed. Although the
investigation of selective blockade of specific Trk receptors
has been attempted in the investigation of many models,
including the developing testis (23), the effects are generally
much less marked than those of K252a, consistent with con¬
siderable redundancy in neurotrophin signaling, as also
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demonstrated by the phenotypes of knockout animals (16).
in this culture system, the integrity of the tissue was well
maintained, and cell proliferation was detected. This was
noted to be at a much higher rate in gonocytes that in other
cell types. The major effect of K252a on the testicular cords
was on gonoevte survival, with relatively little effect on Ser¬
toli cells. Sertoli cells were the primary site of expression of
MGF and NT3, and although the site of expression of Trk
receptors was not demonstrated in the present study, TrkA
has been previously reported to be expressed by rat Sertoli
cells between E16 and P0 (21). These results suggest that
neurotrophins are critical for gonocyte survival and repli¬
cation, but their effects may be mediated indirectly via Sertoli
cells. This is the classic pattern of Sertoli cell/germ cell in¬
teraction, with paracrine signaling between these two cell
populations, most clearly exemplified by the mediation of
the effects of FSH and androgen. It is also apparent that the
relative number of gonocytes and Sertoli cells is maintained
during early testicular development despite a 10-fold in¬
crease in the number of gonocytcs between 6 and 9 wk
gestation (6); the present data suggest that neurotrophin
signaling may contribute to the regulation of this ratio. Se¬
lective gonocyte loss has not previously been reported as a
result of neurotrophin blockade, but cord formation is cer¬
tainly affected, inevitably involving gonocyte survival (23).
These data may be compared with the recent demonstration
that ncurotrophins are involved in germ-cell survival in the
human fetal ovary at a comparable stage of development
(29), although in the ovary it appears that germ cells are a
direct site of neurotrophin action. Although that may also be
the case in the testis, direct evidence is thus far lacking.
Whereas K252a resulted in a marked loss of gonocytes,
there was also a reduction in the number of peritubular cells.
There was also a striking reduction in gonocyte and peritu-
bular-cell proliferation. Because the fall in the number of
BrdU immunopositive peritubular cells was much greater
than the fall in the total number of that cell type (71% vs. 30%),
whereas the comparable figures for gonocytes were similar
(58% vs. 54%), these data may suggest a specific effect of
neurotrophin on peritubular-ccll proliferation in addition to
survival, consistent with those cells being the major site of
expression of NT4 and the p75 receptor. The importance of
ncurotrophins and their receptors in rat testicular cord for¬
mation (21, 23) may also reflect a major site of action on the
peritubular cell population. Because the p75 receptor may
promote apoptosis in the absence of Trk receptor signaling
(37, 46), relatively unopposed p75 signaling may contribute
to the decrease in peritubular cell proliferation and survival
in the presence of K252a.
We have recently demonstrated the expression of estrogen
receptor (ER) |3 within the human fetal testis (47). Sertoli and
peritubular cells were demonstrated to express both ER/3 1
and 2 isoforms, whereas gonocytes expressed only ER/32,
indicating that Sertoli and peritubular cells in particular may
be sites of estrogen action. Estrogen and neurotrophins in¬
teract in neural development, selectively enhancing neuronal
growth and development (48), and ER mR.NIA may be co-
expressed with neurotrophins (49, 50). Some of these effects
of estrogen may be mediated by ER other than the classical
ERa (51). The expression of both neurotrophins and their
receptors and ER/3 in Sertoli cells and peritubular cells sug¬
gest that these pathways may interact in a wide variety of cell
types.
In conclusion, this study demonstrates that neurotrophins
and their receptors are expressed in the developing human
testis during the second trimester. .Ncurotrophins have been
demonstrated to be crucial for cellular migration, germ-cell
survival, and proliferation (21-24,34) in the rodent testis; and
the present results suggest that they are likely to be of similar
importance in the human, with a major role in the regulation
of proliferation and survival of germ cells and peritubular
cells.
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Summary
During mammalian ovary formation, the production of
ovarian follicles is accompanied by an enormous loss of
germ cells. It is not known how this loss is regulated. We
have investigated the role of the Trk tyrosine kinase
receptors, primarily TrkB, in this process. The ovaries of
TrkB ' and TrkC ' mice with a mixed (I29Sv x C57BL/6)
genetic background were examined shortly after birth.
Around 50% of TrkB ' mice had grossly abnormal ovaries
that contained greatly reduced numbers of follicles. No
defects were found in the ovaries of TrkC ' mice. Congenic
TrkB ' mice were generated on 129Sv and C57BL/6
backgrounds: whereas the former had a mixed ovarian
phenotype similar to that of the original colony of mice, the
ovaries of all offspring of the C57BL/6 congenic line
contained reduced numbers of follicles. RT-PCR showed
that mRNA encoding TrkB and its two ligands,
neurotrophin 4 (NT4) and brain-derived neurotrophic
factor (BDNF), were present throughout the period of
Introduction
Female embryonic mice produce tens of thousands of germ
cells as the ovary fonns. Shortly before birth, germ cells
(termed oogonia at this stage) stop mitosis, initiate meiosis
(which is halted at the diplotene stage) and associate closely
with somatic pregranulosa cells to form primordial follicles.
There is now a finite supply of female germ cells (now termed
oocytes), which cannot be replenished if lost. Concurrent with
these processes, there is a massive wave of cell death that
results in the death of 80-90% of oocytes in mice and humans
(Brambell, 1927; Baker, 1963; Hirshfield, 1991). The same
general pattern of oocyte loss occurs in all mammals. In mice,
this wave of oocyte death is most pronounced around the time
of birth, when follicle formation is at its peak; in humans, it
occurs at around five months of gestation. This process is vital
to the reproductive potential of all female mammals because
their reproductive lifespan is determined by the supply of
primordial follicles, but its regulation is not understood.
Primordial follicles consist of an oocyte surrounded by
flattened granulosa cells, and are considered to be at a 'resting'
stage of development. Follicles can remain at this stage
follicle formation in the mouse. In situ hybridisation
showed that TrkB was expressed primarily in the germ cells
before and after follicle formation. Mouse neonatal and
fetal ovaries and human fetal ovaries were cultured in the
presence of K252a, a potent inhibitor of all Trk receptors.
In mice, K252a inhibited the survival of germ cells in newly-
formed (primordial) follicles. This effect was rescued by the
addition of basic fibroblast growth factor (bFGF) to the
culture medium. Combined addition of both BDNF and
NT4 blocking antibodies lowered germ-cell survival,
indicating that these TrkB ligands are required in this
process. The results indicate that signalling through TrkB
is an important component of the mechanism that regulates
the early survival of female germ cells.
Key words: Trk, Oogonia, Oocyte, Survival, Human, Mouse,
Neurotrophin
throughout the reproductive lifespan of a female. The first sign
of further development of the primordial follicle is the
rounding up of granulosa cells. When follicles contain
primarily rounded granulosa cells, they are considered to have
entered the growth phase and are termed 'primary follicles'.
This process first occurs shortly after birth in the mouse.
The neurotrophins are a small family of closely related
peptide factors. Nerve growth factor (NGF) was the first to be
discovered; BDNF, NT3, NT4 and NT6 have since been
identified (Snider, 1994). The neurotrophins act on both high
and low affinity cell-surface receptors. Many of the effects of
the neurotrophins on cell survival and neuronal growth are
mediated by high affinity glycoprotein tyrosine receptor
kinases, or Trk receptors. Trk receptors consist of an
extracellular domain, which contains the neurotrophin-binding
site, a short transmembrane segment, and an intracellular
domain that encodes a tyrosine kinase. The neurotrophins bind
selectively to the high affinity Trk receptors, which form
homodimers and autophosphorylate to trigger the intracellular
cascade (Segal and Greenberg, 1996). There are three members
of the Trk receptor family: TrkA, the receptor for NGF; TrkB,
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the receptor for BL)NF anil NT4; and TrkC, the receptor for
N 13. The functions of truncated forms of the TrkB and TrkC
receptors, which lack the intracellular tyrosine kinase domains
(Klein et al.. 1990; Deehant. 2001). are unclear. In addition to
the Trk receptors, all neurotrophins hind with relatively equal,
low affinity to a membrane receptor known as p75. a member
of the tumour necrosis receptor superfamily. The p75 receptor
lacks tyrosine kinase activity, but it does appear to have
signalling capabilities. It might modulate cellular responses to
the neurotrophins by enhancing the sensitivity of the Irk
receptors (1 lantzopoulos et ah. 1994). whereas in the absence
of Trk receptors it can induce cell death (Friedman. 2000).
'fhe neurotrophins are implicated in a variety of
developmental processes at numerous neural sites. Their best-
known roles are in the regulation ofcell survival. Thus, neurons
that contain one or more of the Trk receptors might require the
presence of sufficient concentrations of the appropriate
neurotrophin(s) for their continued survival. They might also
be involved in the regulation of neuronal differentiation,
growth and migration (Ghosh and Greenberg, 1995; Segal and
Greenberg, 1996).
All three Trk receptors are expressed around the time of
follicle formation in rats and humans (Dissen et al.. 1995;
Anderson et al.. 2002). In rats, expression of TrkB mRNA
increases sharply and Trk.i mRNA decreases abruptly during
the period of follicle formation whereas TrkC remains
constant throughout. Expression of NT4 mRNA increases
concomitantly with that of its ligand TrkII. In humans, the
expression pattern of NT4 mRNA changes as follicles start to
form, with expression, which is predominantly in oogonia
before follicle formation, switching predominantly to the
somatic pregranulosa cells around the time of follicle
formation (Anderson et al.. 2002). Thus, the location of NT4
mRNA production moves from the germ cell to the somatic
cell just as germ cells undergo the massive wave of apoptosis.
Together, this indicates the possible involvement of "IrkB
signalling in regulating germ-cell survival as follicles form.
1 lere, we report evidence that TrkB plays an important role
in the survival of germ cells in mouse and human ovaries
around the time of follicle formation. We have examined the
ovaries of transgenic mice with a mutation in the catalytic
domain of the TrkB and TrkC receptors (Klein et al., 1993;
Klein et al., 1994), and show the results of culturing fetal and
neonatal mouse ovaries and fetal human ovaries in the presence
of (1) K252a, a potent inhibitor of the Trk receptors, and (2)
blocking antibodies against NT4 and BDNF.
Materials and methods
Animals
Mice were housed in an environmentally controlled room on a 14-
hour light, 10-hour dark photoperiod. Animals were provided with
food and water ad libitum, and kept in accordance with UK legal
requirements. Transgenic mice had a mutation in the catalytic domain
of either the TrkB (Klein et al., 1993) or TrkC (Klein et al., 1994)
receptor. Heterozygous pairs were bred to provide TrkB*'* and TrkB'
offspring, and TrkC*1* and TrkC ' offspring. Offspring were
earmarked for identification and DNA prepared from the material
from the ear punches for subsequent genotyping.
Genotyping transgenic mice
For TrkB*1' x TrkB*1 offspring, sense primer 5'-TCGCGTAAA-
GACGGAACATGATCC and antisense primer 5'-AGACCATGAT-
GAGTGGGTCGCC were used to amplify a 900 bp TrkB ~ band, and
sense primer 5'-CCAGCCTCTGAGCCCAGAAAGC and antisense
primer 5'-GCTGAAGGACGCAGCGACAAT were used to amplify a
TrkB band of -450 bp. PGR reactions for the TrkB' ' band and the
TrkB band were performed separately. For TrkC x TrkC
offspring, we used the sense primer 5'-CTGAAGTC ACTGGCTA-
GAGTCTGGG together with antisense primers for TrkC" (5'-GTC-
CCATCTTGCTTACCCTGAGG) and TrkC <5'-CCAGCCTCT-
GAGCCCAGAAAGO. which amplified 400 bp and 500 bp bands, re¬
spectively (Schimmang et al.. 1995). PGR reactions for the TrkC'
band and the TrkC band were performed simultaneously.
Human fetal ovaries
Human fetal ovaries were obtained follow ing medical termination of
pregnancy. Women gave written consent according to national
guidelines (Polkinghorne. 1989) and the study was approved by
the Lothian Paediatrics Reproductive Medicine Research Ethics
Subcommittee. Tennination of pregnancy w as induced by treatment
with mifepristone (200 mg orally) followed 48-hours later by
prostaglandin CI analogue (Ciemcprosi. Beacon Pharmaceuticals.
Tunbridgc Wells. UK) I mg 3-hourly per vaginam. None of the
terminations were for reasons of fetal abnormality, and all fetuses
appeared morphologically normal. Gestational age w as determined by
ultrasound examination prior to termination and confirmed by
subsequent direct measurement of foot length.
Mouse ovary cultures
Neonatal C57BL 6 x CBA/Ca mice were killed by decapitation. Fetal
ovaries were obtained from pregnant females killed by cervical
dislocation 16.5 days after mating. Ovaries were removed aseptically
and placed in watch glasses containing Liebovitz L-15 dissecting
medium (Gibco-BRl. Renfrew. UK) supplemented with 0.3% (vv/v)
bovine serum albumin (BSA) (Fraction V. Sigma. Poole. UK). Tissue
surrounding the ovaries was removed using sterile needles. Freshly
dissected newborn ovaries were bisected using a sterile scalpel blade.
In the first cultures with K252a alone (Calbiochcm. Nottingham. UK)
ovaries w ere subsequently halved again using fine-gauged needles. In
the cultures with K252a and bFGF (R&D Systems. Abington. UK)
and in those with the anti-NT4 and anti-BDNF blocking antibodies
(Sigma), ovary halves were used because the quarter ovaries used in
the earlier experiments were more difficult to handle and process for
histological analysis. Whole ovaries were used with embryonic day
16.5 (Li6.5) mice, as it was not possible to cut the El6.5 ovaries
cleanly because of fragility of the tissue. Tissue was either fixed in
Bouin's for analysis (uncultured control) or cultured. Culture pieces
were placed on a polycarbonate membrane on the base of a 96-well
plate (Iwaki, Japan). Wells contained 100 |il of pregassed medium
overlaid with 100 pi of silicone fluid (Gibco-BRL). Ovarian pieces
were cultured in a-MEM (Gibco-BRI) supplemented with ascorbic
acid (28 pM) and 0.3% (w/v) BSA, with additions as detailed below.
The tissue was cultured in a humidified incubator (5% CO2, 37°C).
Half of the used medium (50 pi) was exchanged for fresh medium
every other day for the duration of the culture period. Upon fixation,
ovarian pieces were washed in PBS containing polyvinyl pyrrolidone
(3 mg ml"') to remove any medium and fixed for 1.5-2 hrs in Bouin's
solution.
Human ovary cultures
Ovaries were dissected free of adherent tissues using sterile technique,
bisected longitudinally and cut into -0.5 mm-thick slices. Samples of
fresh tissue were fixed for histological analysis, 'fhe remaining tissue
fragments were cultured on 0.4 pm pore Millicell CM filters
(Millipore, Bedford, MA, USA) in a 24-well plate (Transwell, Costar,
High Wycombe, UK). Medium (0.4 ml) was added to each well to
just cover the tissue fragments. Any remaining wells were partially
filled with medium to maintain humidity in the culture vessel. The
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medium comprised a MEM containing 3 mg mH BSA, 100 IU ml '
penicillin, 100 |ig ml 1 streptomycin sulphate, 0.125 pg ml-1
amphotericin, 5 |ig ml ' insulin, 5 pg ml1 transferrin, 5 pg ml '1
sodium selenite, 2 mM glutamine and 2 mM pyruvate (all chemicals
supplied by Sigma). Ovaries were cultured in the presence or absence
of K252a. Because K252a was reconstituted in dimethylsulfoxide
(DMSO), the equivalent amount of DMSO was added to control wells.
The cultures were maintained at 37°C in a humidified incubator under
5% CO2 in air for 48 hours and fixed for histological analysis at the
end of the culture period.
Histological assessment of mouse ovaries
After fixation in Bouin's, ovaries or ovarian pieces were embedded in
wax and 5 pm sections cut. Every third (cultured ovarian piece) or
fifth (in vivo ovaries) section was analysed. Individual images were
captured using the Leica Q5001W digital imaging microscope (Leica
Microsystems, Milton Keynes, UK) using a 40xobjective. Healthy
oocytes containing a visible germinal vesicle were counted. In
addition, in the experiment in which NT4 and BDNF activity was
inhibited, a count was made of dead and dying oocytes. In some
culture experiments, the maximum and minimum diameters of each
oocyte were measured. All analyses were carried out blind.
Histological assessment of human ovaries
Sections of tissue were analysed to determine the density ofgerm cells
in the ovary. Analysis was carried out blind using the Area Fraction
Probe in the Stereologer software programme (Systems Planning and
Analysis Inc, Alexandria, VA, USA) as previously described (Sharpe
et al., 2002). A 121-point graticule was used to count the number of
germ cells within a frame: only cells whose nuclei lay beneath the
intersections on the gnd were counted. Between 18 and 42 frames
were used on each ovary piece, as determined by the programme.
Tissue sections were at least 20 pm apart to ensure that no cell was
counted twice. Data are presented as number of germ cells per frame.
RT-PCR
Ovaries were dissected from E16.5, postnatal day 0 (P0) and P4
C57BL/6 X CBA/Ca F1 mice, frozen in liquid nitrogen and mRNA
subsequently extracted using a Quickprep micro mRNA purification
kit (Pharmacia, St. Albans, UK). Brain tissue was collected from mice
at P0. cDNA was prepared from mRNA using random primers
(Promega, Southampton, UK). Separate PCR reactions were then
carried out for cyclophilin, TrkB, NT4 and BDNF. Two separate TrkB
reactions were carried out. The first set ofprimers were to the tyrosine
kinase domain of the gene and, thus, recognised only full length
transcripts ofTrkB, the second were to the ligand-binding domain and
recognised both full-length and truncated TrkB receptors. The
following primers were used:
cyclophilin, S'-CCAGGGTGGTGACTTTACAC-S' (forwaid), 5'-
CGGAAATGGTGATCTTCTTG-3' (reverse);
TrkB (full length), 5'-ATGGCAGAGGGTAACCC-3' (forward), 5'-
CTCTCTGGAGGCATCCAT-3' (reverse) (Singh et al., 1997);
TrkB (full length and truncated), 5'-CTCCGTGTGATTGGTAA-
CATG-3' (forward), 5'-AGTCCAGACACTCAGGATTTGGAC-3'
(reverse) (Anderson et al., 2002);
NT4, 5'-CCCTGCGTCAGTACTTCTTCGAGAC-3' (forward), 5'-
CTGGACGTCAGGCACGGCCTGTTC-3' (reverse) (Botchkarev et
al., 1999); and
BDNF, 5'-GTGAGAAGCTTGATGACCATCC-3' (forward), 5'-
AACAGAATTCCACTATCTTCCC-3' (reverse) (Botchkarev et al.,
1999).
In situ hybridisation
Ovaries from E16.5 and P4 C57BL/6xCBA/Ca F1 mice were fixed
for 30 minutes in freshly-made 4% paraformaldehyde/PBS and
embedded in wax. Sections (6 pm) were cut and mounted on TESPA-
coated slides. Slides were then dewaxed, treated in proteinase K (20
pg ml-1 for 2 minutes at 37°C) and hybridised with digoxigenin-
labelled riboprobes. The probe, which was cloned into pBluescript
(Stratagene, La Jolla, CA, USA), has been described previously
(Klein et al., 1990) and recognised both truncated and full length
TrkB. For antisense probes, plasmids were digested with EcoRl
(Roche, Lewes, UK) and transcribed in vitro with T7 (Roche). For
sense probes, plasmids were digested with Xhol (Roche) and
transcribed in vitro with T3 (Roche). Probes were labelled with
digoxygenin using a DIG RNA-Labeling Mix (Roche) and then
cleaned with 70% ethanol. The probe was revealed with an anti-
digoxigenin alkaline phosphotase antibody (Roche) (100 pi made up
to 50 ml with ddlbO and left overnight at 4°C). Colour detection was
carried out the following day in nitro blue tetrazolium chloride/
5-bromo-4-chloro-3-indlyl phosphate, toluidine salt (Roche), with
levamisole (Vector, Peterborough, UK). Slides were counterstained
with nuclear fast red (Vector).
Immunocytochemistry
Ovaries were fixed in Bouin's fixative for 1 hour then transferred to
a 70% ethanol/eosin solution and embedded in wax. Sections (5 pm)
were cut and mounted on electrostatically charged slides (BDH
Laboratory Supplies), dried overnight in a 60°C oven and dewaxed.
Endogenous peroxidases were quenched with a 3% hydrogen
peroxidase solution in methanol for 30 minutes at room temperature.
Immunocytochemistry was performed as described (Anderson et al.,
2002). Briefly, slides were blocked with 20% normal donkey serum
(NDS; Diagnostics Scotland, Carluke, UK) in TBS containing 5%
BSA and 8 drops avidin solution per ml (Avidin/Biotin Blocking Kit,
Vector) for 30 minutes at room temperature. Slides were blocked
using biotin from the same kit in the same way as avidin. Chicken
IgY primary antibody specific to full-length TrkB was diluted 1/10 in
TBS/BSA/NDS, applied to the slides and incubated overnight at 4°C
(Anti-TrkB In pAb, Promega, UK). Biotinylated donkey anti-chicken
IGY secondary antibody was diluted 1/500 in TBS/BSA/NDS,
applied to the slides and incubated at room temperature for 30
minutes, with avidin biotin horseradish peroxidase linked complex
(DAKO) applied according to the manufacturers instructions.
Bound antibody was visualised using 3,3'-diaminobenzidine
tetrahydrochloride (DAKO). Sections were counterstained with
haematoxylin.
Statistics
Data from mouse in vivo ovary counts were analysed with Mann-
Whitney U tests. Total counts of mouse and human cultured ovaries
were analysed with probability values (P) of differences in oocyte
numbers determined by analysis of variance: where appropriate,
paired comparisons were made using Student's /-test. Where the data
did not have a normal distribution, a Kruskal-Wallis test was used.
The Kolmagorov Smirnov test was used to compare differences in
proportions of oocytes with varying diameters in the cultured mouse
ovaries.
Results
Transgenic mice on mixed genetic background
Ovaries were examined and the total number of oocytes
estimated in 23 TrkB"' ,TrkC" mice (P4-6), 11 TrkB mice
(P4-5) and 10 TrkC^1 mice (P6), all on a mixed C57BL/6 x
129/Sv genetic background. At this age, normal ovaries are full
of follicles at the primordial and primary stage (Fig. 1A). In
~50% of TrkB ' animals, the ovaries were grossly abnormal
(Fig. 1B) and contained substantially fewer oocytes (<1000) than
those of the wild-type animals (>2000) (Fig. 2). Sometimes, the
follicles contained only a few granulosa cells or dark oocytes
with abnormal looking nuclei. In all cases, the ovaries contained





Fig. 1. Sections of ovaries from wild-type and
mutant mice at P4-5 stained with haematoxylin
and eosin. Ovaries from 50% of TrkB ' mice
from a mixed genetic background and all mice
from the congenic C57BL/6 background have
grossly abnormal ovaries that contain greatly
reduced numbers of follicles. (A) TrkB*'* ,TrkC*'*
ovary, containing many follicles. (B) TrkB
ovary on C57BL/6 x 129Sv background with
only few follicles remaining (arrowheads).
(C) Unaffected TrkB ovary on C57BL/6 x
129Sv background, which contains as many
follicles as (A). (D) Ovary from fourth generation
C57BL/6 congenic TrkB mouse, which
contains large areas of cell death and only a few
follicles (arrowhead). Scale bars: 20 |im.
a large number of dark, apoptotic-looking granulosa cells and
the ovary sections had a fuzzy appearance (Fig. 1B,D). This
phenotype was not seen in the -100 ovaries from wild-type mice
that we have examined to date, including the 23 TrkB'* .TrkC"*
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Fig. 2. Ovaries of TrkC"'" mice contain normal numbers of follicles
but those of TrkB"1' mice contain few follicles. This phenomenon is
found in ~50% of TrkB"1" mice on either the mixed genetic
background or the 129/Sv congenic line, but all ovaries in the
C57BL/6 congenic line are affected. Scattergram of number of
oocytes in ovaries of 'TrkB'TrkC*1' mice (column 1); TrkC"' mice
(column 2); TrkB"' mice from the original mixed genetic
background colony (column 3); TrkIC' mice from the 129/Sv
congenic colony (column 4): and TrkB"' mice from the C57BL/6
colony (column 5). In column 1, TrkB*'*, TrkC*'* mouse on
C57BL/6 background is represented with a filled square and those on
129/Sv background are represented with open triangles, other mice
are of the mixed genetic background. In column 5, filled diamonds
represent mice from the seventh generation of the C57BL/6 congenic
line of TrkB"1" mice and crosses are mice from the fourth generation.
of the remaining 50% of the TrkB"'" mice obtained in this
experiment appeared normal (Fig. 1C, Fig. 2) and contained the
expected number of follicles. The ovaries of all TrkC"1" mice
looked normal and contained oocyte numbers comparable with
those of the TrkB*'*, TrkC*'* mice (Fig. 2).
Congenic strains of TrkB-'~ mice
The mixed genetic background of the mice in the original
colony was a likely explanation of the variable effect of the
TrkB"'" mutation on ovarian development described above. To
test this, congenic strains of TrkB ' mice were generated, based
on either C57BL/6 or 129/Sv inbred strains. Breeding pairs
were set up at the fourth (C57BL/6 and 129Sv) and seventh
(C57BL/6) generation to generate TrkB' offspring for
analysis. Examination of all the offspring collected from 10
pairs of fourth generation matings showed that a total of five
out of 225 C57BL/6 pups were TrkB (four of these were
female), in contrast with 19 out of 207 129/Sv pups (nine of
which were female). This indicates that C57BL/6 TrkB " mice
are more severely affected in general (although the 5 C57BL/6
TrkB"' mice that survived to P4 did not appear different from
the TrkB"'" pups on a mixed or 129/Sv background). Fig. 2
shows the number of oocytes in ovaries of the C57BL/6 and
129/Sv congenic strain TrkB females at P4. Of the six TrkB"'"
female mice obtained in the C57BL/6 line, all had severely
affected ovaries with large apoptotic-looking areas (Fig. ID)
and few follicles (Fig. 2). By contrast, the nine female 129/Sv
TrkB"' mice were similar to the original mixed-background
mice, with some ovaries containing normal numbers ofoocytes
and others with areas of cell death and depleted stores of
oocytes (Fig. 2). The Mann-Whitney test showed that there
were significantly fewer oocytes in the ovaries of C57BL/6
TrkB mice than in wild-type ovaries (P<0.000l).
Expression of TrkB, NT4 and BDNF mRNA and
protein
Ovaries were obtained from female mice at F. 16.5, P0 and P4.
RT-PCR showed that TrkB (both full length and truncated),
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NT4 and BDNF were expressed in mice at El6.5 (prior to the
start of follicle formation), at PO (in the middle of follicle
formation) and at P4 (when follicle formation is complete)
(Fig. 3). Full-length TrkB was present at very low levels at all
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Fig. 3. MS (fall length and truncated), NT4 and BDNF are
expressed in mouse ovaries at El6, PO and P4. Full-length TrkB is
expressed at very low levels in all ovary samples. Each RT-PCR
reaction was carried out on PO brain and on ovary at El6.5, PO and
P4. RT-PCR was carried out for: (1) cyclophilin; (2) full-length TrkB
using equivalent amounts of mRNA (in terms of cyclophlin
expression); (3) full-length TrkB receptor with eight times more E16
ovary mRNA than brain mRNA and five times more PO and P4 ovaty
mRNA than brain mRNA (in terms of cyclophlin expression); (4)
TrkB receptor, both truncated and full length, using equivalent
amounts of mRNA (in terms ofcyclophlin expression); (5) NT4,
using equivalent amounts of mRNA (in terms of cyclophlin
expression); and (6) BDNF using equivalent amounts of mRNA (in
terms ofcyclophlin expression).
tissue (as determined by equivalent expression of cyclophilin)
(Fig. 3, lane 2), but when more ovary tissue was used in the
reaction, the presence of the full length form in the ovary was
seen clearly (Fig. 3 lane 3). By contrast, the PCR reaction that
detected both full-length and truncated forms of TrkB showed
expression at high levels in brain and in ovaries at all ages (Fig.
3, lane 4). Thus, truncated TrkB was expressed in the ovary at
a much higher level than full-length TrkB.
In situ hybridisation using a probe that
recognised both full-length and truncated forms
of TrkB showed that expression was primarily
confined to the germ cells, in oogonia at El6.5
and oocytes at P4 (Fig. 4A-D). This probe was
checked by in situ hybridisation using E19 and
PO brain, which showed the same expression
pattern as described previously (Ringstedt et al.,
1993). Immunocytochemistry was then carried
out using an antibody specific for full-length
TrkB. This showed a similar pattern of ovarian
expression, but TrkB protein was much more
abundant in PO oocytes than in E16 oogonia
(Fig. 4E-H).
» 1
Effect of K252a on newborn mouse
ovaries
Ovarian quarters from PO mice were either
fixed immediately or cultured with medium
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Fig. 4. TrkB is expressed in germ cells of ovaries
both before and after follicle formation in the
mouse. Ln situ hybridisation uses a probe that
recognises truncated and full-length forms of TrkB,
whereas immunocytochemistry is specific for full
length TrkB. (A-D) In situ hybridisation. (A) Using
antisense probe (staining is primarily in oogonia,
arrowheads) and (B) sense probe on E16.5 ovaries.
(C) Antisense probe (staining is primarily in
oocytes, arrowheads) and (D) sense probe on P4
ovaries (D). (E-H) Immunocytochemistry. (E) On
E16 ovary with primary antibody present and (F)
negative control for E16 ovary with no primary
antibody, '['here is little full-length TrkB present at
El6, but some expression can be seen in oogonia.
(G) PO ovary with primary antibody present and (H)
PO ovary with no primary antibody (full-length TrkB
is strongly expressed in oocytes). Scale bars: 20 pm
in A-D; 50 pm in E-H.
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ovaries contained primordial follicles. The development of
follicles from the primordial to the primary, growing stage was
supported in culture. This is shown in Fig. 5A,B and was
confirmed by measurements of oocyte diameter (Fig. 6B,C).
Ovaries from P0 mice cultured for 7 days in the presence of
K252a exhibited areas ofextensive cell death with few follicles
present at the end of the culture period (Fig. 5C). There was a
dose-dependent decrease in the total number of follicles in
K252a-treated ovaries, compared to untreated cultured ovaries.
The decrease in follicle number in ovaries cultured in the
presence of 50 nM K252a was not statistically significant
fiP=0.08), but there was a highly significant decrease in the
presence of 100 nM K252a (P<0.005) (Fig. 6A). Fig. 6C shows
the proportion of oocytes at different diameters in control and
K252a-treated cultured ovaries. Although >85% of oocytes
were lost when ovaries were cultured in the presence of 100
nM K252a (Fig. 6A), the surviving oocytes had a similar
distribution in diameter to those in ovaries cultured in control
medium (Kolmogorov Smirnov test showed no significant
difference in distribution). Thus, oocytes that survived in the
presence ofK252a grew to similar diameters to those in control
cultures. K252a, therefore, inhibits the survival of follicles, but
does not affect the growth of follicles that do survive.
Rescue of cultured ovaries with bFGF
Previous studies have shown that, at the doses used here,
K252a blocks Trk receptors but not other tyrosine kinase
receptors, including those for bFGF (Tapley et al., 1992). This
was confirmed in our study by culturing P0 ovaries in media
containing: (1) 100 nM K252a; (2) 40 ng ml1 bFGF; and (3)
100 nM K252a and 40 ng ml-1 bFGF. bFGF acts via a non-Trk
tyrosine kinase receptor (Wert and Palfrey, 2000) and has been
shown to stimulate primordial follicle development (Nilsson et
al., 2001). Ovaries cultured in the presence of bFGF with or
without the addition of K252a looked healthy and contained
many follicles (Fig. 5D,E). Fig. 7 shows the total number of
oocytes in the different treatment groups. The increase in
oocyte numbers in ovaries cultured in bFGF alone was not
significant. Ovaries cultured in 100 nM K252a showed a large
reduction in oocyte survival, with significantly fewer oocytes
present at the end of the culture period (P<0.05). bFGF rescued
follicles from the effect of K252a: there was no difference
between the number of oocytes in untreated ovaries and in
ovaries cultured in the presence of K252a and bFGF. K252a
did not, therefore, block the function of all tyrosine kinase
receptors nonspecifically.
Inhibition of BDNF and NT4 activity
P0 ovaries were cultured for 7 days in control medium or in
medium containing (1) 10 (ig ml 1 anti-BDNF antibody, (2) 10
|Xg ml 1 anti-NT4 antibody, and (3) 10 pg ml -1 each of anti-
BDNF and of anti-NT4 antibody. The addition of either anti-
BDNF or anti-NT4 antibodies alone
had no significant effect on oocyte
survival, but when added in
combination, oocyte survival was
lowered significantly (Fig. 8A;
P<0.05). Examination of the cultured
ovaries showed that all treated
ovaries, but not control ovaries, had
large areas around the edge that
contained no healthy oocytes (Fig. 9).
The density of dying and dead
oocytes was significantly higher in all
three treatment groups than in control
ovaries (Fig. 8B; P<0.05 in all cases).
Fig. 5. Photomicrographs of sections ofovarian pieces stained with
haematoxylin and eosin. (A) Uncultured ovary at P0 containing oogonia
(open arrowhead) and primordial follicles (closed arrowhead). (B) P0
ovary cultured for 7 days, which contains many growing, primary follicles
with larger oocytes (arrowhead). (C) P0 ovary cultured for 7 days in the
presence of 100 nM K252a (which inhibits oocyte survival). The ovary
contains some oocytes and large areas of cell death. (D) P0 ovary cultured
for 7 days in the presence of40 ng ml"1 bFGF contains many healthy
follicles. (E) P0 ovary cultured for 7 days in the presence of 100 nM
K252a and 40 ng ml"1 bFGF. The ovary has
been rescued from the effect of K252a and
contains many healthy follicles. (F) Uncultured
ovary from E16.5 mouse containing oogonia
(arrowhead) but no follicles. (G) El 6.5 ovary
cultured in control medium for 4 days contains
many follicles, all ofwhich are at the primary,
growing stage with rounded granulosa cells
(arrowhead). (H) Ovary at P0, an equivalent age
for the cultured ovary shown in G, with follicles
at the primordial, resting stage with flattened
granulosa cells (arrowhead). Scale bars: 20 pro.
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Fig. 6. K252a reduces oocyte survival in newborn mouse ovaries in
culture, but does not affect the distribution ofoocyte diameters in
surviving follicles. (A) The total number of follicles in uncultured
day 0 ovaries and ovaries cultured in 0 nM, 50 nM and 100 nM
K252a. Asterisks indicate significant difference compared with
control culture (D7 0 nM ), P<0.005. ( B) The proportion of follicles
containing oocytes of various diameters in uncultured day 0 ovaries.
(C) The proportion of follicles containing oocytes of various
diameters in ovaries cultured in 0 nM, 50 nM and 100 nM K252a.
Line between B and C shows the follicle stage that corresponds to
different diameters of oocytes.
Culture of E16.5 ovaries
At the start of the culture period, E16.5 ovaries contained
oogonia but no primordial follicles (Fig. 5F). After culture for
4 days follicles formed, with many oocyte-enclosed follicles
present by the end of the culture period (Fig. 5G). Examination
of sections showed that cultured El 6.5 ovaries appeared not to
form follicles in the normal manner. This was confirmed by
examination of an ovary from a P0 animal in vivo and of an
El6.5 ovary cultured in control medium for 4 days. At P0,
ovaries contain both oogonia and primordial follicles (and
occasional primary follicles) (Fig. 5H). El6.5 ovaries that were
cultured for 4 days (the in vitro equivalent of P0 ovaries)
contained oogonia and follicles by the end of the culture
period. However, in marked contrast to the situation in vivo,
these follicles were virtually all at the primary stage, with
rounded granulosa cells (Fig. 5G). Fig. 10A shows the results
of a detailed comparison of in vivo and cultured ovaries. Both
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Fig. 7. bFGF rescues cultured newborn mouse ovaries from the effect
of K252a. Histogram of the total number of follicles in ovaries
cultured in control conditions and in 100 nM K252a, 50 ng ml"'
bFGF, and K252a plus bFGF. Asterisk indicates significant














































control BDNF NT4 both
Fig. 8. Blocking the effects of BDNF and NT4 in culture decreases
germ-cell survival and increases germ-cell death. (A,B) The density
of healthy oocytes (A), and dying and dead oocytes {B) in ovaries
cultured in control medium or in medium containing 10 |ig ml"1 anti-
BDNF, 10 pg ml 1 anti-NT4, and 10 pg ml 1 each of anti-BDNF and
of anti-NT4. Asterisk indicates significant difference compared to
untreated control culture, P<0.05.





P0 cultured ovaries but not in El6.5 cultured
ovaries.
Culture of fetal human ovaries in the
presence of a Trk receptor blocker
Ovaries from five fetuses, ranging from 13 to 16
weeks of gestation, were cultured in 0 nM or 100
nM K252a. At these ages, ovaries contained oogonia
only (Fig. 11A). Even in control medium, follicles
did not form but oogonia survived (Fig. I IB). In
ovaries cultured in 0 nM K252a, a mean of 78% of
oogonia survived after 48 hours in culture, whereas
only 36% survived when ovaries were cultured in the
presence of 100 nM K252a (P=0.01; Fig. 11C,D).
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Fig. 9. Photomicrographs of sections of ovarian pieces stained with haematoxylin
and eosin. (A-D) Ovaries were cultured for 7 days in control medium (A),
medium containing 10 pg ml-1 anti-BDNF (B), medium containing 10 pg ml 1
anti-NT4 (C) and medium containing 10 pg ml-1 each of anti-B DNF and ofanti-
NT4 (D). Areas around the edge of ovaries cultured in the presence of antibodies
had few if any germ cells. These ovaries also often contained dying/dead oocytes
(white arrowheads).
Oocytes were then further classified into those contained in
primordial and primary follicles. This further classification was
only possible where granulosa cells were clearly visible around
the oocytes and clearly part of that follicle. This was not
possible in ~65% of both in vivo and in vitro ovaries and these
oocytes were excluded from further analysis. The oocytes from
the in vivo ovary were predominantly at the primordial stage
but those in the cultured ovary were virtually all at the primary
stage. E16.5 ovaries were also examined after 1, 2 and 3 days
in culture in control medium (results not shown). Examination
of sections showed that in virtually no instances were
primordial follicles found. It appears, therefore, that when
ovaries containing only oogonia are cultured, follicles form
directly at the primary (growing) stage, and completely bypass
the primordial (resting) stage of development that occurs in
vivo. This culture system was then used to examine the survival
of primary follicles in culture.
Effect of K252a on E16.5 ovaries
El6.5 ovaries were cultured in medium containing 0 nM or
100 nM K252a for four days. There was no difference in
oocyte number between ovaries cultured in the presence of
K252a and those cultured in the absence of K252a (Fig. 10B).
The way in which follicles formed in F.16.5 cultured ovaries,
bypassing the primordial follicle stage, might explain the lack
of effect of K252a. K252a appears to affect follicles
specifically at the primordial stage, which is represented in
Discussion
The factors that determine whether oocytes survive
or die as follicles form are unknown. We have
investigated the possible role of the Trk receptors in
this process by examining TrkBand TrkC mice,
and interfering with the action of Trk receptors and
their ligands in cultures of mouse and human
ovaries.
In the original mixed-genetic background colony
of TrkB mice (C57BL/6 x 129/Sv), -50% of
ovaries contained reduced populations of oocytes,
whereas the remainder appeared normal.
Examination of congenic strains of TrkB~'~ mice
based on either 129/Sv or C57BL/6 lines of mice
showed that, as with the original colony, ~50% of
the ovaries of the 129/Sv congenic TrkBmice had
a normal complement of follicles, but that ovaries of
all TrkB C57BL/6 congenic mice had greatly
reduced numbers of follicles. By contrast, the ovaries of all
TrkC~'~ mice were normal. These findings indicate that TrkB
is an important factor in oocyte survival. The fact that, on
certain backgrounds, its loss does not always have a significant
effect indicates that other factors are also likely to be involved
in oocyte survival. The efficacy ofthese factors might vary with
background, being low in C57BL/6 and high in 129Sv mice.
Similar background effects have been found in the
development of transgenic c*3 Connexin mice (Gong et al.,
1999).
TrkB~'~ offspring have retarded development in general and
die within the first 10 days of birth. The paucity of oocytes in
TrkBmice was not caused by this general retardation
because 50% ofmice on the original mixed background and of
the 129/Sv congenic mice had normal ovaries but retarded
general development. In addition, TrkC~'~ mice exhibited
similarly retarded development but their ovaries were
unaffected.
Ovaries were cultured either prior to (human), or during and
shortly after (mouse) follicle formation, in the presence or
absence of K252a. K252a is an indole carbazole and a potent,
specific inhibitor of the intracellular protein-kinase domain of
the Trk receptors (Tapley et al., 1992). K252a dramatically
inhibited oocyte survival in newborn mouse ovaries in culture,
inducing a loss of 85% of germ cells. In other systems, K252a
is reported to block the activity of Trk receptors but not other
tyrosine kinase receptors at the doses used here (Tapley et al.,
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Fig. 10. Very few primordial follicles form in E16.5 fetal ovaries in
culture and K252a has no etfect on oocyte survival in this culture
system. (Ai) The proportion of oogonia and oocytes in El 6.5 ovaries
cultured for four days and in PO ovary without culture. (Aii) Further
classification of oocytes into those contained in primordial and
primary follicles, in E16.5 ovaries cultured for four days and in P0
ovaiy without culture. (B) The diameters of oocytes in El 6.5 ovaries
cultured in the presence or absence of 100 nM K252a.
1992). Evidence for this in the ovary was obtained by adding
bFGF, which acts via a non-Trk tyrosine kinase receptor, to
cultures containing K252a. bFGF rescued ovaries from the
effects of K252a, indicating that K252a did not block bFGF
receptors. These findings also demonstrate that ovarian cells
are responsive to bFGF. It is conceivable that bFGF is
another survival factor for oocytes acting in concert with
neurotrophins.
RT-PCR showed that mRNA encoding NT4 and BDNF are
both present throughout the period of follicle formation in the
mouse. We have already shown this is the case in humans,
where production of NT4 mRNA moves from a germ-cell to a
somatic-cell location as follicles form (Anderson et al., 2002).
Although NT4 expression increases in rat follicles as they start
to form (Dissen et al., 1995), the fertility of NT4~'~ mice
appears normal (Conover et al., 1995). It is not possible to
examine the fertility of BDNF1' mice because, like TrkB~'~
mice, they die shortly after birth (Conover et al., 1995).
The combined inhibition of NT4 and BDNF activities in
culture using blocking antibodies lowered oocyte survival, but
blocking either ligand alone had no detectable effect. Dead and
dying oocytes were rare in control ovaries, but significantly
increased in all treated ovaries, irrespective of whether
blocking antibodies were added singly or in combination. The
lack of a significant effect of blocking either BDNF or NT4
alone on oocyte survival indicates that the ligands are able to
compensate for each other to a large
extent. The combined addition of anti-
„ _ BDNF and anti-NT4 was less effective
than the addition of K252a, probably
because the antibodies were less able to
penetrate the tissue. This would explain
* the variation in the extent of oocyte loss
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Fig. 11. Effect of K252a on human ovaries in
culture. (A-C) Photomicrographs of human
fetal ovaries at 13-weeks gestation.
(A) Uncultured ovary containing oogonia.
(B) Ovary cultured in the absence of K252a
with many oogonia surviving. (C) Ovary
cultured in the presence of 100 nM K252a
with few oogonia surviving (arrowhead). Scale
bars: 20 gm. (D) Density of germ cells in
uncultured ovaries, and ovaries cultured in the
presence ofO nM and 100 nM K252a. The
number of oogonia was quantified by random
stage microscopy. Data are the number of
oogonia (mean±s.e.m.) per 121-point grid. A
total of 18-42 grids per treatment were counted
in each of five experiments. Asterisks indicate
significant difference compared with control
culture (0 nM K252a), POO1.
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ovaries. A less likely explanation is that other, as yet
unidentified, ligand(s) are involved.
Newborn ovary cultures supported development of follicles
from the primordial to the primary stage. By contrast, culture
of El6.5 mouse ovaries supported formation of follicles from
oogonia such that follicles formed directly at the primary stage,
bypassing the primordial stage of development. K252a had no
effect in this system, indicating that I rk receptors do not play
a role in the survival of primary follicles. We conclude,
therefore, that K252a inhibits the survival of primordial
follicles in newborn ovary cultures. Thus, Trk receptors appear
to play a role in the survival of follicles at the primordial but
not the primary stage of development. Although we found no
indication that neurotrophins affect primary follicle survival,
they do appear to influence follicle function at that stage:
NGF mice have fewer follicles leaving the primordial follicle
pool and undergoing growth initiation (Dissen et al.. 2001),
whereas early postnatal rat ovaries cultured with NGF have
increased numbers of follicle stimulating hormone receptors
(Romero et al., 2002).
The neurotrophins and their receptors also play a role in later
ovarian function. TrkA and NGK are involved in the regulation
of ovulation (Dissen et al.. 1096) and BDNF might be involved
in oocyte maturation in antral follicles (Seifer et al.. 2002). In
addition, there is recent evidence that neurotrophins plav a role
in testis development. TrkA and TrkC male foetuses have
reduced numbers of germ cells and impaired seminiferous
tubule development compared to wild-type mice (Cupp et al..
2002). Similarly, in human fetal testes. Trk-receptor signalling
is involved in the regulation of germ cells and peritubular cells
(Robinson et al.. 2003).
TrkB was present in mouse ovaries throughout the period of
follicle formation, with mRNA (both truncated and full length)
and protein (full length only) located primarily in the germ
cells, lmmunocytoehemistry of full-length TrkB was strongest
in the oocytes of PO ovaries. It is likely that the effect of K252a
on germ-cell survival shown here is caused by inhibition of
TrkB function. It is less likely that it results from either
inhibition of TrkC receptors, given the absence of any ovarian
phenotype in TrkC mice, or inhibition of TrkA receptors,
because expression of these virtually disappears as follicles
form in the rodent (Dissen et al., 1995). Our data do not
exclude a role of TrkA and TrkC in oocyte survival, because
these receptors might become more important in the absence
of TrkB signalling. This could be investigated in double
mutants.
Truncated TrkB mRNA appeared to be more abundant than
full-length TrkB mRNA in ovaries from FI6.5 to P4. This
pattern appears to be common in non-neuronal tissues
(Wetmore and Olson, 1995) but the reason is unclear. The
truncated receptors lack a tyrosine-kinase domain, and their
effects are not well understood. However, the effects of
mutations and antagonists on follicle survival described here
are caused by interference with the low abundance, full-length
Trk receptors. TrkB mice have a mutation in the tyrosine-
kinase domain. Whereas full length TrkB is not expressed in
these mice, examining the head of newborn mice showed that
levels of truncated TrkB receptors remained unchanged (Klein
et al.. 1993). Similarly. K252a blocks the tyrosine-kinase
function of the Irk receptors, but does not interfere with
potential activity of Trk receptors outwith the tyrosine-kinase
domain. The role of the truncated receptors in the ovary
remains to be determined.
It is unclear why some follicles survive in TrkB mice. In
only two instances, both in C57BF 6 congenic mice, were
ovaries with no follicles found. In all other cases, some follicles
survived. Fundy et al. (Fundy et al.. 1999) showed that
primordial follicles contain a variable number of somatic cells,
with the number of granulosa cells in sheep primordial follicles
ranging from three to 52. It has been suggested that oocytes
contained in primordial follicles require a particular number of
associated granulosa cells for their continued survival (Sawyer
et al.. 2002). It is possible that an oocyte needs sufficient
granulosa cells to sequester sufficient neurotrophins for its
continued survival. Surviving oocytes in ovaries of TrkB mice
would, therefore, be the ones that have a sufficient number of
granulosa cells attached (Fig. 12). In these instances, the
increased numbers ofgranulosa cells might produce an increased
amount of either neurotrophins (which might signal through
other Trk receptors) or other factors that might compensate for
a lack of neurotrophin signalling (possibly bFGF).
Culture of human ovaries used foetuses with gestational ages
ranging from 13 to 17 weeks. At these ages germ cells are
proliferating, before primordial follicle formation. Primordial
follicles first appear in the human ovary from approximately
19-weeks gestation. Fack of tissue and the slowness of human
development with respect to that of rodents meant that we
could not do experiments at the equivalent time to that of
follicle formation in the mouse. The experiments on human
ovaries examined the effect of K252a on prefollicular germ
cells (oogonia) only. Human foetal ovaries cultured in the
presence of K252a showed a decrease in oogonia, with K252a
causing the loss of ~50% of oogonia over a 48-hour period.
This indicates that Trk signalling might affect oogonial
survival.











Fig. 12. The possible effect of neurotrophins on folliculogcnesis.
Oogonia and pregranulosa cells associale into primordial follicles,
with flattened granulosa cells, (a 'resting' stage of development).
Oocytes with too few granulosa cells die at litis point. Surviving
oocytes are contained in follicles that have enough granulosa cells to
provide the oocyte with sufficient neurotrophins. Follicles that leave
the primordial stage and enter the primary stage exhibit rounding up
of granulosa cells and undergo oocyte growth. Trk receptors have no
effect on primary follicle survival.
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In conclusion, the data demonstrate that TrkB and its ligands
are present in mouse ovaries as follicles form, as we have
previously shown in human ovaries (Anderson et al„ 2002).
Our studies of mutant mice indicate that TrkB plays an
important role in oocyte survival. Culture of mouse and human
ovaries with a potent inhibitor of all Trk receptors, K252a,
decreases germ-cell survival. This effect appears to be specific
to oogonia and primordial follicles and does not occur in
primary follicles. Blocking NT4 and BDNF also decreased
germ-cell survival. Together, our results point to a role of the
TrkB receptor and its ligands in the regulation of germ-cell
survival at the oogonial and primordial follicle stage in
mammalian ovaries. This pathway is therefore crucial to the
determination of female reproductive lifespan.
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Mammalian ovarian development is characterized by a se¬
quential pattern of mitotic proliferation of oogonia, initiation
then arrest of meiosis, and primordial follicle formation. The
factors regulating these processes are poorly understood. The
neurotropins are survival and differentiation factors in the
nervous system, acting via high affinity receptors of the trk
protooncogene family and the low affinity p75 nerve growth
factor receptor, and have also been described in the rodent
ovary, where changes in NT4/TrkB gene expression have been
detected at the time ofprimordial follicle formation. There are
no data on neurotropin expression in the normal human
ovary. We have investigated the expression and localization of
neurotropins and their receptors in the midtrimester human »
fetal ovary (13-21 wk gestation). Expression of rnRNA for neu¬
rotropins and their receptors was detected by RT-PCR. Clus¬
ters of oogonia were found to be the predominant site of NT4
mRNA expression using in situ hybridization. However, at
later gestations granulosa cells of primordial follicles showed
increased expression, with lesser expression in the enclosed
oocytes. NT4 protein was also localized to the granulosa cells
by immunohistochemistry and at earlier developmental
stages to epithelioid cells, which were mingled with clusters
of oogonia not expressing NT4. TrkB receptor protein was
localized by immunohistochemistry to germ cells at all ges¬
tations examined. The p75 nerve growth factor receptor pro¬
tein was exclusively expressed in the ovarian stroma. These
data demonstrate the expression of neurotropins and their
receptors within the human fetal ovary. Developmental
changes in the pattern of expression of NT4 around the time
of primordial follicle formation suggest that neurotropins
may be involved in signaling between somatic cells and germ
cells at this crucial stage of ovarian development. (J Clin En¬
docrinol Metab 87: 890-897, 2002)
THE DEVELOPMENT of the mammalian ovary is initi¬ated after migration of primordial germ cells from the
extraembryonic mesoderm of the yolk sac to the nephrogo-
nadoblastic ridge (1). The germ cells proliferate both during
and after migration, and associate with mesonephric celLs (2).
This results in nests of syncitial germ celLs surrounded by a
meshwork of the mesoncphric-dcrived ovarian stroma or cell
streams (3). The germ cells subsequently enter meiosis only
to arrest at diplotene of the first meiotic division and at this
time point become surrounded by somatic cells, thus forming
primordial follicles (4). This process, allowing communica¬
tion between oocyte and somatic cell, is crucial for the sur¬
vival of both cell types (5). As reproductive life span is
determined by the continuing presence of primordial folli¬
cles, the regulation of germ cell proliferation and survival in
the form of primordial follicles is central to reproductive
potential. Waves of atresia of oogonia have been identified
at particular stages of development (6, 7), but the factors and
pathways involved are largely unknown, particularly in the
human.
The neurotropins are a family of related growth factors
that are of major importance in the regulation of neuronal
survival and differentiation. Nerve growth factor (NGF) is
the founder member (8) and several other neurotropins have
been identified, including brain-derived neurotropic factor
and neurotropins 3 and 4 (NT3 and NT4, the latter also called
Abbreviations: GAPI)! 1, Glyceraldehvde-3-phosphate dehydroge¬
nase; \Gh nerve growth factor; XGbK, nerve grow th factor receptor;
X 1, neurotropin.
NT5) (9). The biological actions of the neurotropins are me¬
diated by tyrosine kinase receptors encoded by the trk pro¬
tooncogene family, known as TrkA, TrkB, and TrkC (10).
Truncated isoforms of Trk receptors lacking the intracellular
tyrosine kinase domain have also been described (10-12). In
addition, all neurotropins ate recognized by a more widely
expressed low affinity receptor known as p75 nerve growth
factor receptor (NGER), which is a member of the tumor
necrosis receptor superfamily (13). Neurotropins may also
have roles in nonneuronal systems (14,15), and several mem¬
bers of the neurotropin family and their receptors have been
demonstrated in the ovary (16-22). NT4 appears to be ex¬
pressed by oocytes in both the rat and Xenoptis (20, 22), and
the expression of NT4 and its cognate high affinity receptor
TrkB, but not other ncurotropins/receptors, was found to be
increased at the time of primordial follicle formation in the
neonatal rat ovary (22). Conversely, expression of NGF and
its high affinity receptor Trk A were reduced at this time.
Follicular development was reduced in a NGE-null mutant
model (23), although the number of primordial follicles was
maintained. A specific and marked increase in NGE and
TrkA receptor expression has also been demonstrated at the
time of ovulation and suggested to mediate thecal cell dif¬
ferentiation at that time (24, 25).
There is therefore increasing evidence that the various
neurotropins may have specific roles in ovarian develop¬
ment and function, but no data are currently available on
their presence in the normal human ovary. We have therefore
investigated the presence and distribution of the ncuro¬
tropins and their receptors in the developing human ovary
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1 luman fetal ov aries were obtained after medical termination of preg¬
nancy. Women ga\ e written consent according to national guidelines
(26), and the study was approved by the Lothian Pediatries/Reproduc-
ti\e Medicine research ethics subcommittee, termination of pregnancy
was induced bv treatment with mifepristone (200 mg, orally), followed
bv FGEj analog (Gemeprost, Beacon Pharmaceutical, lunbridge Wells,
UK; 1 mg every 3 h, per vaginam). None of the terminations was for
reasons of fetal abnormality, and all fetuses appeared morphologically
normal. Gestational age was determined bv ultrasound examination
before termination and was confirmed by subsequent direct measure¬
ment of foot length. A total of 20 specimens were used for this stud).
Ovaries were dissected free and either fixed for immunohistochem-
ical analysis or snap-frozen and stored at — 70 C. Fixation was carried
out in Bouins for 5 h, followed by transfer to 70".. ethanol before pro¬
cessing into paraffin using standard methods.
Isolation of RNA and synthesis and amplification of cDNA
Total RNA was extracted from snap-frozen samples of fetal ovary
(13—21 wk) using the RNeasy mini kit (Q1AGEN, Crawley, UK). RNA
was treated with deoxyribonuclease (Life Technologies, Inc., Paisley,
UK), KT was performed using a first strand cDN A synthesis kit (Roche,
Lewes, UK), and 1*CR was performed as previously described (27).
Briefly, 1 /xg total RNA was incubated with o!igo(deoxyribonucleic)18
primer for 10 min at 65 C and then placed on ice. A reaction mix
comprising buffer, 1 niM each of d.N IP, ribonuclease inhibitor, and 50
U reverse transcriptase was added to each tube in a total volume of 50
/xl, and the tubes were then incubated at 40 C for 2 h. Subsequently, PCR
was performed by incubating l-/xl cDNA samples with laq UNA poly¬
merase (AGS Gold, 1 lv baid, Ashford, UK) in buffer with 0.2 mxi of each
dNIP and forward and reverse oligonucleotide primers. Two control
tubes were run in parallel, one in which water replaced the RNA and
a second omitting reverse transcriptase to ensure that there was no
genomic D.N A contamination. Positive control samples (rat brain) were
also run in parallel (not shown). PCR amplification was carried out for
35 cycles. Primers specific for human neurotropins and their receptors
were used (I able 1), designed to span an intron to ensure that genomic
DNA was not amplified. Primers for the constitutiv elv expressed gene
glyceraldehvde-3-phosphate dehydrogenase (GAPD11) were used to
confirm the integrity of the RNA and the efficacy of the PCR reaction.
I he identities of all PCR products were confirmed bv direct sequencing
using a PL Applied Biosvstems 373A automated sequencer (Foster
City, CA).
In situ hybridization for NT4
Riboprobes were generated using a ICR strategy to incorporate SP6
or 17 phage promoter sequences into N 14 PCR product. Briefly, for the
antisense probe, the NT 4 PC K product was amplified using N 14 forward
primer (5'-C1 1 ICGGC.AG 1CAGCAGG1GC-3') and NT 4 reverse
primer, which had the T7 promoter sequence added to its 5'-end
(5'T AA i ACGAC1CAC1A1AGGG AG AC AGGCAG IG1CAA1 1CG A-
A1CC-3'). For the sense probe, product was amplified using the NT 4
forward primer linked to the SP6 promoter sequence (5'-ATTT AGGT-
G AC AC 1 A 1 AG AAG1GCI f ICGGGAG ICAGCAGGTGC-3') and
N14 reverse primer (5'-C AGGC AG 1 G 1C AA 1 1CGAA 1 CC-3').
pGLM-I plasmid DNA containing human NT4 insert (nucleotides
401-11)99) was used as a template. Primers specific to human N 14 were
used to make the plasmid insert (Table 1). After PCR, products were
purified (High Pure PCR product purification kit, Roche) and used
directly for transcription w ith 17 or SP6 RNA polymerase to generate
antisense and sense riboprobes, respectively. Probes were labeled w ith
digoxigenin using a commerciallv available kit (Maxiscript, Ambion,
Inc., Huntingdon, UK), incubated with ribonuclease-free deoxv ribonu¬
clease 1 and purified through Chromaspin columns (DtlXZ-lCK), CLON-
ILC11 Laboratories, Inc., Palo Alto, CA).
Sections (5 /xm) were ait over diethylpvrocarbonate-treated water
and transferred to SuperFrost Plus-coated slides (BD.V1, Poole, UK),
dewaxed in xylene, and rehy drated through a graded series of ethanol.
Slides were then treated with 1.5 /xg/ml proteinase K at 37 C for 10 min.
Sections were incubated with prehv bridization buffer, then hybridized
at 50 C ov ernight with hybridization buffer containing 2 /xl appropriate
riboprobe/50 /xl hybridization buffer. Sections were then incubated in
ribonuclea^A and blocked with avidin and biotin < Vector Laboratories,
Inc., Peterborough, UK) before detection of digoxigenin label using
sheep antidigoxigenin (1:100 in normal rat serum/ 1 ris-buffered saline,
Roche), biotinylated rabbit antisheep lgG (1:500 in normal rat serum/
Iris-buffered saline, Vector Laboratories, Inc.), avidin-biotin horserad¬
ish peroxidase-linked complex (L)AKO Corp., Copehagen, Denmark),
and diaminobenzidene liquid substrate-chromagen system (DAKO
Corp.). Sections were then counterstained in hematoxy lin, dehydrated,
and mounted with DPX.
Im m anoh istochem istry
lmmunohistochemistrv was performed as previously described (27).
Sections (5 /xm) were mounted on ILSl'A (Sigma, Poole, UK)-coated
slides, dew axed, and rehvdrated. After inhibition of endogenous per-
TABLE 1. Sequence of primers used for detection of neurotrophins and their receptors
Gene Primer Sequence (5'-3'i Product size <bp>
NGF Forward TAAAAAC CCC CCACTCCCTT 167
NGF Reverse ATTCCCCCCTCTCCAACATC 167
B1)NF Forward AACAATAACCACCCACCATT 222
B1)NF Reverse TCCACTCTTTTTCTCTCCCC 222
NT3 Forward TACCCCCACCATAACACTCAC 334
NT3 Reverse CCCACACACACACCACCT CT C 334
NT4 Forward CTTTCCCCACTCAC CACCTC C 400
NT4 Reverse CACCCACT CT CAATTCCAAT CC 400
NT4 (plasmid insert) Forward TCTTTCCCCACTCAACTTTTTACC 698
NT4 (plasmid insert) Reverse CCCACTCCCCCTCACCACTCT 698
TrkA Forward TCTTCACTCACTTCCTCCAC 247
TrkA Reverse TTCTCCACCCCCTCTCCACA 247
TrkB Forward ACTCCACACACTCACCATTTCTAC 522
TrkB Reverse CTCCCTCTCATTCCTAACATC 522
trTrkB Forward CATCTTACCAATCACACCCACTA 430
trTrkB Reverse CCATCCACTCCCATCTTATCAAA 430
TrkC Forward CATCCATCTCCAATACTACC 228/204-spliced variants
TrkC Reverse T CCC TCACACTCATAC CACC 228/204-spliced variants
p75 NGFR Forward CTCCACACCCTCACCTTCTCC 489
p75 NGFR Reverse CTCCCACCCTCCTCCCTATCA 489
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oxidase activity by incubation in 3"'.. 11202 in methanol, sections were
blocked in normal swine, donkey, or rabbit serum (Diagnostics Scotland,
Carluke, UK! for A 14, IrkB. and p73 XGI-K detection, respectively, and
with axidin and biotin (both from Vector Laboratories, Inc.). lhe fol¬
lowing primary antibodies were used: V!4 (rabbit polyclonal, Santa
Cruz Biotechnology, Inc., Santa Cruz, CA), IrkB (chicken polyclonal,
1'romega Corp., Southampton, UK), p73 \GH< (mouse monoclonal,
Xeomarkers, Freemont, CA). ihese xvere applied at dilutions of 1:11)0,
1:23, and 1:23, respectively, in the appropriate serum at 4 C overnight.
Sections were then washed and incubated \\ ith appropriate biotiny luted
secondary antibody diluted 1:300 (X I4 and p73 XGLK, Diagnostics
Scotland, 1 rkB. 1 he Jackson Laboratory, Bar I larbor, ME). Sections were
incubated with ax idin-biotin horseradish peroxidase-linked complex
(DAKO Corp.) according to the manufacturer's instructions. Bound
antibody was xisualizexi using 3,3'-diaminobenzidine tetrahvdro-
chloride (DAKO Corp.). Primary antibodies xvere omitted as negative
controls.
All sections were counterstained with hematoxylin, dehydrated,
mounted, and visualized bv light microscopy. Images were captured
using an I'rovis microscope (Olympus Corp., London, UK) equipped
with a Kodak DCS330 camera (Eastman Kodak Co., Rochester, XY) and
assembled using Photoshop 3 (Adobe, Becton Dickinson, Inc., Mountain
View, CA).
ImmunobloUing
Letal ox aries were homogenized in denaturing buffer containing l"x.
SDS. Samples (20 q.g protein) xvere diluted xvith an equal volume of
reducing loading buffer |1S7 mm Iris (pi 1 6.8), 2"x> SDS, 2% j8-mercap-
toethanol, 1% sucrose, and 0.01bromophenol blue] and boiled for 3
min. Proteins xvere separated by SDS-PAGE on a 4 -20":. gradient lris-
glycine gel (Xovex, lnx itrogen. Paisley , UK) in parallel with prestained
protein mol wt markers (Bio-Kad Laboratories,Inc., Richmond, CA)and
blotted onto polvx invlditluoride membranes (Amersham Pharmacia
Biotech, Little Chalfont, UK). Membranes were blocked in 3",, (xvt/xol)
BSA (Sigma) and 3% powdered milk and then incubated ox ernight with
the primary antibody. Antibodies to X I4 (rabbit polyclonal,Santa Cruz
Biotechnology, Inc.), full-length IrkB (rabbit polyclonal. Oncogene,
Cambridge, MA), and p73 XGEK (mouse monoclonal, .Xeomarkers)
were used at dilutions of 1:3110, 1:30, and 1:300, respectively. Primary
antibody was omitted as a negative control. Bound antibody was
detected using horseradish peroxidase-linked secondary antibodies
(1:4000; Amersham Pharmacia Biotech) and the enhanced chemilumi-
nescence visualization system (Amersham Pharmacia Biotech) accord¬
ing to the manufacturer's instructions.
Results
RT-PCR
After RT-PCR, cDXJA was amplified from RXIA extracted
from fetal ovaries for each of the neurotropins, NGF, NT3,
NTT, and brain-derived neurotropic factor (Pig. 1). cDNA for
each of the receptors, TrkA, full-length TrkB, the truncated
form of TrkB, TrkC and p75 NGFR, were also identified (Fig.
1). Positive results were found at all gestations examined for
each of these neurotropics and their receptors over the range
13-21 wk. Products of 228 and 204 bp were detected for TrkC
(Fig. ID), representing spliced variants of the gene (28), both
confirmed by direct sequencing. In some samples an addi¬
tional PCR product of 300 bp was detected; sequence analysis
showed that it was unrelated to the tyrosine kinase receptor
family.
In situ hybridization [or NT4
Hybridization histochemistry demonstrated that the germ
cells were the predominant site of expression of NTT mRXJA
within the ovary before the formation of primordial follicles
(Fig. 2, A and B). The pattern of expression clearly demar¬
cated the ovarian stroma, within which some cells showed
NTT mRNA expression, from the more uniformly and in¬
tensely stained clusters of oogonia (Fig. 2A). .No marked
change in the level or pattern of expression was detected
before the formation of primordial follicles. However, at that
stage of development, intense staining was detected in the
flattened granulosa cells surrounding the enlarged oocytes
(Fig. 2C), in which NTT expression was reduced, but still
present. Less mature oogonia, situated more peripherally in
the ovary, continued to express NTT mRXIA as in the earlier
gestations examined. The cells of the ovarian surface epi¬
thelium did not express NTT mRNA.
Immunohistochemical localization o[NT4. TrkB, and
p75 NGFR
Expression of NTT, TrkB, and p75 NGFR proteins was
detected by immunohistochcmistry in all specimens exam¬
ined across the gestational range 13-21 wk. Oogonia showed
weak cytoplasmic immunostaining for NTT at all gestations
(Fig. 2, D-F), but marked staining was detected in epithelioid
cells among and immediately surrounding the nests of germ
cells, consistent with early differentiation of pregranulosa
cells (Fig. 2D). This pattern strikingly outlined the germ cells,
both individually and in clusters. Generally, cells ot the ovar¬
ian stroma showed only slight staining, although individual
cells at the edge of the stroma, thus in close proximity to
oogonial clusters, showed more marked staining (arrow, Fig.
2D). The most intense expression of NTT protein was, how¬
ever, seen in the cytoplasm of flattened granulosa cells of
primordial follicles at later gestations. This pattern of stain¬
ing very clearly demarcated formed primordial follicles pre¬
dominantly located in the medullary region of the ovary
from the more peripheral oogonia; thus, a medullary/cor¬
tical gradient was observed (Fig. 2, E and F). The pattern of
distribution of NTT protein therefore differed from that of
NTT mRNA at earlier gestations, but was similar once pri¬
mordial follicles were formed. No staining of the ovarian
surface epithelium was detected. Using an antibody specific
to full-length TrkB, the protein was immunolocalized to the
cytoplasm of ovarian germ cells across the gestational range
examined (Fig. 2, G and H). In particular, clear staining of the
cytoplasm of oocytes in primordial follicles was observed
(Fig. 2H), with faint staining of the cytoplasm of pregranu¬
losa cells.
The distribution of expression of p75 NGFR protein was
very different. p75 NGFR was predominantly localized to
cells of the ovarian stroma at all gestations examined (Fig. 2,
1-K), thus clearly demonstrating the branching pattern of the
stroma from the medulla toward the surface of the ovary,
surrounding, but not becoming intermixed with, the clusters
of oogonia. p75 NGFR immunostaining was not detected in
genii cells at any gestation examined. In contrast to the
expression of NTT, the flattened granulosa cells of primordial
follicles clearly did not express p75 NGFR, although it was
present in the immediately adjacent cells of the ovarian
stroma (Fig. 2K). p75 NGFR was not expressed by the ovarian
surface epithelium.
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Fir.. 1. Expression of mRNA for neurotropins and their receptors in human fetal ovary. RT-PCR analysis of samples extracted from whole
ovaries obtained from 13-21 wk gestation, as indicated abort' each panel. A-H and -J. mRNA expression for various neurotropins and then-
receptors as labeled. D. Products of 228 and 204 bp were detected for TrkC representing spliced variants of the gene, and in some samples an
additional PCR product of 300 bp was detected: sequence analysis showed that it was unrelated to the tyrosine kinase receptor family. 1. GAPDH
expression in these samples. Lanes marked RT— contained samples in which the reverse transcriptase was not included.
Immunoblotling
The presence of NT4, TrkB, and p75 NGFR proteins in the
fetal ovary was confirmed by immunoblotting. NT4 protein
expression was detected as a single band of 21 kDa (Fig. 3A),
also observed in the positive control (rat cerebral cortex).
Two immunoreactive bands of 110 and 95 kDa were ob¬
served for TrkB (Fig. 3B). As the antibody specifically detects
full-length TrkB, these bands may represent variously glv-
cosylated forms of the full-length molecule (11) rather than
the truncated form. A band of 110 kDa was also detected in
the positive control of rat cerebral cortex. Differences in
lower mol wt forms may reflect differences in the pattern of
glycosylation between the two tissues (Fig. 3B). A prominent
75-kDa band representing the p75 NGFR protein was ob¬
served (Fig. 3C). An additional 65-kDa band was also de¬
tected, representing another fonn of the molecule as detected
by others (29,30). A similar band was detected in the positive
control tissue. The intensity of expression was comparable
among the samples used (13—21 wk gestation) for the three
proteins, although insufficient samples were available for
rigorous quantitative analysis. A negative control was also
performed for all three proteins by omitting the primary
antibody, and in all cases immunoreactivity was abolished
(data not shown).
Discussion
The present results demonstrate the expression of neuro-
tropin mRNA and protein within the developing human
ovary. Expression of both the high affinity Trk receptors and
the low affinity nonselective p75 NGFR receptor was also
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Flfi. 2. //? s/7« hybridization and immunohistochemical localization of neurotropins and their receptors in human fetal ovary. In situ hybrid¬
ization: A, localization of NT4 mKNA expression in a 16 wk ovary (antisense probe; inset shows results for sense RNA probe). B, NT4 mRNA
expression in 16 wk ovary at higher magnification. C, NT4 mRNA localization in 21 wk gestation ovary, lmmunohistochemistrv: 1), 13 wk ovary
stained for NT4. The arrow indicates positively stained stromal cells. E, 21 wk ovary stained for NT4; F, 21 wk ovary at higher magnification,
stained for NT4; G, 18 wk ovary stained for TrkB; H, 21 wk ovary stained for TrkB linset shows same ovary at higher magnification); 1. 17 wk
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demonstrated. Localization of NTT m KNA confirmed that
the germ cells are the predominant site of expression of this
neurotropin before the formation of primordial follicles. Ex¬
pression was, however, developmentally regulated, thus af¬
ter the formation of primordial follicles, the predominant site
of expression of NTT mRNA and protein was the flattened
granulosa cell, whereas its cognate high affinity receptor
TrkB was localized to the oocyte using immunohistochem-
istry. These data therefore indicate the involvement of neu¬
rotropins in this crucial step in ovarian development, i.e. in
the formation of the essential structures of the ovary.
Tissue specimens were obtained after medical termination
of pregnancy, induced by administration of the antigestogen
mifepristone and PGFj. it is possible that the administration
of these drugs, directly or indirectly, might have affected the
expression of neurotropins in the fetal ovary, in which there
is some expression of steroidogenic enzymes at these gesta¬
tions (31). Hypoxia has also been demonstrated to modify
expression of neurotropins and their receptors in several
tissues (32, 33). Although the results presented here are in
broad agreement with the limited data obtained in the de¬
veloping rodent ovary (see below), it would be appropriate
to corroborate the present data in specimens obtained by
other methods.
Neurotropins, specifically NGF, were originally identified
on the basis of their role in the regulation ofneuronal survival
(8). They are small, secreted proteins related to the TGE/3
superfamily. The neurotropin hypothesis holds that devel¬
oping axons require target-derived factors for their survival,
and that these factors arc produced in limited quantity, re¬
sulting in competition between in-growing axons and selec¬
tive survival (34). Trk-mediated cell survival requires protein
synthesis, and neurotropins are predominantly believed to
act by suppression of apoptosis. Neurotropins may also reg¬
ulate cell migration (35) and differentiation (15). In addition
to these prodevelopment roles, neurotropins can promote
cell death. T his had been suggested to be a function of the p75
NGFR receptor when present without the coexistence of Trk
receptors, whereas in their presence p75 NGFR promotes cell
survival (36). Differential effects of p75 NGFR activation on
Trk receptor autophosphorylation dependent on both ligand
and Trk subtype have been previously described (37). There
is thus the potential for complex interplay between the dif¬
ferent receptor pathways.
There are no previous data on the presence of neurotropins
in the human ovary, but their expression has been demon¬
strated in the rat ovary (21-23). The immediate postnatal
period in the rat is the time of primordial follicle fonnation,
and increased expression of NT4 and its high affinity recep¬
tor TrkB, but not other neurotropins/Trk receptors, was
demonstrated at that time (22). NT4 expression has been
localized to the germ cell in both rodent and Xcnopim (20,22).
The present results are therefore in broad agreement with the
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limited previous data in other species. NTT protein was not,
however, predominantly localized to the germ cells. The
main site of localization was granulosa cells surrounding
oocytes in primordial follicles and, at earlier developmental
stages, iir epithelioid stromal cells within clusters of oogonia.
It appears likely that these cells are the precursors of the
granulosa celLs. I bis is similar to the pattern of development
demonstrated in the rodent, where these cells are derived
from the cells of the rete ovarii, which, in turn, derive from
the mesonephros (reviewed in Ret. 2). The rete ovarii is also
recognized to be of central importance in the regulation of the
onset of meiosis (38) and of the cortical/medullary pattern in
the rodent ovary (39,4(1). The neurotropins may therefore be
involved in the regulation of development of the oocyte in
the human ovary at a number of leveLs.
A central component of the mechanism of action of neu¬
rotropins in the nervous system is that they are produced and
released by the target cell in proportion to the final inner¬
vation density, taken up by the innervating neuron, and
transported to the nucleus where they mediate their pro-
survival effects (41,42). The predominant localization of NT4
mRNA and protein in different cell types before primordial
follicle formation is consistent with a similar pattern of se¬
cretion/uptake by germ celLs and somatic cells, respectively,
suggesting that NT4 is involved in the intercellular commu¬
nication between these cells types. The change in pattern of
expression of NTT mRNA, being low in the oocyte and high
in the granulosa cell after primordial follicle formation, in¬
dicates that the signals mediated by this pathway may vary
according to the developmental status of the germ cell/
somatic cell. The localization of TrkB to the germ cells sug¬
gests that these are a major site of NTT action, whereas p75
NGFR was localized to the ovarian stroma and was not
present in the granulosa cells of primordial follicles. The
distribution of p75 NGFR in the human fetal ovary is there¬
fore very similar to that in the neonatal rat ovary (22). The
differential distribution of the several receptors may con¬
tribute to the regulation of neurotropin signaling in the im¬
mediate environment of the forming primordial follicle. The
localization of other Trk receptors has not been investigated.
In the newborn rat, TrkB mRNA appeared to be localized to
presumptive pregranulosa cells (22). Whetherthis is a species
difference or reflects a particular developmental stage is un¬
clear at present. Developmental changes in the requirement
for specific neurotropins during neuronal differentiation and
survival have been described (34). It has long been recog¬
nized that oocytes must interact with somatic cells to fonn
primordial follicles and survive (5). The intermingling of
NT4-immunopositive epithelioid cells within the clusters of
oogonia may indicate a crucial role for oogonial-derived
neurotropins in determining germ cell survival by enhancing
the movement and dif ferentiation of somatic cells and thus
promoting primordial follicle development.
ovary stained for p75 NGFR; -J. 21 wk ovary stained for p75 NGFR; K. 21 wk ovary stained for p75 NGFR at higher magnification; L.
representative section of fetal ovary omitting primary antibody. Positive staining in all panels is brown, and sections are counterstained with
hematoxylin. Oo, Oogonia; o, oocyte; pf. primordial follicle; gc, granulosa cell; os, ovarian stroma. The scale bur in 11 represents 250 pin and
applies to J, L. and A inscl.; the scale bur in E represents 1000 jim and applies to I and A; the scale bar in F represents 100 p.m and applies
to K; the scale bur in G represents 250 pin and applies to H; the scale bar in H inscl represents 100 pin. The scale bar in C represents 50 pm
and applies to B.
896 J Clin Endocrinol Metab. February 2002. 87<2):890-897 Anderson et al. • Neurotropins in Human Fetal Ovary
(A) NT4








13 15 16 19 control
52-
FlC. 3. Western blot of NT4, TrkB. and p75 NGFR in human fetal
ovary. Total protein extracts (20 /rg) from whole ovaries at 13—21 wk
gestation, as indicated, were separated by SDS-PAGE, transferred to
polyvinylidene difluoride membrane and incubated with anti-NT4,
-TrkB, and -p75 NGFK antibodies. A, NT4, a protein band that mi¬
grated with an apparent molecular size of 21 kDa is indicated. B,
TrkB, protein bands with an apparent molecular size of 110 and 95
kDa are indicated, representing two forms of full-length TrkB. C, p75
NGFR, a protein band with an apparent molecular size of 75 kDa and
an additional band of approximately 65 kDa. Control tissue was rat
cerebral cortex in each case. The positions ofmolecular mass markers
are indicated. No immunoreactive bands were detected in the absence
of primary antibody (data not shown).
Three Trk receptors with high affinity for specific neuro-
tropins have been identified as well as the low affinity p75
NGFR receptor (10, 13). Truncated isoforms of TrkB and
TrkC resulting from alternative splicing have also been de¬
scribed (10-12). The present results demonstrate that mRNA
for both full-length and truncated isoforms of TrkB is ex¬
pressed in the human fetal ovary. The truncated isoforms of
the Trk receptors lack the intracellular, tyrosine kinase do¬
main, but retain the ligand-binding domain, and may be
found in both neuronal and nonneuronal cell types, although
the truncated form may be more abundant in the latter (11,
43). Changing patterns of expression of full-length vs. trun¬
cated forms have been demonstrated during tissue repair in
certain regions of the nervous system (44). TrkB-truncated
isoforms have recently been suggested to be involved in
neurotropin endocytosis (45) and in regulation of specific
patterns of dendritic growth distinct from those mediated by
the full-length isoform (46). Conversely, several neuro¬
tropics and their receptors may require to be coexpressed by
specific cell types (47,48). The relevance of Trk splice variants
to ovarian development and function remains to be
investigated.
Although the present study does not comprehensively
localize within the ovary all identified members of the neu¬
rotropin family and their receptors, the differential localiza¬
tion of TrkB, p75 NGFR, and NTT may indicate multiple roles
for neurotropin signaling. Indeed, neurotropins have been
implicated in several processes in the rodent ovary. Increased
NT4/TrkB mRNA expression was associated with primor¬
dial follicle formation (22), whereas increased NGF/TrkA
expression was induced by the LH surge during first ovu¬
lation (24) and is involved in the regulation of intercellular
gap junction integrity between thecal cells (25). Increased
NGF production within the ovary resulted in disruption of
estrous cyclicity (49). It therefore appears that individual
neurotropin/receptor pathways are involved in the regula¬
tion of specific intraovarian processes. Direct evidence for the
importance of neurotropins in ovarian development is
scanty. In vitro incubation of neonatal rat ovary with the
nonselective Trk receptor antagonist K-252a reduced the
number of primordial follicles present (22). Recent studies of
mice with an inactivating mutation of TrkB are consistent
with this pathway having an important role in primordial
follicle formation (50), although transgenic NTT knockout
mice appear to be normally fertile (51). The ovaries of neo¬
natal NGF-knockout mice also show reduced proliferation of
mesenchymal cells and reduced primordial follicle growth,
suggesting that both cell populations are targets for NGF
action (23). Mice carrying a null mutation of the p75 NGFR
gene appear to have normal numbers of ovarian follicles, but
this receptor may be involved in the reduction in mesen¬
chymal cell proliferation found in the NGF-knockout mouse
(23), as this is the site of expression of the p75NGFR. Later
stages of ovarian development in neurotropin/Trk knockout
models have not been studied in detail, as they are generally
nonviable (52).
These results therefore demonstrate the presence of neu-
rotropins and their receptors in the developing human ovary.
Differential patterns of expression between cell types and
developmental changes, particularly associated with primor¬
dial follicle formation, suggest multiple roles for them in the
regulation of germ cell and somatic cell proliferation, sur¬
vival, and differentiation.
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Germ cell specific expression of c-kit in the human fetal
gonad
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The proto-oncogene receptor, c-kit, and its ligand have been demonstrated to be essential to the processes of germ
cell migration, proliferation and survival in the rodent. The aim of the present study was to investigate the
expression of c-kit mRNA and protein in human fetal ovary and testis across the gestational period 13-21 weeks.
In the ovary, this crucial period of development spans the transition from oogonial replication by mitosis to
primordial follicle formation. In the testis, germ cells (gonocytes) are mitotically active. Expression of c-kit mRNA
was demonstrated by reverse transcription-polymerase chain reaction (RT-PCR) in both ovary and testis at all
gestational ages examined. Testicular germ cell specific expression of c-kit mRNA was confirmed by RT-PCR using
specific cell types recovered by laser capture microscopy. The expression of c-kit protein by both male and female
germ cells was demonstrated by immunohistochemistry at all gestational ages examined, and was confirmed by
immunoblotting. In both, c-kit was localized to the cell membrane except in oocytes within primordial follicles
where it was localized to the cytoplasm. These data demonstrate that the expression of c-kit mRNA and protein is
germ cell specific in human fetal gonads and are consistent with an important role for the c-kit/kit ligand signalling
system in germ cell proliferation and survival in the developing human gonad.
Key words: c-kit/gonocyte/human/oocyte/laser capture microscopy
Introduction
In the human the genital ridge destined to develop into either
a testis or an ovary appears as a thickening of the intermediate
mesoderm at 4 weeks and remains identical in males and
females until the seventh week. At 8 weeks the testis and
ovary can be distinguished morphologically from each other
and the testis can be seen to contain testis cords containing
Sertoli cells surrounded by an interstitium which includes
Leydig cells (Gilbert, 1997). Germ cells of vertebrate species
do not initially form within the genital ridge but originate in
the extraembryonic mesoderm of the yolk sac. Primordial
germ cells increase by mitosis during migration and become
associated with the cells within the gonadal ridges at ~6 weeks
(Byskov, 1986). During fetal life, male germ cells continue to
proliferate up to about week 22 of gestation (Hilscher, 1991).
Within the fetal ovary, following oogonial replication by
mitosis, nests of syncytial germ cells form and are linked by
cytoplasmic bridges. The germ cells subsequently enter meiosis
only to arrest at diplotene of the first meiotic division (Hilscher,
1991). At this time point, the germ cells become surrounded by
somatic cells, thus forming primordial follicles. This process,
allowing communication between oocyte and somatic cell, is
believed to be crucial for the survival of primordial follicles
which may be required to remain in that arrested state for up
to 50 years (Gosden, 1995).
Studies in rodents have highlighted the importance of the
c-kit proto-oncogene receptor and its ligand, the kit ligand
(stem cell factor), in migration of germ cells from the yolk
sac to the developing gonad and in their subsequent survival
and development (Manova et al., 1990; Godin et al., 1991;
Pesce et al., 1993). For example, analysis in mice of the
effects of mutations of the White Spotting and Steel loci
(encoding c-kit and the kit ligand respectively) has allowed
the demonstration of the importance of this ligand-receptor
pair in multiple stem cell lineages including melanogenesis
and haematopoiesis as well as gametogenesis (Besmer, 1991;
Ashman, 1999). c-kit is predominantly expressed by germ
cells in the rodent testis although it has also been suggested
to be expressed by Leydig cells (Manova et al., 1990), whereas
kit ligand is expressed by a wider range of cell types. The
presence of a functional c-kit receptor has been implicated in
spermatogonial proliferation, survival and adhesion to Sertoli
cells (Loveland and Schlatt, 1997). Vincent et al. have demon¬
strated expression of c-kit by pachytene spermatocytes and
proposed that the kit/kit ligand interaction is essential for
meiosis (Vincent et al., 1998).
mRNA encoding c-kit and kit ligand have been detected in
fetal mouse ovaries between embryonic days 8 and 14.5,
consistent with a role in germ cell migration and proliferation
(Driancourt et al., 2000). In their review, Driancourt and
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colleagues used ovaries from mice in which one copy of the
kit gene was replaced by a lac-z reporter construct (Bernex
et al., 1996) to demonstrate that c-kit mRNA is not present in
oogonia in fetal ovaries on day 15.5, but is transcribed at high
levels in oocytes in primordial and growing follicles. These
results are in agreement with the other findings (Manova et al.,
1990) using in-situ hybridization studies. Functional effects of
kit ligand/c-kit in the ovary may persist into adult life, for
example in the regulation of persistence of meiotic arrest
(Horie et al., 1991; Ismail et al., 1997) and activation of
primordial follicle growth (Yoshida et al., 1997; Parrott and
Skinner, 1999).
Studies identifying the sites of expression of c-kit in the
human fetus have been very limited compared with those in
rodents and there are inconsistencies between the results so
far reported. Horie and co-workers used specific immunohisto-
chemistry to detect c-kit protein on frozen sections from a
number of human tissues, and in their paper immunopositive
staining of single sections from a human fetal testis (18 weeks)
and human fetal ovary (20 weeks) was shown (Horie et al.,
1993). However, other investigators have suggested that c-kit
is not detectable in the fetal testis after 15 weeks gestation
(Rajpert de-Meyts et al., 1996). It is notable that in one study
(Rajpert de-Meyts et al., 1996), c-kit remained detectable in
intersex testes until later in gestation, and other studies from
the same group have demonstrated that c-kit is a marker of
carcinoma in situ (CIS), a pre-malignant lesion thought to be
associated with persistence of fetal-type germ cells in the adult
testis (Rajpert de-Meyts and Skakkebaek, 1994). Consistent
with the suggestion that signalling via c-kit is important in
normal male germ cell development and function, alterations
in c-kit/kit ligand expression have also been demonstrated in
some patients with defective spermatogenesis (Mauduit et al.,
1999), with reduced expression associated with increased germ
cell apoptosis.
As the second trimester is the major time for the regulation
of germ cell numbers in the female (Baker, 1963) and is a period
of continuing testicular development (Wartenberg, 1989), we
have examined the expression and localization of c-kit in the
human gonad between 13 and 20 weeks of development. Our
studies have demonstrated that c-kit mRNA and protein are




Human fetal gonads were obtained following medical termination of
pregnancy. Women gave consent according to national guidelines
(Polkinghorne, 1989) and the study was approved by the Lothian
Paediatrics/Reproductive Medicine Research Ethics Sub-Committee.
Termination of pregnancy was induced by treatment with mifepristone
(200 mg orally) followed by prostaglandin E| analogue (Gemeprost;
Beacon Pharmaceuticals, Tunbridge Wells, UK) 1 mg 3 hourly per
vaginam. None of the terminations were for reasons of fetal abnormality,
and all fetuses appeared morphologically normal. Gestational age was
determined by ultrasound examination prior to termination and con¬
firmed by subsequent direct measurement of foot length. A total of
20 specimens was used for this study, divided equally between male
and female.
Ovaries and testes were dissected free, and either fixed for immuno-
histochemical analysis or snap-frozen and stored at -70°C. Fixation
was carried out in Bouin's fluid for 5 h, followed by transfer to 70%
ethanol prior to processing into paraffin using standard methods.
Isolation of RNA and synthesis of cDNA from whole tissues
Total RNA was extracted from snap-frozen samples of fetal ovary
(13-21 weeks, n = 10) and testis (14-19 weeks, n = 6) using the
RNeasy mini kit (Qiagen, Crawley, UK). RNA was treated with
DNase (Gibco, Paisley, UK) and reverse transcription performed
using a first strand cDNA synthesis kit (Roche Diagnostics, Lewes,
UK). Briefly, 1 pg total RNA was incubated with oligo (dT)18 primer
for 10 min at 65°C and then placed on ice. A reaction mix comprising
buffer, 1 mmol/1 each deoxynucleotide triphosphate (dNTP), ribo-
nuclease inhibitor and 50 IU reverse transcriptase, was added to each
tube in a total volume of 50 pi and the tubes were then incubated at
40°C for 2 h.
Isolation of RNA by laser capture microscopy
Sections (5 pm) were cut from paraffin wax-embedded 19 week
human fetal testis samples and mounted on plain, uncoated, glass
slides. Sections were dewaxed in xylene, rehydrated then subjected
to immunostaining. To visualize the cells within the seminiferous
cords, an anti-Mullerian hormone (AMH) polyclonal antibody was
used as detailed below except that the protocol was modified for
short, typically 10 min, incubation times at each step to reduce the
chance of RNA degradation, and RNAse inhibitor (200 IU/ml,
Promega) was included in all the immunohistochemical reagents.
After colour development with diaminobenzidine (DAB), the sections
were dehydrated through graded alcohols and finally xylene. Sections
were stored in a vacuum desiccator for at least 30 min prior to
capture. Care was taken throughout to avoid RNase contamination
of sections and all aqueous solutions were prepared with DEPC-
treated water.
Individual cell fragments were recovered from the stained sections
by microdissection using the PixCell II LCM system (Arcturus
Engineering Inc., Mountain View, CA, USA) according to the
manufacturer's instructions. Briefly, each section was overlaid with
a thermoplastic membrane mounted on optically transparent caps and
cell fragments were captured by focal melting of the membrane due
to laser activation (Figure 1). The parameters of the laser shot used
in this study were: spot size 7.5 pm in diameter, power 45 mW and
duration time 0.5 ms. The same parameters and number of laser shots
(-600) were used for each cell type to normalize the amount of
cellular material isolated.
Total RNA was extracted from micro-dissected samples with the
Micro RNA Isolation Kit (Stratagene, La Jolla, CA, USA). After incuba¬
tion with 200 pi of denaturing buffer and 1.6 pi of (3-mercaptoethanol
at room temperature for 10 min, the sample was extracted with 20 pi of
2 mol/1 sodium acetate, 220 pi phenol and 60 pi chloroforrmisoamyl
alcohol (24:1). The aqueous phase was mixed with 1 pi of 10 mg/ml
carrier glycogen and then precipitated with 200 pi of isopropanol. After
a 70% ethanol wash followed by drying in air, the pellet was resuspended
in 10 pi of RNase free H20. The extracted RNA was reverse transcribed
using 10 pmol random hexamer primers and 200 IU of Superscript
II (Gibco BRL) reverse transcriptase according to the manufacturers
instructions. An aliquot of cDNA was then amplified using a modified
degenerate oligonucleotide primed polymerase chain reaction (DOP-
PCR) protocol (Kasai et al., 2000) using the primer UNI, 5'-CCGAC-
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Figure 1. Laser capture microdissection. (A) The transfer polymer
attached to a cap is brought into contact with the fixed, stained
tissue section. (B) Areas of transfer polymer in contact with the
selected cell fragments are activated using the laser pulse, the
diameter of which can be varied. (C) The cap is removed with the
selected cells attached, non-selected material is left behind.
Captured material can now be used in a number of downstream
applications; in this study mRNA was extracted and gene
expression examined.
TCGAGNNNNNNATGTGG-3' in a total volume of 25 pi. 5 pi of
amplified cDNA was then used in subsequent PCR reactions using
primer sets for specific sequences.
Amplification of specific cDNA by PCR
c-kit
PCR was performed by incubating either 1 pi (whole tissue extracts)
or 5 pi (samples from LCM) cDNA with Taq DNA polymerase (AGS
Gold; Hybaid, Ashford, UK) in buffer containing 0.2 mmol/1 of each
dNTP and forward and reverse oligonucleotide primers. Two control
tubes were run in parallel, one in which water replaced the RNA and
a second omitting reverse transcriptase to ensure that there was no
genomic DNA contamination. PCR amplification conditions consisted
of an initial denaturation step at 95°C for 2 min, followed by 35
cycles of denaturation at 95°C for 30 s, annealing at 50°C for
30 s and extension at 72°C for 45 s; a final extension period at 72°C
for 5 min completed the amplification. Three sets of primers specific
for human c-kit (Vandenbark et al., 1992) were used, one for cDNA
from whole tissue extracts (set 1), the other two following laser
capture of samples [sets 2 and 3 (nested)]. All three pairs of primers
were designed to span an intron to ensure that genomic DNA was
not amplified. Set 1, 5' -AAGGACTTGAGGTTTATTCCT-3' (sense)
and 5'-CTGACGTTCATAATTGAAGTC-3' (antisense), amplified a
product of 345 bp; set 2, 5' -GTGGTTAAAGGAAACGCTCG-3' and
5'-CATACATTTCAGCAGGTGCG-3', amplified a product of 232 bp;
set 3, 5' -AAGTGGATGGCACCTGAAAG-3' and 5'-GAACTTA-
GAATCGACCGGCA-3', amplified a product of 138 bp from within
the product of primer set 2. Primers for the constitutively expressed
gene GAPDH were used to confirm the integrity of the RNA and efficacy
of the PCR reaction. The identity of all PCR products were confirmed
by direct sequencing using an Applied Biosystems 373A automated
sequencer.
Anti-Miillerian hormone (AMH)
The following primers were used to identify samples containing Sertoli
cell mRNA recovered by LCM (all primers were based on the sequence
of human AMH; accession no. NP000470): set 1, 5'-TGCAACA-
CCGGTGACAGGCAG-3' and 5'-GCAGCCCAGCCCTCGTCA-
CAG-3', amplified cDNA 238 bp; set 2 (nested), 5'-GCT-
GCCTTGCCCTCTCTAC-3' and 5' -GAACCTCAGCGAGGGTG-
TT3', amplify a product of 117 bp from within the product of primer
set 1.
Immunohistochemistry
Sections (5 pm) were mounted on TESPA (Sigma, Poole, Dorset)-
coated slides, dewaxed and rehydrated. Endogenous peroxidase
activity was inhibited by incubation in 3% H202 in methanol for
30 min. After a wash in water, slides were transferred into Tris-
buffered saline (TBS; 0.05 mol/1 Tris, 0.85% NaCl, pH 7.6) for
5 min and blocked for 30 min in normal rabbit serum (NRS;
Diagnostics Scotland, Carluke, UK) diluted 1:4 in TBS containing
5% bovine serum albumin (NRS/TBS/BSA). Sections were then
blocked with avidin (0.01 mol/1; 15 min) and biotin (0.001 mol/1;
15 min; both from Vector, Peterborough, UK) with washes in TBS
in between. The primary antibody (anti-c-kit goat polyclonal; cat.
No. M14 Santa Cruz) was applied at a dilution of 1 in 300 in NRS/
TBS/BSA at 4°C overnight. Sections were washed and incubated for
30 min with biotinylated rabbit anti-goat antibody (Dako, Cambridge)
diluted 1:500 in NRS/TBS/BSA. Following washes in TBS, sections
were incubated with avidin-biotin-horseradish peroxidase linked
complex (Dako) according to the manufacturer's instructions. Bound
antibody was visualized using 3,3'-diaminobenzidine tetrahydro-
chloride (Dako). A second anti-c-kit primary antibody (rabbit poly¬
clonal, dilution 1:30; Dako) was also used in some experiments.
Testis sections were stained with AMH primary antibody (rabbit
polyclonal, gift of Dr R.Rey, Buenos Aires, Argentina) used at a
dilution of 1:500 following antigen retrieval using citrate buffer (0.01
mol/1, pH 6.0, pressure cooked for 2.5 min). Swine anti-rabbit second
antibody (Dako) was used in both cases. Primary antibodies were
omitted as negative controls.
Sections were counterstained with haematoxylin, dehydrated,
mounted and visualized by light microscopy. Images were captured
using an Olympus Provis microscope (Olympus Optical Co., London)
equipped with a Kodak DCS330 camera (Eastman Kodak), stored on
a Macintosh PowerPC computer and assembled using Photoshop 5
(Adobe, Mountain View, CA, USA). A total of six ovaries and six
testes were examined using immunohistochemistry.
Immunoblotting
Fetal ovaries (n = 2) and testes (n = 4) were homogenized in
denaturing buffer [58 mmol/1 Tris pH 6.8, 1% sodium dodecyl
sulphate (SDS), 1% glycerol; all from Sigma], Samples (10 pg
protein) were diluted with an equal volume of reducing loading buffer
(187 mmol/1 Tris pH 6.8, 2% SDS, 2% P-mercaptoethanol, 1%
sucrose, 0.01% bromophenol blue) and boiled for 5 min. Proteins
were separated by SDS-polyacrylamide gel electrophoresis on a 7.5%
acrylamide gel in parallel with prestained protein molecular weight
markers (Biorad, CA, USA) and blotted onto PDF membranes
(Amersham Pharmacia, Buckinghamshire, UK) overnight using wet
blot apparatus (Biorad). Thereafter, membranes were blocked for 2 h
at room temperature in 0.02 mol/1 TBS (pH 7.6) containing 3% w/v
BSA (Sigma). Membranes were washed in TBS with 0.1% Tween-
20 (TBST) and then incubated for 2 h with the primary antibody
(anti-c-kit goat polyclonal, 1:750, Santa Cruz) in TBST with 1%
BSA. Primary antibody was omitted as a negative control. Bound
antibody was detected using a rabbit anti-goat HRP linked secondary
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antibody (1:6000, Dako) and the enhanced chemiluminescence visual¬




Expression of c-kit mRNA
By RT-PCR, a single cDNA (345 bp) was amplified from
RNA extracted from both fetal ovaries and testes at all
gestational ages examined (13-21 weeks) (Figure 2A).
Although the PCR was not quantitative, the amount of mRNA
detected appeared higher in samples from testis.
Analysis of cell populations recovered from fixed sections
of a week 19 testis by laser capture microscopy showed that
at this age expression of c-kit mRNA was confined to the
germ cell population (gonocytes) and was not expressed in
either Sertoli cells or within the interstitium (Figure 2B-D).
Immunohistochem istry
c-kit protein was detected by immunohistochemistry in all
specimens examined, across the gestational range 14-21 weeks
(ovary) and 13-19 weeks (testis) (Figure 3, representative
sections from a total of six ovaries and six testes). Both anti¬
c-kit antibodies tested gave similar staining patterns. In the
ovary, positive staining was seen in oogonia and oocytes
(Figure 3A-C), with the great majority of germ cells being
stained. The surface epithelium, the ovarian stroma and the
pregranulosa cells of primordial follicles were all immuno-
negative. This was particularly apparent in the 21 week
gestation specimen in which there were a large number of
primordial follicles which were not present at earlier gestations
(Figure 3C). It was notable that although the c-kit protein
appeared to be concentrated at the cell membrane of the
oogonia at earlier gestational ages (Figure 3A and B), at 21
weeks the protein was clearly spread throughout the cytoplasm
of the oocytes (Figure 3C).
Within the testis, c-kit protein was localized to gonocytes
within the testicular cords (Figure 3D-F) consistent with
the cell specific expression of c-kit mRNA. Although most
gonocytes were immunopositive at all ages examined (13-19
weeks), some immunonegative cells were also present (e.g. 17
weeks, Figure 3F). As with the ovary, immunohistochemical
staining was concentrated at the germ cell membrane (Figure
3F). c-kit immunoexpression was not detected in the peritubular
cells, interstitial cells (Figure 3F) or the surface epithelium
(not shown). Sertoli cells were identified by immunostaining
for AMH (Figure 3G). No staining was seen on sections of
ovary (Figure 3H) or testis (Figure 31) in which the primary
antibody was not included.





Figure 2. Expression of c-kit mRNA in human fetal ovary and
testis. (A) Reverse transcriptase-polymerase chain reaction
(RT-PCR) analysis of samples extracted from whole ovaries
obtained at 14, 16 and 21 weeks, and testis at 14. 17 and 19 weeks
as indicated. A product of 345 bp was detected in each sample.
Lanes labelled 'n' contained samples in which reverse transcriptase
was not included. Molecular weight marker: PCR marker
(Promega). (B. C, D) Results of RT-PCR analysis of cell fragments
recovered from a 19 week fetal testis by laser capture as described
in Materials and methods. Tissues were immunostained for AMH to
identify the positions of Sertoli cells and gonocytes within the
seminiferous cords. The mRNA for c-kit (panel B) was detected in
gonocytes (G) and whole testis (T) but not in Sertoli cells (S) or
the interstitium (In). AMH (panel C) was only detected in S or T
but not in G or In. GAPDH (panel D) was detected in all samples.
Lane bl denotes the blank in which reverse transcriptase was not
included. Molecular weight marker: 100 bp ladder.
the primary antibody. The experiment was repeated three times
with similar results.
Immunoblotting
The presence of c-kit protein in both fetal ovary and testis
was confirmed by immunoblotting. A prominent 145 kDa band
corresponding to the size of the transmembrane receptor protein
was detected in samples from gonadal tissues of both sexes
(Figure 4). There was no immunoreactivity in the absence of
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Discussion
The results presented demonstrate unequivocally that the
expression of c-kit mRNA and protein occurs in the germ cells
of both ovary and testis in the human fetus during the second
trimester.
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Figure 3. Immunohistochemical localization of c-kit (A-F) and anti-Miillerian hormone (AMH) (G) proteins to fixed tissue sections from
human fetal ovary and testis. (A) 14 week ovary; inset shows oocyte staining for c-kit, (B) 17 week ovary, (C) 21 week ovary. (D) 14 week
testis, (E) 16 week testis, (F) 17 week testis, (G) 17 week testis, AMH. (H and I) Representative sections of fetal ovary and testis
respectively omitting anti-c-kit antibody. Staining for c-kit and AMH is brown. G = gonocyte; i = interstitium; o = oocyte; p = peritubular
cells; pf = primordial follicle; s = Sertoli cells; t = tubules. Scale bar in A represents 200 |tm and applies to A, D. E, G, H and I; scale







Figure 4. Western blot of c-kit in human fetal ovary and testis.
Total protein samples (10 pg) from ovary (14 weeks gestation) and
testes (15 and 17 weeks gestation) were separated by sodium
dodecyl sulphate-polyacrylamide gel electrophoresis, transferred to
nylon membrane and incubated with anti-c-kit antibodies. Positions
of molecular weight markers are indicated; the arrow marks the
position of the single protein band which migrated with an apparent
molecular size of -145 kDa. No immunoreactive bands were
detected in the absence of primary antibody (not shown).
In the rodent ovary, expression of the c-kit gene has been
detected very early in development and is high in proliferating
germ cells (Manova and Bachvarova, 1991); however, expres¬
sion stops when oogonia enter meiosis (Manova et al., 1990).
In the human ovary, entry into meiosis occurs over a wide
timescale, being detectable as early as 11 weeks gestation
(Gondos et al., 1986) although it is believed to be maximal at
-20 weeks (Baker, 1963). Thus over the range of gestations
examined in the present study, many oogonia will continue to
proliferate by mitosis while an increasing proportion enter
meiosis. The absence of a closely defined time at which mitosis
ceases and meiosis is initiated throughout the ovary is likely
to account for the detection of c-kit mRNA in whole tissue
samples at all gestations examined up to 21 weeks, at which
time many primordial follicles were present. The detection of
c-kit protein in all specimens examined up to and including
21 weeks gestation is consistent with a previous report in
sheep where c-kit protein, but not mRNA, was detected
in oocytes undergoing meiosis (Tisdall et al., 1999). It is
possible that the apparent change in intracellular localization
of c-kit protein from the membrane to the cytoplasm seen in
human primordial follicles may be related to this underlying
change in gene expression, c-kit protein has been previously
localized to the oocytes of a 20 week gestation fetus (Horie
et al., 1993), but in that study, which was undertaken on frozen
sections, it was unclear whether c-kit was localized to the
cytoplasm or cellular membrane.
The range of gestational ages examined in this study covers
the period of definitive histogenesis of the ovary, when
the finite population of oocytes which will survive within
primordial follicles and thus determine reproductive potential
is regulated, c-kit and its ligand, stem cell factor or kit ligand,
may have an important role in these processes. Mutations in
the genes for these factors result in loss of primordial germ
cells (Besmer et al., 1993), and effects of kit ligand/c-kit
signalling on germ cell survival and protection from apoptosis
have been demonstrated in vivo and in vitro (Godin et al.,
1991; Pesce et al., 1993; Yee et al., 1994). It has been
suggested that the pro-survival effects of c-kit in the ovary
may be mediated by increased expression of the anti-apoptotic
factor. Bcl-2 (Tilly, 1996). Such studies have also suggested a
role for this pathway in regulation of the onset of primordial
follicle formation and growth of primary follicles (Yoshida
et al., 1997). Kit ligand/c-kit may also have a role in later
folliculogenesis: both promotion of follicle development and
maintenance of arrest of meiosis have been suggested (Horie
et al., 1991; Ismail et al., 1997; Parrott and Skinner, 1999).
Kit ligand appears to have effects on surrounding stromal cells
in addition to the oocyte (Parrott and Skinner, 2000). c-kit is
also present in the adult human ovary, in both oocytes and
granulosa cells (Tanikawa et al., 1998) and has been suggested
to have an autocrine role in the ovarian surface epithelium
(Parrott et al., 2000). c-kit expression appeared to be confined
to germ cells within the ovary in the present study: no
consistent staining of stromal cells was observed.
The technique of laser capture microscopy (LCM) was
developed at the National Institutes of Health in the USA to
allow sampling of individual, or groups of cells from complex
tissues in such a way that mRNA and/or proteins could be
extracted from them and analysed (Emmert-Buck et al., 1996).
The method has recently been applied to the recovery of
seminiferous tubules from frozen sections of mouse testis
(Suarez-Quian et al., 2000). In the present study, the LCM
microscope was used with the laser set to the smallest size
available (7.5 pm) to allow for sampling of single gonocytes.
Recently the size of male germ cells in the human fetal testis
(7—10 weeks) has been reported as being 9 pm in diameter
(Bendsen et al., 2001). To enable us to locate individual
gonocytes, fixed tissue sections were used and these were
stained using a modified immunohistochemical technique. The
use of fixed sections meant that only short fragments of cDNA
could be identified by RT-PCR (Goldsworthy et al., 1999)
and we employed a nested PCR strategy to increase signal
intensity and specificity. We believe that this is the first time
LCM methodology has been used to sample individual cell
types from the human fetal testis and it has allowed us to
show that c-kit mRNA is expressed in fetal gonocytes at 19
weeks gestation.
In a previous study on human fetal testes, c-kit protein was
not detected in the testis beyond 15 weeks gestation using
immunohistochemistry (Rajpert de-Meyts et al., 1996). In
another study, presence of c-kit in the human fetal testis was
reported in cells described as spermatogonia in a fetus of 18
weeks gestation (Horie et al., 1991). The results we have
obtained using specific immunohistochemistry and Western
analysis all demonstrate that c-kit protein is expressed in the
fetal germ cells up to and including 19 weeks of gestation.
Gonocytes are believed to be the cell of origin of gonadoblas-
tomas (Jorgensen et al., 1997), and it has been suggested that
prolonged expression of c-kit in germ cells in individuals with
intersex conditions may be a component of abnormal germ
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cell development in such individuals who are at increased
risk of testicular neoplasia (Rajpert de-Meyts et al., 1996).
Following laser capture of cells from a 19 week fetus, we
failed to detect expression of c-kit mRNA in interstitial cells.
Although this result is based on a single stage of development,
it was in agreement with a lack of immunostaining in the
interstitium at all ages examined and would not therefore be
consistent with findings in the mouse (Manova et al., 1990).
Studies of mice in which mutations in c-kit or its ligand have
been well documented and result in a failure in migration of
germ cells into the genital ridge (Besmer et al., 1993); however,
the use of a blocking antibody against c-kit has led to
the suggestion that c-kit is important in proliferation of
differentiated spermatogonia (Yoshinga et al., 1991) and pro¬
tection from apoptosis (Packer et al., 1995). A role in spermato-
gonial differentiation rather than proliferation has also been
suggested on the basis of experiments involving transplantation
of germ cells into testes of Steel mice (Ohata et al., 2000) and
other studies have shown a role for the kit-kit ligand in meiosis
(Vincent et al., 1998). Taken together, these data reinforce the
importance of c-kit and its ligand in multiple cell lineages
both during development and in adulthood.
In conclusion, this study demonstrates conclusively that c-kit
mRNA and protein are expressed in oogonia during the
transition from rapid proliferation by mitosis to the formation of
primordial follicles, and in gonocytes of the developing testis
during the second trimester, c-kit has been demonstrated to be
crucial for germ cell migration, survival and proliferation in the
mouse: the present results suggest that c-kit is likely to be of
similar importance in the human.
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Matrix metalloproteinases and tissue inhibitors of
metalloproteinases in human fetal testis and ovary
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Matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) are major regulators of tissue
remodelling of the extracellular matrix (ECM) and may also be involved in the control of growth factor availability.
We have investigated their production and localization in the developing human gonad during mid-gestation using
zymographic techniques and immunohistochemistry. The secretion of MMP-2, MMP-9 and all four TIMP was
demonstrated from both testis and ovary, with the predominant gelatinase produced by both being MMP-2. In the
testis, MMP-1, MMP-2, MMP-9 and all TIMP family members were localized to the interstitium and to varying
degrees within the tubules. MMP-9 and TIMP-4 were abundant in both Sertoli cells and gonocytes and MMP-1
and TIMP-1 were localized in particular to Sertoli cells. In the ovary, all TIMP and MMP-1, MMP-2 and MMP-9
were localized to the oogonium/oocyte cytoplasm with varying intensities and MMP-1, TIMP-2 and TIMP-3 were
also detected in the ovarian stroma. This study demonstrates that MMP-1, MMP-2, MMP-9 and all TIMP family
members are secreted by the developing ovary and testis and are localized to specific cell and tissue sites. MMP
and TIMP are likely to play a role in ECM remodelling during gonadal development and also in the cell and
matrix interactions that control a range of cellular functions.
Key words: fetus/matrix metalloproteinase/ovary/testis/TIMP
Introduction
The development of the human fetal gonad is a complex
process involving dramatic structural changes, the control
mechanisms of which remain unclear. In both sexes, primordial
germ cells migrate to the nephrogonadoblastic ridge where
they replicate by mitosis. Invasion of mesonephric cells results
in the formation of testicular cords containing Sertoli cells and
gonocytes in the testis, while in the ovary the ovarian stroma
divides clusters of oogonia which subsequently form primordial
follicles (Byskov, 1986; Motta et al., 1997). By that stage,
oogonia have entered meiosis and arrest at the diplotene stage.
In both fetal ovary and testis, the extracellular matrix (ECM)
provides the scaffold to which cells attach and also, by binding
to specific cell surface receptors, modulates their function (Vu
and Werb, 1991). Remodelling of the ECM may play an
integral role in fetal gonadal development, including cell
migration, organization, differentiation and function.
Matrix metalloproteinases (MMP) are a family of enzymes
essential for proteolytic degradation of the ECM. A family of
four specific tissue inhibitors of MMP (TIMP) have also been
identified and the extent of ECM remodelling depends on the
ratio of MMP to TIMP (Salamonsen, 1996). Regulation of
ECM remodelling by MMP and TIMP is vital to provide an
environment that supports initiation of growth, migration and
differentiation by a range of mechanisms (Behrendtsen and
Werb, 1997; Giannelli et a!., 1997; Nagase and Woessner,
1999; Li et al., 2000). These proteins can act from within the
matrix and also at the cell surface, where, for example,
MMP-2 and MMP-9 are known to bind to heparan sulphate
proteoglycans. They are thus positioned for interaction with
cell surface adhesion molecules or receptors and for regulating
the turnover of these molecules (Yu and Woessner, 2000).
MMP and TIMP also regulate proliferation of a variety of
cell types (Edwards et al., 1996a) and are involved in the
regulation of cytokines and their receptors both directly and
indirectly via effects on the ECM. Growth factors bound to
ECM are biologically inactive and must be liberated and in
some cases activated before binding to receptors (Vu and
Werb, 2000); for example, MMP-9 proteolytically activates
latent transforming growth lac tor-(3 (TGF-(3) (Yu and
Stamenkovic, 2000). MMP may also control bioavailability
by cleaving binding proteins, thus MMP-1 can degrade insulin¬
like growth factor binding protein (IGFBP) into fragments
with low affinity for insulin growth factor (IGF), thus increasing
the bioavailability of IGF (Rajah et al., 1995). Regulation of
proteolytic degradation of the ECM may therefore provide an
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important mechanism for controlling growth factor availability
and activity, thus influencing tissue differentiation during organ
development. Secretion of MMP and TIMP is under the control
of a wide range of cytokines and growth factors (Nagase
and Woessner, 1999), such as platelet-derived growth factor
( PDGF) (Johnson and Knox, 1999) and TCF-P (Edwards et al..
1996b). Sex hormones such as progesterone are also significant
in regulation of ECM remodelling via inhibition of MMP-1,
MMP-3 and MMP-7 synthesis and stimulation of TIMP-1 and
TIMP-2 production (Imada et al., 1994; Marbaix et al., 1995).
Signalling pathways also lead to expression of particular MMP
genes as in the case of MMP-1 which is mediated by the MAP
kinase pathway (Reunanen et al., 1998).
The MMP are produced by a variety of ovarian cell types
including mature oocytes, granulosa cells and luteal cells in
the rat (Bagavandoss, 1998), and in the bovine ovary, MMP-9
and TIMP-1 have been associated with follicular growth
(Kaiura et al., 2000; McCaffery et al., 2000). TIMP have also
been identified in the gonadal tissue of various species including
the adult human (Curry et al., 1990). The objective of this
study was to establish the secretion and localization of a range
of MMP and all TIMP family members to determine their
possible role in the development of the fetal testis and ovary.
Materials and methods
Collection of tissue samples
Gonadal tissue was collected from 21 fetuses after termination of
pregnancy induced by priming with mifepristone (200 mg, orally)
followed 48 h later by prostaglandin E[ analogue (Gemeprost, Upjohn)
1 mg 3 hourly p.v. All fetuses appeared morphologically normal. The
gestational age was assessed by the date of the last menstrual period
and by ultrasound scanning during pregnancy, and confirmed by foot
length measurement post mortem. The gonads were removed and
either placed in a sterile Petri dish containing minimal essential
medium a (MEMa; Gibco, Paisley, UK) prior to culture or were
immediately fixed in Bouin's fluid for histological analysis. Tissues
were collected under the approval of the Lothian Research Ethics
Committee in accordance with the Guidelines of the British Govern¬
ment (Polkinghorne. 1989). Informed consent was obtained from
each of the patients undergoing termination of pregnancy.
Explant culture
Gonads from two fetuses of each sex (ovaries at 12 and 14 weeks
gestation, and testes at 17 weeks gestation) were dissected free of
adherent tissues using sterile technique, bisected longitudinally and
then cut into slices -0.5 mm thick. Three tissue fragments were
cultured on blocks of 2% agarose gel in 12-well plates (Transwell,
Costar, High Wycombe. UK) in 0.4 ml of medium, sufficient to form
a meniscus at the level of the tissue. The medium comprised MEMa
containing 3 mg/ml bovine serum albumin, antibiotics (100 lU/ml
penicillin. 100 pg/ml streptomycin sulphate. 0.125 pg/ml amphoter¬
icin), insulin, transferrin and selenium (5 pg/ml insulin. 5 pg/ml
transferrin and 5 pg/ml sodium selenite), 2 mmoL/1 glutamine and
2 mmol/1 pyruvate (all chemicals supplied by Sigma, Poole, Dorset).
The cultures were maintained at 37°C in 5% C02 in air in a humidified
incubator. After 48 h the media were collected in a sterile container
and frozen at -20°C prior to analysis by zymography. Histological
analysis of cultured tissue confirmed that morphology was maintained
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Figure 1. Gelatin zymography gel showing gelatinase activity
(visualized as lighter bands) in conditioned medium from explant
cultures of fetal ovary and testis. Ovary 1, 14 weeks; ovary 2,
12 weeks; testis 1 and 2, 17 weeks. The predominant gelatinase
activity is due to MMP-2 (latent form; 72 kDa). Molecular weight
(MW) markers are as indicated (kDa). A sample of human term
amniotic fluid (Af) was used as a positive control.
Detection of gelatinase activities by zymography
Activities of MMP-2 and MMP-9 were determined using gelatinase
zymography, as described previously in detail by this laboratory
(Riley et al., 1999a). Briefly, samples of conditioned medium were
lyophilized, reconstituted in 0.1% SDS and separated by sodium
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE;
7.5% gels; Minigel apparatus; BioRad, Hemel Hempstead, Herts,
UK) containing gelatin (1 mg/ml) using non-reducing conditions. The
presence of SDS both activates the latent forms of MMP and
dissociates them from their inhibitors, so all forms are detected. Gels
were washed [twice, 2.5% (v/v) Triton X-1001 and incubated in
digestion buffer [200 mmol/1 NaCl, 50 mmol/1 Tris, 5 mmol/1 CaCl2,
1 pmol/l ZnCN. 0.02% (v/v) Brij-35. pH 7.6| for 18 h at 37"C. Gels
were stained (0.5% Coomassie Blue R250 in 30% methanol/10%
glacial acetic acid in H20) for 3 h at 23°C, then destained (staining
solution omitting Coomassie Blue), revealing localized regions where
the substrate has been degraded. Human amniotic fluid collected at
term during labour was used a positive control which clearly demon¬
strates the latent forms of MMP-2 (72 kDa), MMP-9 (92 kDa),
a lipocalin-proMMP-9 complex (120 kDa) and dimeric MMP-9
(-210 kDa).
Detection of TIMP by reverse zymography
The activities of TIMP were detected by reverse zymography as
described previously using a commercially available kit (University
Technologies Inc., Calgary, Canada) with some minor adaptations
(Riley et al., 1999b). Culture medium samples were lyophilized.
reconstituted in 0.1% SDS and separated by PAGE (12% gels)
containing gelatin (1 mg/ml) and a preparation ofMMP-2 (conditioned
medium from BHK-21 cells which constitutively express MMP-2;
University Technologies Inc.) using a minigel apparatus. Gels were
washed [wash buffer: 50 mmol/1 Tris, 5 mmol/1 CaCl2, 2.5% (v/v)
Triton X-100; for 2.5 h at 23°C[ and incubated in digestion buffer
(wash buffer excluding Triton X-100) at 37°C for 17 h. Gels were
stained (0.5% Coomassie Blue R250 in 30% methanol/10% glacial
acetic acid) and destained (staining buffer omitting the Coomassie
Blue). The TIMP inhibitory activity appeared as dark bands against
a lighter background. TIMP were identified and characterized by
comparison with molecular weight markers (BioRad). control standard
solutions containing mouse TIMP-1, TIMP-2 and the glycosylated
and unglycosylated forms of TIMP-3 (University Technologies Inc.),
and also human amniotic fluid, which contains all TIMP isoforms
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Table I. Primary antibodies for matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) used for immunostaining of human fetal
ovary and testis
Antibodv Species raised Optimal dilution Source
(flg/ml)
MMP-1 Mouse 2 Chemicon International Inc.. Harrow. UK
MMP-2 Mouse 5 Calbiochem, Nottingham, UK
MMP-9 Mouse 10 Insight Biotechnology, Wembley, Middlesex, UK
TIMP-1 Rabbit 2 Sigma, Poole, Dorset, UK
TIMP-2 Rabbit 5 Triple Point Biologies, Forest Grove, OR, USA
TIMP-3 Rabbit 5 Sigma, Poole, Dorset, UK
TIMP-4 Rabbit 5 Chemicon International Inc., Harrow, UK
Table II. Semi-quantitative analysis of cellular and spatial localization of matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) by









MMP-1 +/- + + + + + + + +
MMP-2 - + +/- + + +/- +
MMP-9 - + + + + + + + +
TIMP-1 +/- + + + + + +/- +
TIMP-2 - +/- +/- + + - +
TIMP-3 +/- - - + + + - +








Figure 2. Reverse zymography gel demonstrating the secretion of
tissue inhibitors of metalloproteinases (TIMP) (visualized by darker
bands) into culture medium from explant cultures of fetal ovary and
testis. Ovary 1, 14 weeks; ovary 2, 12 weeks; testis 1 and 2, 17
weeks. Three predominant bands of TIMP activity are observed
at 27-30, 24 and 21 kDa. The standards (stds) of TIMP-1 and
TTMP-2 (Tl: TIMP-1 as a broad band at 27-30 kDa; T2: TIMP-2
at 21 kDa) and TIMP-3 (gT3: glycosylated TIMP-3 at 28-30 kDa;
ungT3: unglycosylated TIMP-3 form at 24 kDa) are indicated by
arrows. Molecular weight markers are as indicated (kDa). A control
of unconditioned medium showing no activity is shown (med).
(Riley et al., 1999b). Analysis of samples by PAGE with gelatin
substrate omitted demonstrated no significant detectable underlying
protein staining at the molecular weights at which TIMP were
observed, demonstrating the specificity of the reverse zymography
for detection of TIMP activity.
Table 111. Semi-quantitative analysis of cellular and spatial localization of
matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases
(TIMP) by immunohistochemistry in the fetal ovary between 13 and 21
weeks gestation
77 Oocyte Ovarian Surface Vascular
58 cytoplasm stroma epithelium endothelium
35 MMP-1 + + +/- +/- +
MMP-2 + + - +/- +
MMP-9 + + - +/- +
28 TIMP-1 + + + - +/- +
TIMP-2 +/- +/- - +
TIMP-3 +/- +/- +/- +
20 TIMP-4 + + - - -I-
Localization of MMP-1, MMP-2, and MMP-9 and TIMP by
immunohistochemistry
Immunoreactive MMP-1, MMP-2 and MMP-9, and TIMP-1, TIMP-
2, TIMP-3 and TIMP-4 were localized in tissues using immunohisto¬
chemistry and antibodies characterized and described in detail previ¬
ously (Riley et al., 1999b). In brief, tissue sections (5 pm) were
mounted on silane-coated slides. Sections were washed with histoclear
(National Diagnostics, Atlanta, GA, USA) to remove the wax,
rehydrated and endogenous peroxidase activity inhibited by incubation
in H202 (3% in H20; 20 min). Sections were washed and a blocking
step applied (5% normal goat or horse serum, appropriate to the
primary antibody and detection system used; 30 min). The sections
were blocked with avidin and then biotin (Vector Labs, Burlingame,
CA, USA; 15 min each block) to inhibit any endogenous avidin-
biotin interactions with the antibodies and then incubated overnight
with the primary antibody at 4°C in a humidified atmosphere. Optimal
antibody concentrations were established in a series of preliminary
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in table I. Primary antibody was detected using a goat anti-rabbit or
horse anti-mouse biotinylated second antibody as appropriate, and an
avidin-peroxidase complex according to the manufacturer's instruc¬
tions (Vector Labs). The primary antibody was omitted for negative
controls (see representative section Figure 3). Term human fetal
membranes were used as a positive control (Riley et al., 1999b).
Sections were counterstained with haematoxylin, dehydrated, mounted
and visualized by light microscopy.
Analysis of immunohistochemistry
Immunostaining of tissue sections was assessed semi-quantitatively
for both the ovary and testis using + and — symbols as a measure of
the intensity and amount of staining in particular cell types (Tables
11 and 111) + indicates pale staining in this cell type. ++ indicates
marked staining, and + + + signifies intense immunostaining. These
scores also reflect that the majority of cells of that particular type
have stained positively. A score of +/- means that some but not
most of these cells have stained, while a score of - means that there
is no positive staining in any cell of this type.
Results
Secretion of MMP and TIMP by the fetal testis
In culture medium conditioned by the fetal testis for 48 h,
high levels of gelatinase activity were detected at 120, 92, 86
72 and 66 kDa. These molecular weights correspond to the
MMP-9-lipocalin complex, the latent form of MMP-9, active
MMP-9, MMP-2-activated protein in the latent form and
the active form of MMP-2 respectively (Figure 1). The
predominant gelatinase activity detected was the latent form
of MMP-2.
The examination of TIMP activity in the testis using
reverse zymography showed predominant gelatinase inhibitory
activity at 27-30 kDa, which corresponds to the molecular
weights of TIMP-1, glycosylated TIMP-3, and TIMP-4 (Figure
2). Bands of activity were also present at 24 kDa (corresponding
to unglycosylated TIMP-3) and 21 kDa (corresponding to
TIMP-2). These bands aligned with standards to TIMP-1,
TIMP-2 and glycosylated and unglycosylated TIMP-3. Reverse
zymography is unable to distinguish precisely between the
TIMP isoforms of 27-30 kDa molecular weight. The presence
of these TIMP of similar molecular weights, including TIMP-4,
was therefore confirmed by immunohistochemistry.
localization of MMP and TIMP in the fetal testis
Sections of human testis from 10 fetuses between 13 and 19
weeks gestation were used for analysis. Table II shows the spatial
and cellular localization of MMP and TIMP immunoreactivity
and relative intensity of staining, and Figure 3A-G and O shows
representative photomicrographs. MMP-1 was found in abund¬
ance in the cytoplasm of the interstitial cells and to a lesser
extent in the surface epithelium (Figure 3A). MMP-1 was also
distributed among some of the peritubular cells and within the
testicular cords, particularly in Sertoli cells. MMP-2 was pre¬
dominantly localized to the interstitium of the testis and also
found within the cytoplasm of some of the tubular cells, being
more prevalent in gonocytes than Sertoli cells (Figure 3B). It was
also present in the surface epithelium but absent in the peritubular
cells. MMP-9 was present chiefly within the testicular cords and
was also present in some of the interstitial cells and surface
epithelium (Figure 3C). Like MMP-2, MMP-9 was not observed
in the peritubular cells.
TIMP-1, TIMP-2, TIMP-3 and TIMP-4 were also immuno-
localized within the fetal testis. TIMP-1 was localized to the
cytoplasm of the interstitial cells and also within the testicular
cords, staining Sertoli cells in particular (Figure 3D). TIMP-2
was predominantly localized to the interstitium, there being
little within the cords and no immunoreactivity in the peri¬
tubular cells or surface epithelium (Figure 3E). Staining for
TIMP-3 was intense within the interstitium and was also
present although to a lesser degree in some of the peritubular
cells (Figure 3F). There was no TIMP-3 immunostaining
within the cords and surface epithelium. TIMP-4 was present
mainly in the interstitial cells but there was also strong positive
staining within the Sertoli cell and gonocyte cytoplasm (Figure
3G). It was absent from both the peritubular cells and the
surface epithelium. Immunostaining was also observed in
the vascular endothelium for MMP-1, MMP-2, MMP-9 and
TIMP-1, TIMP-2, TIMP-3 and TIMP-4 (Table II). No major
changes were seen in immunostaining for any MMP or
TIMP examined over the gestational range examined. Sections
incubated without primary antibody showed no non-specific
staining (Figure 30).
Secretion of MMP and TIMP by the fetal ovary
Analysis using zymography of culture medium conditioned by
the fetal ovary for 48 h demonstrated, in the two samples
examined, that the predominant gelatinase activity was identi¬
fied at 72 kDa molecular weight, corresponding to the latent
form of MMP-2 (Figure 1). The active form of MMP-2, which
has a molecular weight of 66 kDa, was also detected but at a
lower level. Gelatinase activity was also detectable at 92 kDa,
corresponding to latent MMP-9, and a less intense band of
activity was observed at 120 kDa, corresponding to the MMP-
Figure 3. Localization of matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in human fetal gonadal
tissue. (A) MMP-1 in fetal testis. Arrow denotes surface epithelium (ep). (B) MMP-2 in fetal testis (C) MMP-9 in fetal testis. Arrow
indicates endothelial cells (ec). (D) TIMP-1 in fetal testis. Arrow indicates peritubular cells. (E) TIMP-2 in fetal testis. Arrow denotes the
surface epithelium. (F) TIMP-3 in fetal testis. (G) TIMP-4 in fetal testis. (H) MMP-1 in fetal ovary. Inset demonstrates primordial follicles
(pf) stained with MMP-1 (I) MMP-2 in fetal ovary. Inset shows primordial follicles with staining for MMP-2 in oocyte cytoplasm.
(J) MMP-9 in fetal ovary. Inset shows oocytes stained with MMP-9. (K) TIMP-1 in fetal ovary. (L) TIMP-2 in fetal ovary. Inset shows
oocytes and rete ovarii staining with TIMP-2. (M) TIMP-3 in fetal ovary. Arrow denotes surface epithelium. (N) TIMP-4 in fetal ovary.
Arrow denotes primordial follicle. Inset shows oocyte staining for TIMP-4. (O) Representative section of fetal testis omitting primary
antibody. (P) Representative section of fetal ovary omitting primary antibody. I = intcrstitium: t = tubules: os = ovarian stroma;
o = oocyte. Scale bar represents I(K) put for panels A. 15. C and E: 30 put for panels I) and F-P; and 12 put lor insets in panels A-C.
E. G-L and N.
645
L.L.L.Robinson et al.
9-lipocalin complex. A faint band of active MMP-9 (86 kDa)
was also detected. In one sample, MMP-2 (latent and active)
and MMP-9 were identified in much smaller amounts.
A broad spectrum of TIMP activity was detected in culture
medium conditioned by the fetal ovary for 48 h by reverse
zymography (Figure 2). Three bands of gelatinase inhibitory
activity were present at 27-30 kDa (corresponding to the
molecular weight of TIMP-1, glycosylated TIMP-3 and
TIMP-4), at 24 kDa (corresponding to unglycosylated TIMP-3)
and 21 kDa (corresponding to TIMP-2). As with zymography,
one of the samples showed very low levels of TIMP activity.
localization of MMP and TIMP in the fetal ovary
Sections of fetal ovaries from 11 fetuses between 13 and 21
weeks gestation were used for analysis. Table III and Figure
3H-N and P describe and demonstrate the spatial and cellular
localization of MMP and TIMP and relative intensity of
immunostaining found. As with the fetal testis, no major or
systematic variation in immunostaining was seen for any MMP
or TIMP examined with increasing gestational age.
MMP-1 was abundantly present in the cytoplasm of the
oocytes throughout the ovarian cortex and was also localized
to some of the cells of the ovarian stroma and the surface
epithelium, although this immunoreactivity was less intense
(Figure 3H). MMP-2 was predominantly found in the oocyte
cytoplasm and was also present in some of the cells of the
surface epithelium but was absent from the ovarian stroma
(Figure 31). A similar staining pattern in the oocyte cytoplasm
and surface epithelium was found with MMP-9 (Figure 3J).
All four members of the TIMP family were also localized
within the fetal ovary. TIMP-1 was found chiefly in the
cytoplasm of the oocytes but was also present in the surface
epithelium (Figure 3K). TIMP-2 was weakly associated with
the oocyte cytoplasm but was more localized to the ovarian
stroma and was absent from the surface epithelium (Figure
3L). TIMP-3 was widely distributed, immunostaining some of
the oocyte cytoplasm, ovarian stroma and cells of the surface
epithelium (Figure 3M). Immunostaining for the TIMP-4
antibody was restricted to the oocyte cytoplasm (Figure 3N).
MMP-1, MMP-2, MMP-9 and all four TIMP were also
localized to the vascular endothelium (Table III). No immuno¬
staining was observed in the negative control (Figure 3P).
Discussion
This study demonstrates the presence of MMP-1, MMP-2,
MMP-9 and all four TIMP family members in the human fetal
ovary and testis during mid-gestation. MMP-2 appears as the
predominant gelatinase MMP secreted by the gonads, being
most abundant in its latent form. All of the TIMP family were
secreted by both the testis and ovary. These data therefore
indicate the likely involvement of MMP and TIMP during this
time of gonadal development. In the ovary, this is a period of
intense oogonial proliferation, and the time for entry of an
increasing number of oogonia into meiosis (Baker and Neal,
1974; Gondos et al., 1986). Towards the end of this period,
there is migration of granulosa cell precursors from the
mesonephros-derived ovarian stroma into the clusters of
oocytes with subsequent formation of primordial follicles
(Byskov, 1986; Motta et al., 1997; McNatty et al., 2000).
While such marked structural changes are not occurring in the
testis, the tubules having formed earlier in development, there
is continuing proliferation of the various cell types, and
marked steroidogenic activity in the fetal Leydig cells (Majdic
et al., 1998).
Using zymographic techniques, we are unable to comment
on the absolute amounts of MMP and TIMP present as they
are not quantitative, but they do allow relative intensities of
activity to be established. However, one of the ovarian samples
analysed (at 14 weeks gestation) appeared to be producing
much lower levels of MMP and TIMP than the other samples
tested. This may be due to a change in secretion levels over
gestation or to a delay in receiving the tissue after termination.
Immunolocalization does not specifically identify the cellular
site of production of these TIMP and MMP as they are secreted
and may bind to the ECM or directly to the cell; however, it
is likely that the MMP and TIMP have been directly secreted
at these sites to mediate specific functions (Vu and Werb, 2000).
The drugs used to induce termination included mifepristone and
a prostaglandin E| analogue. Mifepristone is a potent anti-
progestin and anti-glucocorticoid, which also has anti-oestro-
genic effects (Teutsch and Philibert, 1994). Although concen¬
trations of mifepristone reaching the chorionic villi are low
compared with those in serum and decidua (Wang etal., 1994),
it may have some effect on the fetal gonadal tissue, yet the
nature and extent of any such effects are currently unknown.
Exogenous prostaglandin E| is also used to induce uterine
contractions and promote cervical dilatation at termination.
Prostaglandins are involved in many aspects of normal ovarian
function and it is uncertain whether these concentrations used
in the termination procedure might cross the placenta to the
fetus and then have an effect on the fetal gonadal tissue
(Greystoke et al., 2000).
Both MMP and TIMP are likely to be involved in the tissue
remodelling that accompanies the rapid growth, differentiation
and structural changes of the fetal gonads in the second
trimester. Interactions between MMP and TIMP are probably
important in controlling both remodelling of fibrillar collagen
(by MMP-1), an important structural matrix component, and
also of collagen IV (by MMP-2 and MMP-9), a major
component of basement membranes. Thus, cells can be permit¬
ted to grow, differentiate and undergo mitosis. Cell migration
may also be allowed (Giannelli et al., 1997), as seen for
instance in the formation of primordial follicles in the ovary
that occurs at this time in development and the movement of
gonocytes from a central location within the testicular tubule
to lying adjacent to the basement membrane. MMP and TIMP
influence many cellular functions (Salamonsen, 1996; Vu and
Werb, 2000) and may play other roles within the gonads. The
interaction between a cell and its surrounding matrix, for
instance via integrins and focal adherins, is a vital regulator
of cell function (Brooks etal., 1996;Giancotti, 1997; Steffensen
et al., 1998) and studies on roles of MMP at the cell surface
have shown that they can stimulate cell proliferation through
interaction with cytokines (Edwards et al., 1996a). MMP-1,
MMP-2 and MMP-9 bind to heparan sulphate proteoglycans
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on the cell surface (Fisher et al., 1994; Yu and Woessner, 2000),
possibly preventing diffusion of the MMP and conferring a
high degree of local control for tissue remodelling, cell-matrix
interactions and local modulation of cytokine shedding or
degradation. The binding of MMP-2 and MMP-9 to heparan
sulphate proteoglycan therefore may have an effect on pro¬
cesses involving excessive tissue breakdown, such as angiogen-
esis. As we have observed vascular staining in both testis and
ovary for MMP-1, MMP-2 and MMP-9 and all four TIMP, it
is likely that these proteins are involved in angiogenesis within
the gonadal tissue (Yu and Woessner, 2000). MMP-1 may also
have another role in angiogenesis as it enhances smooth muscle
cell migration within the vessel wall by degrading collagen to
gelatin, leaving this available for the action of gelatinases such
as MMP-2 (Pilcher et al., 1997).
MMP and TIMP may also regulate cell cycle progression
or death (Boudreau et al., 1996). T1MP-3 induces apoptosis
of colon carcinoma cells (Smith el al., 1997), and in mammary
cells inhibition of MMP activity rescues cells from apoptosis
(Schedin et al., 2000). The number of germ cells within the
ovary reaches a peak at -20 weeks gestation (Baker and Neal,
1974) with a parallel increase in the number of atretic cells.
The rapid increase and subsequent loss of germ cell numbers
at this time is likely to have a major impact on the complement
of primordial follicles. The regulatory mechanisms involved
are fundamental to the determination of reproductive lifespan
but are poorly understood. The presence of MMP-1, MMP-2,
MMP-9, TIMP-1 and TIMP-4 in the oocytes suggests that
they may potentially regulate survival signals and therefore
possibly affect cell proliferation. MMP also regulate growth
factor activity by cleaving the proteins that bind them. Both
MMP-1 and MMP-2 can degrade IGFBP allowing IGF to
become active (Rajah et al., 1995; Vu and Werb, 2000). IGF,
its receptor and binding proteins are expressed in the human
ovary and have been implicated in follicular development
(Zhou and Bondy, 1993a,b). In addition, TIMP also
stimulate proliferation directly in other cell systems (Hayakawa
et al., 1994) and MMP activity and its control by TIMP
regulates activation of cytokines such as tumour necrosis factor
a (McGeehan et al., 1994) at the cell-matrix interface.
The TIMP-l-procathepsin L complex has been previously
suggested to be a potent activator of steroidogenesis in the rat
testis and is secreted by Sertoli cells (Boujrad et al., 1995).
The present data suggest that TIMP-1 is mainly localized to
the Sertoli cells within the testicular cords, thus it may play a
similar steroidogenic role in the human fetal testis.
In conclusion, this study demonstrates that MMP and TIMP
are secreted by the human fetal gonad during mid-gestation
and are localized with discrete cellular and spatial distributions
within the fetal testicular and ovarian tissue. These results
suggest that MMP and TIMP are involved in ECM remodelling
at this time. They may also play a role in paracrine regulation
of functions including germ cell proliferation by regulating
growth factor availability and action and possibly also by
regulating steroidogenesis in the testis. This study provides a
basis from which to work towards further assessment of the
functions of MMP and TIMP within the human fetal gonad
during this period of structural change and development.
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